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 ABSTRACT 
DEPLETION OF THE RNA HELICASE SKIV2L2  
IMPEDES MITOTIC PROGRESSION AND  
HISTONE MRNA TURNOVER IN  
MURINE CELL LINES 
Alexis M. Onderak 
Marquette University, 2016 
RNA surveillance via the nuclear exosome requires cofactors such as the helicase 
SKIV2L2 to process and degrade certain noncoding RNAs. This dissertation aimed to 
characterize the phenotype associated with RNAi knockdown of SKIV2L2 in two murine 
cancer cell lines: Neuro2A and P19. Skiv2l2 knockdown in Neuro2A and P19 cells 
induced changes in gene expression indicative of cell differentiation and reduced cellular 
proliferation. Analysis of the cell cycle revealed defective progression through mitosis 
following SKIV2L2 depletion. These results indicate that SKIV2L2 enhances mitotic 
progression, thereby maintaining cancer cell proliferation and preventing differentiation. 
Indeed, SKIV2L2 levels were found to be downregulated during chemically induced 
differentiation, further implicating SKIV2L2 in maintaining proliferation and 
multipotency in cancer cell lines.  
Because SKIV2L2 targets RNAs for processing and degradation via the nuclear 
exosome, it was hypothesized that with SKIV2L2 depletion, the accumulation of some 
RNA target triggers mitotic arrest. In search of such a target, RNA-seq was utilized to 
identify RNAs that were elevated in Skiv2l2 knockdown cells. SKIV2L2 depletion 
resulted in the accumulation of non-coding RNAs, intergenic RNAs, ribosomal protein 
mRNAs, and replication-dependent histone mRNAs. Given that the regulation of histone 
mRNAs is tightly linked to the cell cycle, further experiments were conducted to confirm 
SKIV2L2 targets histone mRNAs for degradation. RNA immunoprecipitation 
demonstrated direct binding between SKIV2L2 and histone mRNAs, and RNA 
degradation assays showed that the half-life of histone mRNAs doubles with SKIV2L2 
depletion. The resulting histone imbalance following loss of SKIV2L2-directed RNA 
surveillance could impede mitotic progression, resulting in mitotic defects and indirectly 
triggering differentiation
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CHAPTER I: INTRODUCTION 
1.1 RNA surveillance 
During the course of transcription and post-transcriptional processing, certain 
aberrant RNAs arise in the cell, being expressed at the wrong time or the wrong form. 
With the cell depending on the expression of coding and non-coding RNAs, several 
quality control mechanisms exist within the cell to ensure that each RNA transcript is 
expressed in the correct cell type at the proper time, localized to the appropriate 
subcellular locale, and correctly processed to aid in the function of the RNA. RNA 
surveillance directs RNA processing and degradation to prevent the detrimental 
accumulation of incorrectly processed or expressed RNAs in the cell. To accomplish the 
quality control of RNAs, RNA surveillance detects, tags, and directs RNAs to nucleases 
for processing or degradation (Andersen, 2008). While RNA surveillance mechanisms 
have been characterized, and complications in RNA surveillance are linked to disease 
states, the importance of these mechanisms in cellular processes and overall health has 
not been clearly defined. This dissertation investigates the role of RNA surveillance in 
proliferating cells and establishes which RNAs are targeted for processing and 
degradation to maintain cell health and function.   
RNA surveillance consists of multiple types of quality control mechanisms and 
protein complexes within the cell (Schmidt, 2013). Types of RNA surveillance can be 
characterized by the location and class of RNA targeted for processing and degradation. 
While similar in overall function, the detailed mechanisms behind RNA surveillance are 
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different for nuclear versus cytoplasmic RNAs and coding RNAs versus non-coding 
RNAs. Much of mRNA surveillance occurs in the cytoplasm and depends on translation 
(J Lykke-Andersen, 2014). As the ribosome translates mRNAs, nonsense mediated decay 
recognizes premature stop codons, which often arise during splicing, and degrade the 
mRNA so that it will not be translated into a potentially deleterious truncated protein 
(Chang, 2007). Other mRNA surveillance mechanisms, such as nonstop decay and no-go 
decay, trigger the degradation of transcripts that cause the ribosome to stall (J Lykke-
Andersen, 2014). Certain mRNAs utilize these pathways so that the mRNA is degraded 
under specific conditions. For example, replication-dependent histones are transcribed at 
high levels during S phase but are rapidly turned over upon entry into G2 phase 
(Marzluff, 2008). This turnover at the end of S phase has been previously linked to the 
translational machinery and the nonsense-mediated decay factor Upf1 (Kaygun, 2005). 
Researchers have found that at the end of S-phase, histone mRNAs are oligouridylated, 
and SLBP, a protein bound to the 3' stem loops of histone mRNAs, associates with the 
decay factor Lsm1 (Zhang, 2012; Mullen, 2008). As a result, the histone mRNAs are de-
capped and degraded by the exoribonuclease Xrn1 and the cytoplasmic exosome 
(Kaygun, 2005).  
Because non-coding RNAs differ from mRNAs in structure and function, non-
coding RNA surveillance requires unprocessed or aberrant RNAs to be detected, tagged, 
and directed to nucleases for processing or degradation without the assistance of 
translational machinery (Andersen, 2008). More recently, non-coding RNAs, such as 
microRNAs, long non-coding RNAs, and spurious transcripts, have been discovered to 
arise from what was previously characterized as “junk DNA.” The majority of these non-
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coding RNAs are processed in the nucleus, with many functioning in the nucleus as well. 
Because understanding how, when, and why these RNAs are degraded offers insight into 
their regulation and function, RNA surveillance mechanisms that target non-coding 
RNAs for processing and degradation within the nucleus are of particular interest and are 
highlighted in this dissertation.  
1.2 The nuclear TRAMP Complex 
In the nucleus and nucleolus, RNA surveillance centers on targeting RNAs to the 
nuclear exosome (Fig 1.1). Highly conserved, the eukaryotic nuclear exosome consists of 
Fig 1.1. Mammalian nuclear RNA surveillance. In the mammalian nucleus, RNA 
surveillance influences the turnover and processing of RNAs. Two complexes, the 
TRAMP and the NEXT complex, partner with the nuclear exosome (yellow) to target 
various classes of RNAs for degradation in the nucleolus and nucleoplasm, respectively.  
4 
 
a 9-subunit catalytically inactive core, a trimeric cap that binds RNA, and accessory 
proteins consisting of both endonucleases and exonucleases, such as Rrp44 and Rrp6 
(Lykke-Anderson, 2009). The 3'→5' exoribonucleolytic activity of the nuclear exosome 
requires a series of cofactors for preparation and delivery of RNA substrates to facilitate 
their processing and degradation (Houseley, 2006). One such complex of cofactors, the 
Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex, was first discovered in 
Saccharomyces cerevisiae (Houseley, 2006; La Cava, 2005). The yeast TRAMP complex 
consists of the non-canonical poly-A-polymerase Trf4/5p, the RNA binding protein 
Air1/2p, and the helicase Mtr4p. The TRAMP complex exists in two forms, TRAMP4 
(Trf4p/Air1/2p/Mtr4p) and TRAMP5 (Trf5p/Air1p/Mtr4p).  
While the mechanism behind TRAMP complex recognition of target RNAs 
remains elusive, the action of the TRAMP complex on such targets has been extensively 
studied (Fig 1.2). The TRAMP complex tags the 3' end of nuclear RNAs to be degraded 
with adenosines, guides those RNAs to the exosome, and then activates the 
exonucleolytic activity of the exosome (Lykke-Anderson, 2009; Houseley, 2006; La 
Cava, 2005). More specifically, Air1/2p binds RNA substrates through a series of five 
zinc knuckles, and Trf4/5p, which lacks an RNA binding domain, adenylates the RNA 
transcript (La Cava, 2005). The short A-tail added by Trf4/5p not only allows for 
exosome substrates to be distinguished from RNAs stabilized by a longer poly-A-tail 
(Andersen, 2008) but also creates a 5-6 nucleotide overhang on the 3' end that is 
preferentially bound by the helicase Mtr4p (Anderson, 2008; Jia, 2012). Mtr4p is 
necessary to unwind any secondary structure that would impede entry into the nuclear 
exosome (La Cava, 2005; Jia, 2012), and the binding of the TRAMP complex to the 
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nuclear exosome stimulates exonucleolytic activity to promote 3'end trimming or 
degradation of the transcript (Andersen, 2008). In yeast, the TRAMP complex has been 
found to be essential in RNA surveillance of several transcripts, including the turnover of 
hypomodified tRNAi
MET
 (Wang, 2007), 3' end trimming of the 5.8S rRNA (de la Cruz, 
1998) and processing of the 7S rRNA precursor (Callahan, 2009), degradation of cryptic 
unstable transcripts (CUTs) arising from heterochromatic regions (Thiebaut, 2006), and 
efficient splicing and intron degradation (Kong, 2013; Nag, 2012). 
The TRAMP complex components are found across the domain Eukarya, with 
extensive studies on their function being done in yeast, Arabidopsis, and teleost fish (La 
Cava, 2005; Lange, 2011; Cox, 2011). Recently, the homologs of the yeast TRAMP 
complex were found to be highly conserved in mammals (Fig 1.3), with the poly-A-
polymerase PAPD5 having 37% amino acid sequence identity to Trf4p in its catalytic 
domain, ZCCHC7 showing similarity to Air1p in its five zinc knuckles, and SKIV2L2 
retaining 51% amino acid sequence identity with the helicase Mtr4p (Schmidt, 2013; 
Norbury, 2011). This mammalian TRAMP complex is hypothesized to target RNAs for 
degradation and processing through adenylation, similar to its yeast counterpart. 
However, in addition to the TRAMP complex, mammalian SKIV2L2 interacts with the 
zinc knuckle protein ZCCHC8 and the putative RNA binding protein RBM7 to form the 
Nuclear Exosome Targeting (NEXT) Complex (Norbury, 2011; Lubas, 2011), which 
lacks a poly-A-polymerase and therefore must target RNAs through a unique mechanism 
(Fig 1.3). Studies suggest that the TRAMP complex’s location and RNA targets may be 
primarily nucleolar, while the NEXT complex appears to be located in the nucleoplasm 
and targets nuclear RNAs (Lubas, 2011). 
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Research focused on identifying substrates of the mammalian nuclear exosome 
has demonstrated that SKIV2L2 is necessary for the maturation of ribosomal RNA 
precursors, including 3' end trimming of 5.8S rRNA (Schilders, 2007; Lubas, 2015), and 
facilitates the degradation of PROMPTs (promoter upstream transcripts) in concert with 
the NEXT complex (Tiedje, 2014). Furthermore, PAPD5 has been shown to bind RNA 
independent of the TRAMP complex (Rammelt, 2011) and modify miRNAs in vivo to 
alter their stability (Boele, 2014). The evolution of the mammalian TRAMP complex to 
perform functions beyond those seen in yeast suggests that RNA surveillance may have 
many roles to play in multicellular organisms, particularly in coordinating changes in the 
expression of RNAs involved in mammalian development. 
 
Fig 1.2. Predicted TRAMP complex mechanism of action. The TRAMP complex is 
thought to target RNAs to the nuclear exosome in three steps: first (1), the RNA is 
bound by the TRAMP complex members, second (2), PAPD5 adenylates the 3' end of 
the RNA, and third (3), SKIV2L2 unwinds the RNA and delivers the RNA to the 
nuclear exosome. 
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1.3 SKIV2L2 functions as a helicase in RNA decay pathways 
Because the helicase SKIV2L2 plays a central role in both the TRAMP and the 
NEXT complex, it acts as the key player in mammalian nuclear RNA surveillance. 
SKIV2L2, and its yeast homolog Mtr4p, both are categorized as SF2 helicases (Johnson, 
2013). The SF2 superfamily helicases share two RecA domains that are essential for the 
core helical function (Johnson, 2013). The SF2 superfamily contains many different RNA 
and DNA helicases that vary widely based on their function in the cell and their 
mechanism of action. Despite large differences between the helicases, the SF2 
superfamily is divided into families of helicases based on structure and unwinding 
mechanism. The DExD/H helicase family consists of three types of SF2 helicases: DEAD 
box helicases, DEAH helicases, and Ski2 helicases. While SKIV2L2 and Mtr4p fall 
Fig 1.3.  Mammalian nuclear RNA surveillance requires two complexes. SKIV2L2 
functions in two known complexes: the TRAMP complex in the nucleolus and the 
NEXT complex in the nucleoplasm. Verified TRAMP RNA targets include rRNA and 
snoRNAs, while verified NEXT RNA targets include lncRNAs and PROMPTs. 
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under the Ski2 helicase category, they also share properties with other DEAD box 
helicases, making both groups of helicases relevant to understanding how SKIV2L2 
functions in nuclear RNA surveillance. (Johnson, 2013) 
DEAD-box helicases are unique from other SF2 helicases in that they contain the 
amino acid sequence DEAD (Jarmoskaite, 2011). The yeast Mtr4p and human homolog 
SKIV2L2 function similar to DEAD-box helicases, as they both have ATPase-dependent 
3'→5' RNA helicase activity (Norbury, 2011; Weir, 2010).  DEAD-box helicases bind to 
ssRNA or dsRNA tightly when bound to ATP, but as ATP is hydrolyzed to ADP, the 
affinity of the helicase for RNA decreases, and the helicase “translocates” along the RNA 
(Jarmoskaite, 2011). As ATP is bound, hydrolyzed, and released, strand separation 
occurs, coupling RNA unwinding with ATP hydrolysis. However, DEAD-box helicases 
are not very processive and only unwind or remodel short RNA duplexes (Jarmoskaite, 
2011). With both DEAD-box and Ski2 helicases, the helicase binds non-specifically to 
the sugar-phosphate backbone of the RNA, and binding specificity comes from the 
interaction of the helicase with other proteins or RNPs (Jarmoskaite, 2011). More 
specifically, Mtr4p and SKIV2L2 are classified as members of the Ski2 helicase family. 
Ski2 helicases have two additional domains, the winged helix domain and the ratchet 
domain, which along with the two RecA domains form a unique ring-like tertiary 
structure (Johnson, 2013). This unique structure allows for single stranded RNA to be fed 
through the core of the helicase. Ski2 helicases, which function primarily in RNA decay, 
are usually part of protein complexes that help mediate specific binding of RNAs 
(Johnson, 2013).  
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There are two major Ski2 family helicases, Ski2 and Mtr4p/SKIV2L2, and both 
are required for exosome activation. Both Ski2 and Mtr4p/SKIV2L2 separate RNA 
duplexes, and the resulting 3' end of the ssRNA is actively fed into the exosome as the 
helicase translocates along the RNA (Johnson, 2013). In the cytoplasm, Ski2 complexes 
with Ski3 and Ski8, and the Ski complex directs the degradation of RNAs via the 
exosome in the cytosol (Johnson, 2013). In the nucleus, Mtr4p/SKIV2L2 interacts with 
different proteins to form the TRAMP complex, common to most eukaryotes, and the 
NEXT complex found in mammals (Fig 1.3). While Ski2 does not interact directly with 
the exosome, SKIV2L2 directly binds to two nuclear exosome components in humans: 
MPP6 and PM/Scl-100 (Rrp6) (Johnson, 2013; Lubas, 2011). SKIV2L2 and the yeast 
Mtr4p both contain a distinguishing arch domain thought to facilitate this interaction 
(Johnson, 2013). In humans, this arch domain is necessary for the degradation of RNAs 
via Rrp6 but not for the degradation of RNAs via Rrp44 (Johnson, 2013). This essential 
arch domain, which is similar to that found in ribosomal proteins, results in a preference 
for binding RNA with a short 3' overhang (Jackson, 2010; Weir, 2010). Together, these 
properties define SKIV2L2 as a helicase that has uniquely evolved to unwind short 
duplexes in RNA, feed the RNA directly into the nuclear exosome, and activate the 
degradation or 3' end trimming of that RNA.  
1.4 Stem cells are maintained through a variety of mechanisms 
 This dissertation evaluates SKIV2L2, and therefore nuclear RNA surveillance, as 
a potential factor in stem cell maintenance. Before delving deeper into the role of RNA 
surveillance in stem cells, it is necessary to understand what characterizes stem cells and 
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how stem cells are maintained. Stem cells have the potential to develop into multiple cell 
lineages. Stem cells can be further classified into totipotent, pluripotent, or multipotent. 
Totipotent cells can differentiate into all embryonic and extraembryonic tissue types, 
pluripotent cells can differentiate into embryonic endoderm, mesoderm, and ectoderm 
tissues, and multipotent cells can give rise to multiple, but not all, cell types (He, 2009). 
This totipotency and pluripotency is essential during development because one fertilized 
zygote must give rise to all the cells in the body through cell division and subsequent 
differentiation. In addition to maintaining pluripotency in the developing embryo, adult 
organisms have stem cell pools, which mostly contain multipotent stem cells that produce 
new cells to replenish old cells. For example, bone marrow contains stem cells that 
produce new blood cells, and stem cells located near hair follicles produce new epithelial 
cells. These stem cells are located in particular niches, which maintain the stem cell’s 
ability to proliferate and differentiate into multiple lineages. (Morrison, 2008) 
 Various mechanisms are involved in stem cell maintenance, and each stem cell 
niche is unique. However, commonalities exist in stem cell maintenance, including cell 
signaling, transcription factors, and epigenetic factors, which work together to control the 
expression of genes necessary for self-renewal. Self-renewal means that as the cell 
divides, the cell maintains the potential to differentiate into multiple lineages. With 
asymmetric self-renewal, one cell retains pluripotency and continues to proliferate, while 
the other daughter cell leaves the stem cell niche and receives signals to differentiate into 
a specific cell type (He, 2009; Morrison, 2008). Self-renewal requires that extracellular 
signals from the niche regulate the expression of different proto-oncogenes, which 
support proliferation and pluripotency, and tumor-suppressors, which limit self-renewal 
11 
 
and protect against propagating DNA damage to daughter cells (He, 2009). The 
JAK/STAT, BMP, Wnt, Notch, CXCL12, and Hedgehog signaling pathways work in 
different stem cell niches to maintain self-renewal (Morrison, 2008). These signaling 
pathways regulate the expression of proto-oncogenes and tumor-suppressors. The most 
well-characterized instance of this is that signaling pathways regulate the expression of 
the pluripotency transcription factors Oct4, Sox2, Klf4, c-Myc, and Nanog. In turn, these 
transcription factors repress developmental genes and activate the expression of genes 
necessary for pluripotency and self-renewal (Liu, 2013a). For example, during 
reprogramming of iPSCs, Nanog directs Tet1 and Tet2 to pluripotency genes, where Tet1 
and Tet2 remove cytosine methylation to epigenetically reactivate genes necessary for 
self-renewal (Costa, 2013). In stem cells, these signaling pathways must also activate 
tumor suppressors that prevent damaged stem cells from self-renewing, such as p53 and 
Rb, which trigger cell senescence and death in response to DNA damage (Morrison, 
2008).  
 Stem cell maintenance must be tightly regulated throughout each developmental 
stage of life. Premature loss of stem cell pools negatively impacts development, and stem 
cell pools diminish as self-renewal decreases with age (He, 2009). On the other hand, 
cancer cells inappropriately express pluripotency and self-renewal factors, and some 
cancer cells take on the proliferative and multipotent nature of stem cells. In certain 
tumors, cancer stem cells express pluripotency factors like Nanog, Sox2, and Oct4, which 
drive self-renewal and tumorigenesis (Liu, 2013a). These cancer stem cells, which are 
found in mouse tumors like those that are immortalized into cell lines, approximate the 
behavior of stem cells because cancer stem cells are self-renewing, proliferative, and 
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multipotent. Therefore, understanding which factors are necessary for stem cell 
maintenance is important for the study of developmental diseases and aging-associated 
diseases, where stem cell pools may be diminished, and cancer, where cells take on stem 
cell characteristics.  
 This dissertation explores the possibility that RNA surveillance influences stem 
cell maintenance. In human cells, cytoplasmic NMD factor Upf1 must be downregulated 
during differentiation, and NMD influences both the TGF-β and BMP signaling pathways 
involved with maintaining stem cell niches and directing differentiation of daughter cells 
(Lou, 2016). However, it is unclear why nonsense-mediated decay must be 
downregulated during differentiation or if the regulation of other RNA surveillance 
pathways differs between stem cell niches and differentiated cells. This dissertation 
centers on the hypothesis that SKIV2L2-mediated RNA surveillance might also have a 
role to play in stem cell maintenance and differentiation.  
1.5 The potential role of SKIV2L2 in development 
In support of a role in stem cell maintenance and differentiation, SKIV2L2 has 
been implicated in animal development. Forward genetic screens in zebrafish identified 
SKIV2L2 as a possible factor in stem cell maintenance, as mutant zebrafish have reduced 
eye and brain size and lack the ability to regenerate melanocytes after cell ablation or 
regrow tails after surgical removal (Cox, 2011; Yang, 2007; Hultman, 2010). In the 
closely related medaka fish, Skiv2l2 mutants fail to develop the thymus or spleen 
(Iwanami, 2009), suggesting that SKIV2L2-directed RNA surveillance may be of 
significance to immune system development. In zebrafish, Skiv2l2 mRNA co-localizes 
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with the cell proliferation marker PCNA (Yang, 2007), indicating that Skiv2l2 expression 
is enhanced in actively dividing populations of stem cells. Taken together, the phenotype 
associated with loss of SKIV2L2 in fish indicates that SKIV2L2 may help maintain stem 
cell populations. In mammals, large-scale RNAi screens identified a possible correlation 
between SKIV2L2 depletion, impaired cell division, and death of embryonic stem cells 
(ES cells). However, the results of these studies were preliminary, often inconsistent, and 
not explored in depth (Fazzio, 2008; Neumann, 2010). 
Additionally, an extensive bioinformatic study used microarray data from stem 
cells before and after differentiation to determine genes in the mouse genome whose 
expression correlates with pluripotent embryonic stem cells. It was found that Skiv2l2 
falls within the top 2% of genes whose expression is positively correlated with 
pluripotent embryonic stem cells and negatively correlated with differentiated cells 
(Cinghu, 2014). Developmental downregulation of Skiv2l2 has also been observed in the 
testes where SKIV2L2 levels decline in response to testosterone during spermatogenesis 
(Osman, 2011). Because Skiv2l2 expression and function appear to be important in 
development, this dissertation focuses on discerning how SKIV2L2, and therefore RNA 
surveillance, might affect pluripotency and differentiation in mammalian cancer cell 
lines. 
 Stem cell maintenance requires that cell signaling pathways regulate the 
expression of genes necessary for pluripotency and self-renewal. During differentiation, 
the transcriptome changes so that pluripotency and proliferation genes are repressed and 
one set of cell-fate specific genes are activated (Guttman, 2011; Choi, 2013). The ability 
of the stem cell to maintain expression of pluripotency and proliferation genes while 
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repressing differentiation genes often depends on microRNAs (Wang, 2008), long 
noncoding RNAs (lncRNAs) (Guttman, 2011), and other noncoding RNAs, which may 
be targets of nuclear RNA surveillance. If these RNAs are targets of nuclear RNA 
surveillance, SKIV2L2 may help regulate their steady-state levels in the cell and 
influence stem cell maintenance and differentiation. 
1.6 Aims and Hypotheses 
Because the TRAMP and NEXT complexes target specific nucleolar and nuclear 
RNAs to the exosome (Lubas, 2011; Lubas, 2015), these RNA surveillance complexes 
also determine which RNAs persist in the cell. This notion led to the hypothesis that 
RNA surveillance may play a role in cell proliferation or pluripotency by altering the 
stability and/or processing of nuclear RNAs.  To study this, cancer cell lines, which 
consist of cancer stem cells that exhibit stem cell like properties, were used to define the 
phenotype associated with Skiv2l2 knockdown, and consequently depletion of SKIV2L2-
mediated RNA surveillance. Neuro2a (N2a) cells derived from a murine neuroblastoma 
(Nilbratt, 2009; Tremblay, 2010; Zhi, 2012) and P19 cells derived from a murine 
embryonic teratocarcinoma (Jasmin, 2010) were used to investigate the role of SKIV2L2 
in proliferation and differentiation. These mammalian cancer cell lines provide a system 
to investigate cell proliferation and model differentiation, as chemicals induce the 
differentiation of N2a cells into neurons (Nilbratt, 2009; Tremblay, 2010) and P19 cells 
into either neurons or myocytes (Jasmin, 2010; Dong, 2012). To classify the phenotype 
associated with loss of SKIV2L2-mediated RNA surveillance, both N2a and P19 cells 
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were treated with Skiv2l2 siRNA and compared to both control cells and chemically 
differentiated cells.  
1.7 Summary of Findings 
This dissertation characterizes the anti-proliferative effects associated with 
SKIV2L2 depletion and identifies RNA substrates of SKIV2L2 which could be 
responsible for mediating developmental changes. Skiv2l2 knockdown cells were found 
to exhibit changes in cell morphology and gene expression associated with cellular 
differentiation, including an increase in cell-fate specific gene expression and a decrease 
in the expression of pluripotency genes. Skiv2l2 knockdown via RNAi also reduced 
cellular proliferation, which was found to be particularly attributed to defective 
progression through mitosis.  
Little is known about the mammalian TRAMP complex are still in their infancy, 
and no previous studies have analyzed the role of SKIV2L2 in mammalian cells. By 
coupling large-scale RNA-seq with molecular techniques targeting specific RNA 
transcripts, this research defined the phenotype associated with loss of SKIV2L2 in 
mammalian cells, determined which cellular processes are controlled by RNA 
surveillance, and identified novel RNA targets of SKIV2L2. Following observation of 
mitotic arrest after SKIV2L2 depletion, RNA-seq was performed to identify RNAs 
accumulating in Skiv2l2 knockdown cells that could impede progression through mitosis. 
While previous research has uncovered non-coding RNAs targeted for processing and 
degradation by the TRAMP and NEXT complexes, this research uncovered both non-
coding and coding RNAs to be targets of nuclear RNA surveillance.  Previous classes of 
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non-coding RNAs known to be TRAMP and NEXT complex targets were investigated in 
mouse and human cells, with this research detecting miRNA 5' leader sequences 
(Dorweiler, 2014), snoRNAs (Berndt, 2012; Lubas, 2015), rRNAs (Schilders, 2007; 
Lubas, 2015), PROMPTs (Tiedje, 2014), and lncRNAs (Beaulieu, 2012) targeted by 
SKIV2L2 for degradation or processing. While non-coding RNAs represent one class of 
nuclear RNA surveillance targets, elevated levels of replication-dependent histone 
mRNAs following loss of SKIV2L2-directed RNA surveillance suggest that SKIV2L2 
mediates the turnover of certain mRNAs as well. Because histone mRNAs lack a poly-A-
tail like many non-coding RNAs (Marzluff, 2008), it reasons that the nuclear turnover of 
histone mRNAs may be similar to that seen for non-coding RNAs. While the cytoplasmic 
turnover of histones via nonsense mediated decay has been extensively studied (Kaygun, 
2005; Mullen, 2008), this dissertation presents evidence that SKIV2L2 is involved with 
nuclear turnover of histone mRNAs. SKIV2L2 directly binds histone mRNAs, as 
demonstrated through RNA immunoprecipitation (RIP), and SKIV2L2 depletion leads to 
a doubling of histone mRNA half-life. With Skiv2l2 knockdown, histone mRNAs fail to 
be properly turned over at the end of S phase, leading to a histone imbalance, which has 
previously been shown to disrupt mitosis (Singh, 2010; Meeks-Wagner, 1986; 
Günesdogan, 2014). This study presents novel findings that link RNA surveillance via 
SKIV2L2 to mammalian cellular proliferation. 
1.8 Significance of Findings 
By exploring which RNAs are targeted by SKIV2L2 for processing and 
degradation and how loss of SKIV2L2 affects cellular health, RNA surveillance was 
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found to be an integral part of maintaining cell proliferation in two murine cancer cell 
lines. While the techniques utilized are not exceptionally novel, this dissertation offers an 
in-depth characterization of SKIV2L2 function in a mammal, which has not previously 
been accomplished, and presents evidence supporting a nuclear pathway for the 
degradation of histone mRNAs, a process once thought to only occur in the cytoplasm. 
Additionally, investigating the function of the TRAMP complex in cell proliferation and 
differentiation has implicated SKIV2L2 and RNA surveillance in stem cell maintenance 
and tumor growth, with possible implications on cancer treatment, adult neurogenesis, 
and stem cell therapy.  
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CHAPTER II: DIFFERENTIATION OF MURINE CELL LINES IS 
ASSOCIATED WITH DOWNREGULATION OF SKIV2L2 EXPRESSION 
 
2.1 Introduction 
Hypothesis: Skiv2l2 is downregulated in murine cancer cell lines following chemical 
differentiation. 
 In light of a previous bioinformatic study drawing a positive correlation between 
Skiv2l2 expression and pluripotency in ES cells (Cinghu, 2014), it was hypothesized that 
Skiv2l2 was actively downregulated during differentiation. Pluripotent cells have the 
potential to differentiate into ectoderm, endoderm, or mesoderm cells and can self-renew. 
Pluripotent cells, such as ES cells and iPSCs, express a series of pluripotency factors that 
support self-renewal and a chromatin landscape that represses differentiation genes while 
still allowing for their future activation (Maden, 2007; Guttman, 2011). Pluripotency 
factors include Oct4, Sox2, Klf4, and c-Myc, which serve as transcriptional activators of 
genes necessary to maintain pluripotency and self-renewal, including genes involved in 
signaling pathways and chromatin remodeling (Takahashi, 2006). More recent studies 
have identified miRNAs and non-coding RNAs that function in maintaining pluripotency 
(Anokye-Danso, 2011). As pluripotent cells begin to differentiate, there are significant 
changes in gene expression due to epigenetic, transcriptional, and post-transcriptional 
changes. For example, a proportion of development genes in ES cells have bivalent 
promoters with both repressive (H3K27me3) and activating (H3K4me3) chromatin marks 
(Bird, 2007). Upon differentiation, genes to be expressed will retain the activating 
H3K4me3 modification, while other genes will maintain the H3K27me3 mark and be 
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silenced (Bird, 2007). These changes in gene expression also coordinate the upregulation 
of genes specific to one developmental pathway with the permanent silencing of both 
pluripotency genes and genes specific to different developmental pathways (Chen, 2008). 
This silencing can be accomplished through miRNAs, such as let-7, epigenetic silencing 
via the Polycomb complex, and CpG methylation (Bird, 2007). Given that Skiv2l2 shares 
a CpG island promoter with the neighboring gene, Dhx29, Skiv2l2 could be silenced in a 
developmental manner during differentiation.  
 In support of the hypothesis that Skiv2l2 might be associated with pluripotency 
and is downregulated during differentiation, co-immunoprecipitation studies have 
demonstrated protein-protein interactions between SKIV2L2 and the pluripotency factors 
Nanog and Sox2 (Cox, 2013; Costa, 2013; Engelen, 2011). Sox2 and Nanog activate the 
transcription of genes necessary to maintain pluripotency, and Sox2 drives the 
reprogramming of differentiated cells into induced pluripotent stem cells,  as it works in 
concert with Oct4, c-myc, and Klf4 to upregulate genes necessary for epigenetic 
reprogramming and  maintaining pluripotency (Takahashi, 2006). This establishes a 
physical connection between SKIV2L2 and pluripotency factors. Transcription factors 
like Nanog and Sox2 bind to DNA to regulate transcription and epigenetic changes, and it 
is possible that the physical interaction between Nanog, Sox2, and SKIV2L2 coordintaes 
their binding to a given location on the genome. Because RNA surveillance often occurs 
as RNAs are being transcribed, RNA surveillance factors such as SKIV2L2 bind nascent 
transcripts, tethering the RNA surveillance machinery to a specific genomic location 
(Lubas, 2015). The association between Sox2, Nanog, and SKIV2L2 could target RNA 
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surveillance factors to genes bound by Sox2 and Nanog to direct RNA turnover and 
processing events essential for pluripotency. 
Evidence also supports the hypothesis that Skiv2l2 may be regulated both 
transcriptionally and post-transcriptionally through signaling pathways known to support 
cell proliferation or trigger cell differentiation. Chromatin immunoprecipitation coupled 
with DNA sequencing (ChIP-seq) suggests that multiple transcription factors such as 
STAT3 (Hutchins, 2013; Chen, 2008), CREB (Lesiak, 2013), E2F1 (Chen, 2008), and 
Myc (Chen, 2008; Sabo, 2014) bind to the Skiv2l2 promoter, and a microarray study 
demonstrated that Skiv2l2 mRNA increases with cAMP/PKA activation (Guo, 2012). 
Additionally, the SKIV2L2 protein has been previously found to be a target of the 
MAPK-ERK signaling cascade in mice (Sundaram, 2013), and the transcription factor 
Smad4 has been shown to regulate Skiv2l2 transcription (Fei, 2010). However, seeing as 
the majority of these studies were large scale screens, the transcriptional regulation of 
Skiv2l2 by these signaling pathways was not investigated in depth. Nevertheless, these 
findings connect Skiv2l2 expression signaling pathways that control transcription in 
pluripotent and differentiating ES cells. Under specific conditions, these signaling 
pathways are activated to modulate the expression of genes involved in cell proliferation, 
pluripotency, self-renewal, and differentiation. These signaling pathways all work in 
different ways to closely regulate stem cell maintenance and properly direct 
differentiation and development. Additionally, knockdown of mir-297, a miRNA that is 
depleted in colon cancer (K Xu, 2012), has been shown to result in Skiv2l2 upregulation 
(Parikh, 2010), suggesting that Skiv2l2 is targeted by at least one miRNA necessary to 
prevent tumor cell proliferation. Given that Skiv2l2 expression has been linked to 
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proliferation or pluripotency genes, the possibility that Skiv2l2 could be downregulated 
during differentiation was investigated in the following experiments. 
2.2 Approach and Results 
To determine whether Skiv2l2 is downregulated upon differentiation, it was first 
necessary to implement a model for pluripotent cells and differentiating cells. Two 
murine cancer cell lines were selected for this purpose. Neuro2a (N2a) cells and P19 cells 
are derived from a male mouse neuroblastoma (Zhi, 2012) and a male mouse embryonic 
teratocarcinoma of the testes (Dong, 2012), respectively. Both N2a and P19 cells are 
considered to be multipotent, meaning that they can differentiate into many cell types but 
not all germ layers. Fetal bovine serum (FBS) is used in culture medium to flood N2a and 
P19 cells with various growth factors required to sustain this multipotency and keep cells 
proliferating. Over time, the components of the FBS are exhausted or degraded, leading 
to differentiation and ultimately cell death (Phillips, 2006). This requires the cells to be 
passaged periodically into new growth medium with fresh FBS. However, the natural 
ability of N2a and P19 cells to mirror the physiological differentiation of neuronal stem 
cells and embryonic stem cells allows them to serve as a model in differentiation studies. 
The expression of Skiv2l2 following differentiation was monitored following chemical 
differentiation using Western blotting to measure protein levels and quantitative RT-PCR 
(qRT-PCR) to measure mRNA steady-state levels. 
 Differentiation of N2a and P19 cells can be augmented using both serum 
starvation and chemical treatment, which result in exit from the cell cycle at G1 phase 
and terminal differentiation (Tremblay, 2010; Dong, 2012). However, terminally 
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differentiated N2a and P19 cells cannot be maintained indefinitely in culture, ultimately 
leading to differentiated cells detaching from the tissue culture plate and undergoing 
apoptosis. Nevertheless, N2a and P19 cells serve as an excellent model for studying 
changes in gene expression during differentiation. Treatment of N2a cells with all-trans 
retinoic acid (ATRA) alone induces differentiation into cholinergic neurons (Tremblay, 
2010; Sun, 2010). Additionally, serum starvation where the FBS content is reduced from 
10% to 2% of culture volume also triggers N2a cell differentiation, resulting in multiple 
neuronal cell types (Tremblay, 2010). Growing cells in 20 μM ATRA with 2% FBS 
enhances N2a cell differentiation, leading to the terminal differentiation of N2a cells into 
cholinergic neurons (Figure 2.1a). N2a cell differentiation into neurons is readily 
observed as the extension of neuronal processes. Counting the number of cells exhibiting 
axon and dendrite extension allows for easy quantification of differentiation (Sun, 2010). 
Both differentiation and pluripotency markers can also be measured to assess the extent 
of N2a cell differentiation. For example, proliferating N2a cells express Sox2 at high 
levels, while terminally differentiated N2a cells express very little Sox2 (Liu, 2013b). 
During N2a cell differentiation, the axon specific tubulin Tubb3 is upregulated (F Zhi, 
2012), and either acetylcholinesterase (ChAT) or tyrosine hydroxylase (TH) are 
upregulated for cholinergic and dopaminergic neuronal function, respectively 
(Sidiropoulou, 2008; Tremblay, 2010). 
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Fig 2.1. Cell lines as a model for differentiation. A. Treatment of N2a cells with 
retinoic acid induces differentiation into cholinergic neurons.  N2a cells plated in 2% 
FBS with 20 μM retinoic acid (ATRA) differentiate into cholinergic neurons. This 
differentiation can be monitored through changes in cell morphology and gene 
expression, where Nestin and Sox2 are downregulated during differentiation, and 
ChAT and Tubb3 are upregulated. B. P19 cells can differentiate into neurons or 
myocytes depending on treatment. P19 cells express Nanog and Sox2, which are 
downregulated during differentiation. Treatment with 20 μM ATRA leads to 
expression of the neuronal marker Tubb3, and treatment with 0.1% DMSO induces 
differentiation into myocytes. Differentiation into myotubes leads to upregulation of 
Nkx2.5, GATA4, Desmin, and Fabp3.  Expression of these markers can be used to 
measure differentiation 
A. 
B. 
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 Because cancer cell lines only approximate the behavior of stem cells, both N2a 
and P19 cells were used to study Skiv2l2 expression to ensure results were not specific to 
any one cell line. P19 cells are unique in that they are able to differentiate into a vast 
array of cell types, including cardiac, skeletal, and smooth muscle myocytes, and multiple 
neuronal cell types including cholinergic, dopaminergic, and GABAergic neurons (Dong, 
2012). Differentiation of P19 cells is accomplished through chemical treatment only, as 
serum starvation leads to apoptosis (Fig.2.1b). P19 cells can be forced to form embryoid 
bodies in solution by plating the cells on untreated, polystyrene petri dishes, and 
treatment of these embryoid bodies with 0.1% DMSO induces terminal differentiation 
into cardiomyocytes (Jasmin, 2010). P19 cells will also form embryoid bodies during 
natural differentiation on adherent tissue culture plates in certain conditions such as the 
natural depletion of FBS (Jasmin, 2010; Dey, 2010). Additionally, P19 cell treatment 
with ATRA can be utilized to force differentiation into the neuronal cell fates (Dong, 
2012). While embryoid body formation is observable, the presence of mixed cell 
populations makes quantification of differentiation based on cell morphology difficult. 
For these reasons, measuring differentiation in P19 cells depends on monitoring the 
pluripotency marker Sox2, which is downregulated during terminal differentiation into all 
cell types (Dong, 2012). Desmin, an intermediate filament specific to all muscle cell 
types, and Fabp3, a cardiac muscle marker, are upregulated in P19 cells following 
differentiation into cardiomyocytes (Choi, 2004; Dey, 2010; Zhu, 2011). The 
measurement of neuronal differentiation in P19 cells proves more difficult, as P19 cells 
express Tubb3 due to their testicular origin, and differentiation with ATRA produces an 
assortment of neuronal cell types.  It is worth noting that not all P19 cell lines retain the 
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ability to be chemically induced to differentiate into all possible cell fates due to the high 
rate of mutation in cancer cells. Pilot studies demonstrated that ATRA cannot be used to 
effectively differentiate the P19 cell line utilized in these experiments because ATRA 
treatment led to substantial cell death. For these reasons, P19 cell differentiation was 
induced by 0.1% DMSO to form cardiomyocytes. Regardless, N2a and P19 cells 
provided a model where two different cancer cell lines were differentiated into two 
different cell types: neurons and myocytes.  
 
2.2.1 N2a and P19 cells differentiate into cholinergic neurons and cardiomyocytes 
following chemical treatment 
 
To validate the established model for differentiation, the ability to differentiate 
N2a and P19 cells via chemical treatment was first confirmed. N2a cells were grown in 
either 10% FBS (control) or 20 μM ATRA with 2% FBS for forty-eight hours, at which 
point the cells were either observed for changes in cell morphology or harvested for the 
isolation of protein and RNA (Fig 2.1a). Differentiation was first verified by the 
extension of axons and dendrites.  To better visualize axons and dendrites, N2a cells were 
stained with the Neuronal Outgrowth Staining Kit®, which stained cell membranes bright 
orange and viable cell bodies green (Fig 2.2). Neuronal processes were readily seen as 
bright orange extensions on an inverted microscope. Viable cells (appearing yellow with 
the overlay of orange and green) extending neuronal processes that were two times the 
diameter of the cell body in length were considered to exhibit a neuronal cell phenotype. 
Compared to 1% of cells grown in 10% FBS, 19% of cells grown in 2% FBS, 20 μM 
ATRA were found to extend neuronal processes (two proportion Z-score= -11.8, p-
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value< 0.0001, Fig 2.2). Approximately 1% of both control and chemically differentiated 
cells were non-viable, as these cells failed to stain with the green viability marker and 
appeared red. Extending the duration of treatment to 72 hours increased the percentage of 
cells with neuronal processes in both control cells and chemically treated to 40% and 
73%, respectively. Although differentiation at 48 hours was not complete, this time point 
was selected throughout further studies. Growth past 48 hours without refreshing the 
medium resulted in significant differentiation of control cells and cell death in chemically 
treated cells. Therefore, in subsequent RNAi experiments cells were grown for 48 hours 
to limit cell death.  
To determine if chemical treatment of N2a and P19 cells induced changes in gene 
expression indicative of cell differentiation, RNA isolated from N2a cells grown either in 
10% FBS or 20 μM ATRA with 2% FBS was reverse transcribed using oligo-dT to 
generate cDNA for quantitative PCR analysis. The differentiation markers ChAT and 
Tubb3 were quantified using ActB as a control (Fig 2.3a). Compared to cells grown in 
10% FBS, ChAT and Tubb3 mRNA levels in chemically treated cells increased by 4.3 
and 1.9 fold, respectively (p-values< 0.006, 0.01), indicative of increased differentiation. 
The pluripotency marker Sox2 was found to decrease 2.8 fold in mRNA levels (p-value< 
0.002), demonstrating both an upregulation of cholinergic neuron markers and a 
downregulation of pluripotency markers following serum starvation and ATRA treatment 
(Fig 2.3a).  
P19 cells were analyzed in a similar manner following growth in either 10% FBS 
or 0.1% DMSO. Cells grown in 0.1% DMSO were found to express 3.3 fold more Fabp3 
and 2 fold more Desmin than cells grown in 10% FBS alone, as measured via qRT-PCR 
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(Fig 2.3b, p-values< 0.0001, 0.02). P19 cells grown in 0.1% DMSO also exhibited a 1.3 
fold decrease in Sox2 mRNA levels (Fig 2.3b, p-value< 0.05). Together, these results 
indicate that DMSO treatment successfully induced differentiation into cardiomyocytes, 
as demonstrated through the downregulation of Sox2 and the upregulation of Fabp3 and 
Desmin. 
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B. 
Fig 2.2. Chemical treatment of N2a cells results in the extension of neuronal processes. 
A.  Fluorescent imaging. N2a cells were stained with the neurite outgrowth staining kit, 
where green is a cell viability stain, orange is a cell membrane stain, and the overlay 
appears in yellow. Scale bar= 500 μm. Neuronal processes seen as red extensions were 
observed in cells grown in 2% FBS, 20 μM ATRA. B. Quantification of neuronal 
processes. Cells with processes (red extensions of axons and dendrites) longer than 
twice the diameter of the cell body were counted and divided by the total number of 
cells scored to obtain the percentage of cells extending neuronal processes.  
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A. 
B. 
Fig 2.3: Chemical differentiation of N2a and P19 cells results in changes in gene 
expression. A. qRT-PCR of N2a cell markers. RNA isolated from N2a cells grown in 
either 10% FBS or 2% FBS with 20 μM ATRA was reverse transcribed and 
amplified. ChAT, Tubb3, and Sox2 expression were calculated from ΔCq values and 
normalized to β-actin expression and control siRNA levels (n=3, p-values< 0.006, 
0.01, 0.002, respectively). F. qRT-PCR of P19 cell markers. RNA isolated from P19 
cells grown in either 10% FBS or 10% FBS with 0.1% DMSO was reverse 
transcribed and amplified. Performed as stated above, Fabp3, Desmin, and Sox2 
expression were calculated from ΔCq values and normalized to β-actin expression  
and control siRNA levels (n=3, p-values< 0.0001, 0.02, 0.05, respectively). 
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2.2.2 Skiv2l2 is downregulated during chemically induced differentiation of N2a and 
P19 cells 
 
 Following chemical differentiation of P19 and N2a cells, total protein and RNA 
were isolated to measure Skiv2l2 levels within the cell. With the hypothesis that Skiv2l2 
is downregulated during differentiation, it was expected that Western blotting against 
SKIV2L2 would show high levels of SKIV2L2 in cells grown in 10% FBS, with lower 
levels found in chemically treated cells. This would demonstrate that SKIV2L2 protein 
levels decrease as cells differentiate. However, lower protein levels could be attributed to 
decreased protein stability, post-transcriptional silencing, or decreased transcription. To 
ascertain at what level Skiv2l2 expression is affected, RNA extracted from the cells was 
reverse transcribed, and Skiv2l2 was amplified using qRT-PCR.  
N2a cells were first grown in either 10% FBS or 20 μM ATRA with 2% FBS to 
induce differentiation. Western blots were utilized to measure SKIV2L2 protein levels in 
both samples after 48 hours.  N2a cells induced to differentiate with ATRA and serum 
starvation were found to express approximately 50% less SKIV2L2 protein when 
compared to N2a cells grown in 10% fetal bovine serum (p-value< 0.0001, Fig 2.4a). 
Western blots were quantified using ImageJ software and normalized to ActB protein 
levels to calculate SKIV2L2/β-actin levels with 10% FBS control levels set to one. To 
investigate whether Skiv2l2 mRNA levels were also reduced in chemically differentiated 
N2a cells, qRT-PCR was used to measure the steady-state level of Skiv2l2 mRNA in 
differentiating cells. Results demonstrated that differentiation induced with ATRA and 
serum starvation downregulates Skiv2l2 mRNA levels by 4.3 fold (Figure 2.4b, p-value< 
0.003).  
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Repeating this process on P19 cells, cells were grown in either 10% FBS or 0.1% 
DMSO with 10% FBS. Differentiation of P19 cells with DMSO resulted in a significant 
86% decrease in SKIV2L2 protein levels (p-value< 0.04, Fig .2.5a) and a 3-fold decrease 
in Skiv2l2 mRNA levels (Fig.2.5b, p-value< 0.03).  This demonstrates that differentiation 
into multiple cell types, specifically cholinergic neurons and cardiomyocytes, correlates 
with a downregulation of Skiv2l2 protein and mRNA. However, because qRT-PCR 
captures the steady-state levels of Skiv2l2 mRNA, it does not distinguish between 
transcription versus post-transcriptional mechanisms that destabilize mRNAs, such as 
miRNAs or increased mRNA turnover. Therefore, although these experiments show that 
both Skiv2l2 mRNA and protein are downregulated during differentiation, they offer little 
insight into whether Skiv2l2 is transcriptionally or post-transcriptionally regulated.  
 
 
  
A.  
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Fig 2.4: Chemical differentiation of N2a cells downregulates Skiv2l2. A. Western blots 
against SKIV2L2 protein in N2a cells grown in 10% FBS or 2% FBS with ATRA. 
SKIV2L2 protein levels (118 kD) were quantified using ImageJ software and 
normalized to β-actin protein levels and 10%  FBS levels (42 kD), with p-value< 0.001. 
B. qRT-PCR of Skiv2l2 mRNA from cells grown in 10% FBS or 2% FBS with ATRA. 
Skiv2l2 expression measured via ΔCq values was normalized to β-actin expression and 
control siRNA levels. Error bars represent ±SD for n=3, p-value< 0.003. 
 
0
0.2
0.4
0.6
0.8
1
1.2
10% FBS 2% FBS, 20μM 
ATRA 
m
R
N
A
 l
e
v
e
l 
n
o
rm
a
liz
e
d
 t
o
 
A
c
tB
 
Skiv2l2
       1.0            .48 A.  
B.  
33 
 
   
  
B. 
A. 
0
0.5
1
1.5
10% FBS 10% FBS,
0.1% DMSO
m
R
N
A
 l
e
v
e
l 
n
o
rm
a
liz
e
d
 t
o
 
A
c
tB
 
Skiv2l2
Fig 2.5: Chemical differentiation of P19 cells downregulates Skiv2l2. A. Western 
blots against SKIV2L2 protein in P19 cells grown in 10% FBS or 10% FBS with 
0.1% DMSO. SKIV2L2(118 kD)  protein levels quantified via ImageJ software were 
normalized to β-actin protein levels and 10%  FBS levels (42 kD), with p-value< 
0.04. B. qRT-PCR of Skiv2l2 mRNA from cells grown in 10% FBS or 10% FBS 
with 0.1% DMSO. Skiv2l2 expression measured via ΔCq values was normalized to 
β-actin expression and 10% FBS levels. Error bars represent ±SD for n=3, p-value< 
0.03. 
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2.2.3 Serum starvation is sufficient to downregulate Skiv2l2 in N2a cells 
 Since N2a cells had been differentiated using serum starvation and retinoic acid 
treatment in the previous experiments, the next question addressed whether serum 
starvation or retinoic acid treatment alone were sufficient to downregulate Skiv2l2 in N2a 
cells. Because the previous experiment revealed that both protein levels and mRNA could 
serve as an indicator of Skiv2l2 downregulation during differentiation, Western blots 
were selected to measure SKIV2L2 protein levels. Cells were either grown in 10% FBS, 
10% FBS with 20 μM ATRA, or 2% FBS.  
 Western blotting demonstrated that cells treated with 20 μM ATRA in 10% FBA 
had SKIV2L2 protein levels similar to those seen in cells grown in 10% FBS (p-value< 
0.55, Fig 2.6a). While treatment with ATRA did not induce differentiation to the extent 
seen in cells grown in 2% FBS with 20 μM ATRA, these results seemed to suggest that 
ATRA was not sufficient to downregulate Skiv2l2, eliminating Skiv2l2 as a potential 
transcriptional target of the ATRA-retinoic acid receptor transcriptional complex. 
However, treatment with 2% FBS alone did cause around a 40% decrease in SKIV2L2 
protein (p-value< 0.01, Fig 2.6b). This demonstrated that serum starvation alone is 
sufficient to downregulate Skiv2l2 during differentiation. Due to the nature of FBS, this 
hints that a growth factor in the serum either directly or indirectly maintains Skiv2l2 
expression in N2a cells.  
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A. 
Fig 2.6: Serum starvation alone downregulated SKIV2L2. A. Western blots against 
SKIV2L2 protein in N2a cells grown in 10% FBS or 10% FBS with ATRA. SKIV2L2 
protein levels (118 kD) were normalized to β-actin protein levels (42 kD) and 10% FBS 
levels following quantification with ImageJ software (p-value> 0.05). B. Western blots 
against SKIV2L2 protein in N2a cells grown in 10% FBS with ATRA or 2% FBS. 
SKIV2L2 protein levels (118 kD) were normalized to β-actin protein levels (42 kD) and 
10% FBS levels quantified using ImageJ software, p-value< 0.01. Doublet represents 
slight protein degradation of SKIV2L2 and quantification included both bands. 
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2.2.4 Skiv2l2 downregulation during N2a cell differentiation does not occur due to 
post-transcriptional regulation via Skiv2l2’s 3'UTR 
 
Although Skiv2l2 downregulation during differentiation was demonstrated 
through Western blotting and qRT-PCR, it was unknown whether this downregulation of 
Skiv2l2 occurs transcriptionally or post-transcriptionally. Reasonably, lower steady-state 
Skiv2l2 mRNA levels measured via qRT-PCR could be attributed to a decrease in 
transcription or a decrease in mRNA stability. Because miRNAs are responsible for many 
changes in cell expression during development, it was hypothesized that Skiv2l2 could be 
directly downregulated by microRNA binding during differentiation. At least one 
miRNA, mir-297, targets Skiv2l2 (Parikh, 2010), and miRANDA prediction tools 
demonstrated multiple putative miRNA binding sites in Skiv2l2’s short 200 base pair 
3'UTR. To test whether miRNAs downregulate Skiv2l2 during differentiation, N2a cells 
were transfected with a pMirGlo vector carrying Skiv2l2’s 3’ UTR inserted at the 3' end 
of the firefly luciferase gene, allowing for firefly luciferase stability to be influenced by 
the 3'UTR of Skiv2l2 (Fig 2.7). The expression of the luciferase gene off the PGK 
promoter correlates to the bioluminescence of the luciferase protein, which was measured 
using a luminometer. 
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Fig 2.7: The pMirGlo vector provides a luminescent read-out of post-transcriptional 
regulation via the 3' UTR. The 200 bp 3' UTR of Skiv2l2 was fused to the firefly luciferase 
gene. The vector also contains an ampicillin resistance gene for bacterial selection and a 
fusion gene consisting of renilla luciferase as a transfection control. A negative control 
vector (top) was constructed where 200 bp of yeast DNA with no putative miRNA binding 
sites was cloned into the multiple cloning site, producing no change in luciferase 
expression (yellow). However, with luciferase fused to the 3' UTR of Skiv2l2 (middle) 
would be expected to decrease if miRNAs control Skiv2l2 expression. If that were true, 
luciferase would be stable in cells grown in 10% FBS (yellow). However, upregulation of 
certain miRNAs during chemical treatment with 2% FBS and ATRA would result in 
downregulation of luciferase (white, bottom). 
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To account for differences in transfection efficiency and expression of the vector, 
the bioluminescence of firefly luciferase was normalized to the bioluminescence resulting 
from renilla luciferase also expressed off the same pMirGlo vector. Cells were also 
transfected with a negative control pMirGlo vector containing firefly luciferase with 200 
base pairs of yeast Skiv2l2 DNA taken from the 5' end of the open reading frame, which 
contains no putative miRNA binding sites. If miRNAs bind to the 3' UTR of Skiv2l2 to 
downregulate its translation during differentiation, then inducing differentiation with 
serum starvation and retinoic acid treatment would upregulate those miRNAs (Fig 2.7). 
As a result, the miRNAs would repress the translation of firefly luciferase, and 
bioluminescence would decrease. Changes in luciferase translation were normalized to 
those seen in the negative control containing luciferase fused to the yeast genomic insert 
to affirm that any depression of bioluminescence was indeed due to the 3' UTR of 
Skiv2l2. This also was used to verify that miRNAs present in the multipotent, 
proliferating N2a cells did not downregulate Skiv2l2 via the 3'UTR.  
N2a cells were transfected with the following constructs under the following 
conditions: pMirGlo-yeast genomic DNA with growth in 10% FBS, pMirGlo-yeast 
genomic DNA with growth in 20 μM ATRA and 2% FBS, pMirGlo-Skiv2l2 3' UTR with 
growth in 10% FBS, and pMirGlo-Skiv2l2 3' UTR with growth in 20 μM ATRA and 2% 
FBS. Bioluminescence produced by firefly luciferase was measured using the Dual Stop 
and Glo Kit, and firefly luciferase was normalized to renilla luciferase to account for 
differences in transfection efficiency. There was no significant difference in firefly 
luciferase translation across the samples (Fig 2.8, p-values all >0.05). Because Skiv2l2’s 
3' UTR did not destabilize luciferase mRNA under both growth conditions, it was 
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concluded that the 3' UTR of Skiv2l2 does not account for the downregulation of Skiv2l2 
during N2a cell differentiation, meaning miRNAs  are not directly involved in this 
downregulation, at least through binding of the 3' UTR. 
 
  
 
Fig 2.8: The 3'UTR of Skiv2l2 does not affect gene expression. N2a cells were 
transiently transfected with either the control luc-yeast 3' UTR pMirGlo vector or the 
luc-Skiv2l2 3' UTR pMirGlo vector. Cells were then grown in either 10% FBS or 2% 
FBS with 20μM ATRA to induce differentiation. The DualGlo Stop ‘n Glo kit was 
used on harvested cells to measure luciferase expression. Firefly luciferase 
bioluminescence was normalized to renilla luciferase bioluminescence (n=3 biological 
replicates with 3 measurements per sample, p-values all> 0.05). 
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2.2.5 Multiple signaling cascades could indirectly or directly regulate Skiv2l2 
expression 
 
 Because serum starvation, but not miRNAs targeted to the 3' UTR, downregulated 
Skiv2l2, it was hypothesized that proliferative signaling cascades could transcriptionally 
upregulate Skiv2l2, and differentiation signaling cascades could downregulate Skiv2l2. 
Certain signaling pathways are known to support cell proliferation, such as the TGFβ and 
JAK/STAT signaling pathways, as improper activation of these pathways contributes to 
cancer (Chen, 2008). These pathways rely on a series of phosphorylation events that 
eventually lead to the activation of transcription factors. These transcription factors then 
activate the transcription of genes necessary for cell proliferation.  
To determine if a specific signaling cascade involved in stem cell maintenance 
and differentiation might also regulate Skiv2l2 expression, N2a cells were treated with 
small molecule inhibitors of certain kinases that lead to the phosphorylation of 
transcription factors supporting cell proliferation (Fig 2.9). ChIP data suggests that 
multiple transcription factors bind to the Skiv2l2 promoter, and these transcription factors 
are controlled by the JAK/STAT, RAS/RAF/MAPK/ERK, cAMP/PKA, and the TGF-
β/Smad/BMP4 signaling pathways (Hutchins, 2008; Chen, 2008; Sundaram, 2013; Guo, 
2012; Fei, 2010). Respectively, these signaling pathways were inactivated in N2a cells 
through growth in the presence of the following drugs: JAK inhibitor I, AZD6244, H-89, 
and SB505124 (Table 2.1). In an attempt to establish a negative control whose 
transcription factor is not predicted to bind the Skiv2l2 promoter, cells were treated with 
FAK inhibitor IV. However, FAK inhibitor IV proved to be an effective anti-cancer 
agent, inducing differentiation and cell death within hours of treatment. This failed 
41 
 
attempt demonstrated a flaw in this experimental design: the inhibition of these signaling 
pathways could downregulate Skiv2l2 directly or indirectly through crosstalk with other 
pathways that promote differentiation. For this reason, these drug treatments served as a 
putative screen for pathways that could potentially regulate Skiv2l2, and cells were 
harvested within three hours of treatment before significant differentiation could take 
place. 30 μL of the vehicle DMSO served as the control treatment.  
 
N2a cells were grown in the presence of the drugs listed in Table 2.1 to inhibit the 
binding of STAT, Myc, Creb, and Smad transcription factors to target genes (Fig 2.9). If 
the signaling pathways targeted by these drug inhibitors activate Skiv2l2 transcription, 
either directly or indirectly, then treatment with these drugs would trigger a decrease in 
Skiv2l2 levels. Skiv2l2 mRNA levels were assessed using qRT-PCR as outlined above, 
with changes in Skiv2l2 mRNA levels attributed to transcriptional control of Skiv2l2. 
Fig 2.9: Experimental design to test if signaling cascades control Skiv2l2 expression. 
Skiv2l2 levels may be maintained through a signal transduction pathway activated by a 
growth factor in FBS. Loss of those growth factors (removal of FBS) would result in 
decreased Skiv2l2 expression. To determine what signal transduction pathway might 
account for increased Skiv2l2 expression in stem cells, cells were treated with kinase 
inhibitors that target specific growth pathways. If the inhibitor blocks the pathway 
involved in maintaining Skiv2l2 expression, then Skiv2l2 expression would decrease.  
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Finally, SKIV2L2 protein levels were measured via Western blotting to confirm changes 
seen in mRNA levels. 
  
 Treatment of N2a cells with drugs resulted in mixed results that were difficult to 
replicate. This is not surprising because the effect of anti-cancer drugs on cancer cells can 
vary widely as certain cells are more or less drug sensitive (Yang, 2010). Also, anti-
cancer drugs often compromise RNA integrity, making qRT-PCR difficult (Narendrula, 
2016). Treatment with SB505124 to inhibit TGF-β signaling pathways had no effect on 
SKIV2L2 protein levels, with a slight but variable increase in Skiv2l2 mRNAs levels (Fig 
2.10a). Cells treated with AZD6244 expressed both Skiv2l2 mRNA and protein levels 
equivalent to those seen in control cells (Fig 2.10). Two drug treatments did 
downregulate Skiv2l2 mRNA and protein levels in a reproducible manner: JAK inhibitor 
I and H-89. JAK inhibitor I treatment decreased Skiv2l2 mRNA levels by 57% (Fig 
2.10a, p-value< 0.003) and SKIV2L2 protein levels by 65% (Fig 2.10b, p-value< 0.02). 
Table 2.1: Kinase inhibitors applied to N2a cells. 
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Treatment with H-89 did cause a decrease in Skiv2l2 mRNA (Fig 2.10a, 70% decrease, p-
value< 0.08) and protein (Fig 2.10b, 34% decrease, p-value< 0.07), although these results 
were not statistically significant. However, further experimentation with dosage, length 
of treatment, and increased replicates could reveal H-89 as a disruptor of Skiv2l2 
expression via PKA signaling. Previous research found that Skiv2l2 expression is 
responsive to cAMP, a PKA activator, and is downregulated following siRNA 
knockdown of PKA (Guo, 2012). While these results are suggestive that Skiv2l2 could be 
a target of the JAK/STAT and PKA signaling pathway, they are not definitive due to the 
complex effects of cancer drugs on N2a cells. Further experimentation could investigate 
Skiv2l2 transcriptional control via RNAi against STAT3 and CREB to eliminate off-
target effects. However, these experiments were not performed as they were beyond the 
scope of this study. 
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* * 
A. 
Fig 2.10: Treatment of N2a cells with JAK inhibitor I significantly downregulates 
Skiv2l2. A. qRT-PCR of Skiv2l2 mRNA from cells treated with various kinase 
inhibitors. Skiv2l2 expression measured via ΔCq values was normalized to β-actin 
expression and vehicle levels. Error bars represent ±SD for n=3. Statistically 
significant values are denoted with an asterisk (*), where p-value< 0.003, and all 
other values have p-value> 0.05. B. Western blots against SKIV2L2 protein in N2a 
cells treated with various kinase inhibitors. SKIV2L2 protein levels (118 kD) were 
normalized to β-actin protein levels (42 kD) and vehicle levels. Statistically 
significant values are denoted with an asterisk (*), where p-value< 0.02.  
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2.3 Discussion 
These experiments prove that Skiv2l2 is downregulated in both N2a and P19 cells 
following chemically induced differentiation. Decreases in SKIV2L2 can be correlated to 
decreases in Skiv2l2 mRNA. Although there is a slight discrepancy between Skiv2l2 
mRNA and protein levels, this is predicted to be due to differences in experimental 
methods or the high stability of SKIV2L2 protein when in complex with other RNA 
surveillance components. Because the 3' UTR of Skiv2l2 does not destabilize transcripts 
during differentiation, Skiv2l2 is not likely to be regulated by miRNAs and instead could 
be transcriptionally downregulated during differentiation. In support of this hypothesis, 
ChIP studies conducted in other laboratories show the binding of multiple proliferative 
transcription factors to the Skiv2l2 promoter (Hutchins, 2008; Chen, 2008; Sundaram, 
2013; Guo, 2012; Fei, 2010). Removing growth factors contained in FBS and inhibiting 
JAK kinases that support proliferation both resulted in the downregulation of Skiv2l2. 
Together, this suggests that transcription factors activate the expression of Skiv2l2 in 
proliferative N2a cells and that Skiv2l2 levels decline as these transcription factors are 
inactivated during differentiation (Fig 2.11).  
These findings offer an in-depth analysis of Skiv2l2 expression using molecular 
techniques. While previous studies used bioinformatics to correlate lower Skiv2l2 levels 
with cell differentiation, the experiments outlined above demonstrate that Skiv2l2 is 
downregulated at the transcriptional level during the chemically induced differentiation 
of two murine cell lines into two different cell types. Confirming that Skiv2l2 is 
downregulated during differentiation establishes a temporal link between RNA 
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surveillance and development, meaning that RNA surveillance activity may change in 
response to developmental changes. The finding that Skiv2l2’s expression changes in 
during differentiation prompts questions into its role in development, namely why Skiv2l2 
expression is elevated in pluripotent, proliferative cells, how Skiv2l2 expression changes 
after differentiation, and how RNA surveillance is maintained in differentiated cells with 
lower levels of SKIV2L2. Interestingly, analysis of expression shows a high level of 
SKIV2L2 in immune cells (Iwanami, 2009), hinting at a possible correlation between 
immune cell proliferation and nuclear RNA surveillance.  
Skiv2l2 expression changes have been linked to different disease states. Skiv2l2 
expression is upregulated in the blood serum of amyotrophic lateral sclerosis patients 
(Baciu, 2012), and RNAi screens have determined that Skiv2l2 is a metastatic-essential 
gene in breast cancer, as its knockdown impairs cancer cell metastasis (Wang, 2012). In 
light of these studies, establishing that Skiv2l2 is downregulated during differentiation 
could contribute to a better understanding of how RNA surveillance contributes to these 
diseases. Potentially, future studies on Skiv2l2 could focus on utilizing high levels of 
Skiv2l2 as a diagnostic marker in cancer and other proliferative diseases.  
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Fig 2.11: Cells downregulate Skiv2l2 as they differentiate. Following chemically 
induced differentiation, Skiv2l2 mRNA and protein levels drop. Given that this 
reduction in SKIV2L2 also occurs with inhibition of JAK/STAT growth signaling, it 
can be concluded that factors that maintain cells in their proliferative, undifferentiated 
state also promote Skiv2l2 expression. 
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CHAPTER III: KNOCKDOWN OF SKIV2L2 VIA RNAI ENHANCES P19 CELL 
AND N2A CELL DIFFERENTIATION 
 
3.1 Introduction 
Hypothesis: RNAi knockdown of Skiv2l2 promotes P19 and N2a cell differentiation  
 Upon observation that chemically induced differentiation in N2a and P19 cells 
leads to the downregulation of Skiv2l2, it was hypothesized that low levels of SKIV2L2 
might promote differentiation. In support of this hypothesis, RNA surveillance 
mechanisms have been previously shown to impact differentiation in both yeast and 
murine cells (Hiriart, 2011; Tinguely, 2012). In Schizosaccharomyces pombe, the Mmi1 
RNA surveillance machinery, which includes the nuclear exosome component Rrp6, 
mediates the degradation and RNAi-directed silencing of transcripts that direct sexual 
differentiation. To prevent the expression of sexual differentiation genes during 
vegetative growth, Mmi1 recruits the RNA-induced transcriptional silencing complex 
(RITs) to loci that drive sexual differentiation, leading to the formation of 
heterochromatin and silencing of these regions. During sexual differentiation, this 
repression is relieved to allow yeast to express genes necessary for meiosis. (Hiriart, 
2011). This provides one example where RNA surveillance helps regulate changes in 
gene expression during differentiation.  
In addition to RNA surveillance preventing premature sexual differentiation in 
yeast, mRNA surveillance has been found necessary to promote proper differentiation in 
murine immune cells. During B-cell differentiation, the production of diverse Ig 
transcripts depends on error-prone V(D)J recombination, which often results in premature 
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stop codons. These nonsense Ig transcripts accumulate in primary B cells, but the 
increased efficiency of nonsense-mediated decay (NMD) pathways during B cell 
activation results in the degradation of these transcripts and promotes terminal 
differentiation (Tinguely, 2012). Furthermore, NMD guided by Smg6 has been found to 
be necessary to downregulate the pluripotency factor c-Myc, making NMD essential for 
the differentiation of murine embryonic stem cells and iPSCs (T Li, 2015).  
While mRNA surveillance mechanisms have dissimilar effects on differentiation 
in yeast and mice, the established link between mRNA surveillance and differentiation 
lends credence to the hypothesis that nuclear RNA surveillance may also play a role in 
cell differentiation. Converse to how increased NMD activity is necessary to enhance 
differentiation in mouse cells, the timing of Skiv2l2 downregulation suggests that high 
levels of nuclear RNA surveillance activity might prevent differentiation. SKIV2L2 and 
nuclear RNA surveillance have been primarily implicated in the processing and turnover 
of non-coding RNAs. Given that non-coding RNAs, such as miRNAs and lncRNAs, play 
an important role in mammalian pluripotency and stem cell maintenance (Meza-Sosa, 
2014; Ghosal, 2013), it reasons that TRAMP-mediated RNA surveillance could regulate 
the steady-state levels of these non-coding RNAs involved with pluripotency. In stem 
cells, SKIV2L2-mediated RNA surveillance might to target non-coding RNAs that 
function in pluripotency or differentiation to the nuclear exosome for processing and 
turnover. Loss of SKIV2L2-mediated RNA surveillance could cause these pluripotency 
and differentiation RNAs to aberrantly accumulate, triggering changes in differentiation.  
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3.2 Approach and Results 
3.2.1 RNAi knockdown reduces SKIV2L2 levels to negligible amounts in N2a and 
P19 cells 
 
To test the hypothesis that Skiv2l2 downregulation promotes differentiation, 
experimentation began by using RNAi to reduce Skiv2l2 levels in both N2a and P19 cells. 
Following transfection with siRNA ID #177475 complementary to Skiv2l2 sequence 
(Skiv2l2 siRNA), western blotting and qRT-PCR were used to confirm knockdown of 
Skiv2l2 levels.  When compared to N2a cells transfected with non-targeting control 
siRNA, N2a cells transfected with Skiv2l2 siRNA expressed 97% less SKIV2L2 protein 
(p-value< 0.0004, Fig 3.1a). The knockdown of Skiv2l2 mRNA levels was confirmed via 
qRT-PCR, where Skiv2l2 mRNA levels normalized to the expression of β-Actin (ActB) 
showed that Skiv2l2 siRNAs reduced Skiv2l2 mRNA levels by 86% (Fig  3.1b, p-value< 
0.008). Skiv2l2 knockdown was repeated in P19 cells, although this knockdown was 
slightly less efficient than in N2a cells. RNAi against Skiv2l2 in P19 cells led to a 70% 
reduction in SKIV2L2 protein levels compared to control siRNA treated cells when 
measured through western blotting (p-value< 0.0001, Fig 3.2a). SKIV2L2 protein levels 
could be consistently reduced by 70-80%, with a consistent 87% decrease in Skiv2l2 
mRNA levels (Fig 3.2b, p-value< 0.01).  
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Fig 3.1: Verification of Skiv2l2 knockdown in N2a cells. A. Western blots against 
SKIV2L2 protein in cells transfected with non-targeting control siRNA or Skiv2l2 
siRNA. N2a cells transfected with siRNA were grown in 10% FBS. SKIV2L2 protein 
levels (118 kD) were normalized to β-actin protein levels and control siRNA levels (42 
kD), p-value< 0.004. B. qRT-PCR of Skiv2l2 mRNA from N2a cells transfected with 
non-targeting control siRNA or Skiv2l2 siRNA. Skiv2l2 expression measured via ΔCq 
values was normalized to β-actin expression and control siRNA levels. Error bars 
represent ±SD for n=3, p-value< 0.0080. 
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Fig 3.2. Verification of Skiv2l2 knockdown in P19 cells. A. Western blot against 
SKIV2L2 protein in cells transfected with non-targeting control siRNA or Skiv2l2 
siRNA. P19 cells transfected with siRNA were grown in 10% fetal bovine serum. 
SKIV2L2 protein levels (118 kD) were normalized to β-actin protein levels and 
control siRNA levels (42 kD), p-value< 0.0001. B. qRT-PCR of Skiv2l2 mRNA 
from P19 cells transfected with non-targeting control siRNA or Skiv2l2 siRNA. 
Skiv2l2 expression measured via ΔCq values was normalized to β-actin expression 
and control siRNA levels (error bars represent ±SD for n=4, p-value< 0.01). 
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3.2.2 SKIV2L2 depletion enhances morphological changes consistent with 
differentiation  
 
Initial observations revealed that following treatment with siRNAs directed 
against Skiv2l2, N2a cells failed to grow to 100% confluency, unlike N2a cells treated 
with the non-targeting control siRNA. Further inspection revealed increased extension of 
axons and dendrites following SKIV2L2 depletion, hinting that SKIV2L2 may play a role 
in maintaining cancer cell proliferation or preventing differentiation. These observations 
led to experiments to characterize the phenotype associated with Skiv2l2 knockdown in 
regards to increased cell differentiation. 
Because N2a cell differentiation is readily visualized by the formation of axons 
and dendrites, N2a cells transfected with either control siRNA or Skiv2l2 siRNA were 
analyzed using an inverted microscope to better visualize axons and dendrites stained 
with the Neurite Outgrowth Staining Kit® (Fig 3.3a). Neuronal processes were readily 
seen as bright orange following staining of the cell membrane, and cells extending 
processes two times the diameter of cell body were considered to exhibit a neuronal cell 
phenotype. Because cell morphology can be quantified to reflect the extent of N2a cell 
differentiation, an increase in cells extending neuronal processes following Skiv2l2 
knockdown would indicate enhanced terminal differentiation upon SKIV2L2 depletion. 
Cells were counted and scored based on the extension of neuronal processes.  
Accordingly, Skiv2l2 knockdown resulted in a 20% increase in the number of cells 
extending long neuronal processes over control cells (two-proportion Z-score= -14.3, p-
value< 0.0001, Fig 3.3b). This increase in neuronal phenotype following Skiv2l2 
knockdown suggests that loss of SKIV2L2 enhances the differentiation of N2a cells into 
B. 
A. 
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neurons. P19 cell differentiation is not easily quantified by morphological changes, as 
P19 cells grow in clusters and differentiate into multiple cell types. However, Skiv2l2 
knockdown was qualitatively observed to increase embryoid body formation. Embryoid 
body formation occurs in response to DMSO or cellular senescence and correlates with 
increased differentiation into muscle tissue (Jasmin, 2010). The increase in the 
appearance of embryoid bodies with SKIV2L2 depletion is consistent with P19 cell 
differentiation into a variety of myocytes, but it is not a reliable marker for differentiation 
as it occurs under various conditions. 
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Fig 3.3: Skiv2l2 knockdown cells extend neuronal processes. A. Fluorescent imaging. 
N2a cells transfected with control or Skiv2l2 siRNA were stained with the neurite 
outgrowth staining kit, where green is a cell viability stain, orange is a cell membrane 
stain, and the overlay appears in yellow. Scale bar= 250 μm. Neuronal processes seen as 
red extensions were observed. B. Quantification of neuronal processes. Three random 
fields of 300 cells were selected and counted for each treatment. Cells with processes 
longer than twice the diameter of the cell body were counted and divided by the total 
number of cells scored to obtain the percentage of cells extending neuronal processes. 
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3.2.3 Gene expression changes in Skiv2l2 knockdown cells reflect increased 
differentiation 
 
While morphological changes were consistent with enhanced differentiation 
following Skiv2l2 knockdown, it was also necessary to establish that SKIV2L2 depletion 
induces changes in gene expression indicative of differentiation. In both N2a and P19 
cells, differentiation can be characterized by an upregulation of differentiation markers 
and a downregulation of pluripotency markers. As N2a cells differentiate, genes specific 
to neurons, such as ChAT and Tubb3, are transcribed, while pluripotency genes such as 
Sox2 and Nestin are silenced (Zhi, 2012; Tremblay, 2010; Liu, 2013b). An increase in 
ChAT and Tubb3 transcripts, coupled with a decrease in the pluripotency transcripts 
Sox2 and Nestin would reflect cell differentiation following SKIV2L2 depletion.  
Due to the ability of P19 cells to form cardiac muscle, skeletal muscle, and 
various neurons (Dong, 2012; Jasmin, 2010), the phenotype of P19 cells following 
SKIV2L2 depletion could only be examined through qRT-PCR of cardiac myocyte 
markers and pluripotency markers, as cell morphology is not a reliable measurement of 
differentiation into multiple cell types. Gene transcripts selected to screen for 
differentiation included the cardiac muscle transcription factors GATA4 and Nkx2.5 
(Choi, 2004), fatty-acid binding protein 3 (Fabp3) specific to cardiac muscle ( Zhu, 
2011), and the intermediate filament Desmin expressed in all muscle cell types (Dey, 
2010). High levels of the transcription factors Nanog (Zhu, 2011) and Sox2 (Dong, 2012) 
characterize P19 cell pluripotency (Xie, 2010). While P19 cells can also differentiate into 
neurons, the neuronal cell fate was not examined due to the inability to drive P19 cell 
differentiation using retinoic acid, suggesting that the P19 cell line utilized in these 
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studies has not retained the ability to differentiate into neurons. However, increased 
levels of GATA4, Nkx2.5, Fabp3, and Desmin would indicate P19 cell differentiation 
into myocytes following Skiv2l2 knockdown, and a decrease in Nanog and Sox2 would 
reflect a loss of pluripotency (Xie, 2010).  
qRT-PCR was performed on total RNA isolated from N2a cells transfected with 
control siRNA or Skiv2l2 siRNA, and ChAT, Tubb3, Sox2, and Nestin mRNA expression 
was quantified relative to ActB. Following Skiv2l2 knockdown, Tubb3 expression 
increased 2.0 fold (p-value< 0.048), and ChAT mRNA levels increased 3.2 fold above 
those levels seen in control cells (p-value< 0.0001) (Fig 3.4a). This increase in Tubb3 and 
ChAT mRNA levels, representative of axon structure and function, is consistent with the 
enhanced neuronal cell morphology in Skiv2l2 knockdown cells. Furthermore, the 
expression of pluripotency markers Nestin and Sox2 was found to exhibit a 2.97 fold 
decrease (p-value< 0.03) and a 2.98 fold decrease (Fig 3.4b, p-value< 0.01), respectively, 
in Skiv2l2 knockdown cells when compared to control siRNA treated cells. The increase 
in neuronal cell morphology, elevated Tubb3 and ChAT expression, and decrease in Sox2 
and Nestin indicate that SKIV2L2 depletion results in a loss of multipotency and enhance 
cell differentiation in N2a cells.  
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Fig 3.4: N2a cells exhibit changes in gene expression indicative of differentiation 
following Skiv2l2 knockdown. A. qRT-PCR of Neuronal Differentiation Markers. 
RNA isolated from N2a cells transfected with either non-targeting control siRNA 
or Skiv2l2 siRNA was reverse transcribed and amplified. Tubb3 and ChAT 
expression were calculated from ΔCq values and normalized to ActB expression 
and control siRNA levels (error bars represent ±SD, n=3, p-values< 0.05, 0.0001). 
B. qRT-PCR of Pluripotency markers Nestin and Sox2. Performed as stated above, 
Nestin and Sox2 expression were calculated from ΔCq values and normalized to 
ActB expression and control siRNA levels(error bars represent ±SD for n=3, p-
values< 0.03, 0.01). 
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 Following Skiv2l2 knockdown, both GATA4 and Nkx2.5 mRNA levels increased 
3.9 fold above those found in control P19 cells (Fig 3.5a, p-values< 0.0008, 0.008, 
respectively). Fabp3 mRNA levels were elevated 1.8 fold (p-value< 0.02), and Desmin 
mRNA levels increased 2.6 fold (p-value< 0.04) following SKIV2L2 depletion (Fig 
3.5b). Overall, the expression pattern after Skiv2l2 knockdown in P19 cells indicates 
enhanced differentiation into cardiomyocytes. Downregulation of the pluripotency 
transcription factors Nanog by 2.3 fold (p-value< 0.04) and Sox2 by 50 fold (p-value< 
0.00001), respectively, denotes a shift in P19 cells from multipotent to differentiated 
following Skiv2l2 knockdown (Fig.3.5c). Therefore, SKIV2L2 depletion promotes 
differentiation into both neurons in N2a cells and cardiac myocytes in P19 cells. 
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Fig 3.5: P19 cells exhibit changes in gene expression indicative of myocyte differentiation 
following Skiv2l2 knockdown. qRT-PCR of Myocyte Differentiation Markers. RNA 
isolated from P19 cells transfected with either non-targeting control siRNA or Skiv2l2 
siRNA was reverse transcribed and amplified. GATA4 and Nkx2.5 (A) and Fabp3, 
Desmin (B)expression were calculated from ΔCq values and normalized to ActB 
expression (error bars represent ±SD for n=3, p-values< 0.0008, 0.008, 0.02, 0.04). Sox2 
and Nanog (C) pluripotency marker expression levels were calculated as stated above 
(error bars represent ±SD for n=3, p-values< 0.04, 0.0001).  
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3.2.4 SKIV2L2 depletion does not restrict differentiation to one cell type 
To see if SKIV2L2 is involved with repressing any one cell-fate, the cell fates in 
the population of Skiv2l2 knockdown cells were monitored. If SKIV2L2 depletion results 
in differentiation into a single preferred cell fate, SKIV2L2 may be involved in repressing 
particular differentiation pathways (Fig 3.6). N2a cells have the ability to differentiate 
into both cholinergic neurons that express ChAT (Niblratt, 2009; Tremblay, 2010; 
Sidiropoulou, 2008) and dopaminergic neurons that express tyrosine hydroxylase (TH)  
(Tremblay, 2010; Sidiropoulou, 2008) . Retinoic acid treatment induces differentiation 
into cholinergic neurons, while dopaminergic neurons are produced following treatment 
with dibutyryl cyclic adenosine monophosphate (Tremblay, 2010; Sidiropoulou, 2008). 
To determine if SKIV2L2 depletion promotes differentiation into cholinergic neurons, 
dopaminergic neurons, or both cell types, qRT-PCR was performed to measure the 
relative abundance of ChAT and TH. As controls, cells were treated with control siRNA 
or ATRA, which were expected to trigger no differentiation and differentiation into 
cholinergic neurons, respectively. Skiv2l2 knockdown cells were grown in either 10% 
FBS or 10% FBS supplemented with ATRA (which was not found to significantly alter 
SKIV2L2 levels). 
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Fig 3.6: Schematic of N2a cell differentiation. N2a cells can differentiate into 
cholinergic or dopaminergic neurons depending on chemical treatment. However, 
SKIV2L2 depletion may not direct differentiation into any one cell fate. To assess 
whether Skiv2l2 knockdown promotes differentiation in general or differentiation 
into a single cell fate, qRT-PCR will be used to measure TH (dopaminergic marker) 
and ChAT (cholinergic marker) mRNA levels. 
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qRT-PCR was employed to measure ChAT and TH mRNA levels among the cell 
population following either 20 μM ATRA treatment or Skiv2l2 knockdown to assess the 
fates of differentiated cells. As expected, ATRA treatment alone caused a 4.2 fold 
increase in ChAT mRNA levels, with a 3.2 fold decrease in TH mRNA levels (Fig 3.7, p-
value< 0.0001). This confirmed that ATRA drives N2a cell differentiation toward the 
cholinergic fate and away from the dopaminergic fate. However, in Skiv2l2 knockdown 
cells, ChAT mRNA levels were elevated as previously described, but no decrease in TH 
was observed compared to control cells (Fig 3.7, p-value< 0.7). This suggests that 
following Skiv2l2 knockdown, cells express both ChAT and TH, representing a pool of 
differentiated cells with mixed cell fates. Treating Skiv2l2 knockdown cells with ATRA 
caused a significant 10 fold increase in ChAT expression (Fig. 3.7, p-value< 0.001), with 
a 1.2 fold decrease in TH levels (Fig. 3.7, p-value< 0.03). This effect suggests that 
treating Skiv2l2 knockdown cells with ATRA restricts cells to differentiate into 
cholinergic neurons. Taken together, SKIV2L2 depletion alone does not drive 
differentiation into any one neuronal cell type. Instead, Skiv2l2 knockdown cells appear 
to be poised to differentiate into multiple lineages, and differentiation can be directed 
down a certain pathway with chemical treatment.  
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Fig 3.7: N2a cells express both ChAT and TH following Skiv2l2 knockdown. A. qRT-
PCR of the cholinergic neuron marker ChAT. RNA isolated from N2a cells transfected 
with either non-targeting control siRNA or Skiv2l2 siRNA was reverse transcribed and 
amplified. ChAT expression was calculated from ΔCq values and normalized to ActB 
expression and control siRNA levels (error bars represent ±SD for n=3). ATRA, 
Skiv2l2 siRNA, Skiv2l2 siRNA with ATRA all show statistically significant changes 
(p-values< 0.05). B. qRT-PCR of the dopaminergic neuron marker TH. TH expression 
was calculated from ΔCq values and normalized to ActB expression and control siRNA 
levels (error bars represent ±SD for n=3). Statistically significant changes with ATRA 
and Skiv2l2 siRNA, ATRA treatment (p-values< 0.0001, 0.03). 
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3.2.5 Differentiation cannot be directly attributed to the loss of the TRAMP or 
NEXT complexes 
 
 After discovering that Skiv2l2 was downregulated during differentiation and 
lower levels of SKIV2L2 enhance differentiation into multiple cell types, 
experimentation focused on deciphering whether the function of SKIV2L2 in the 
TRAMP complex or the NEXT complex served to block differentiation. To address this 
question, the TRAMP complex member PAPD5 and NEXT complex member ZCCHC8 
were each knocked down using siRNA. Differentiation was then defined through 
morphological and gene expression changes as outlined previously. If the TRAMP 
complex prevented cell differentiation, it was predicted that PAPD5 depletion would 
replicate the enhanced differentiation phenotype seen with Skiv2l2 knockdown. 
Conversely, if the NEXT complex prevented differentiation, then ZCCHC8 depletion 
would enhance differentiation. It is also possible to get different phenotypes when 
knocking down different complex members because different proteins within the 
complex have different functions. For example, the adenylation of TRAMP targets has 
been shown to be nonessential in targeting certain RNAs to the exosome (Schilders, 
2007), PAPD5 adenylates miRNAs independent of the TRAMP complex (Rammelt, 
2011), and the role of ZCCHC8 in the NEXT complex is not well characterized, as all 
three components (Rbm7, Skiv2l2, and Zcchc8) have RNA binding capabilities. Given 
this, it was possible that PAPD5 and ZCCHC8 depletion could have no effect on 
differentiation or influence differentiation in a way distinct from SKIV2L2 function. 
After testing two commercially available antibodies against PAPD5 with no success, 
knockdown efficiency was measured via qRT-PCR for both Papd5 and Zcchc8, as 
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mRNA levels were previously found to be comparative to protein levels following 
Skiv2l2 knockdown. Due to reduced transfection efficiency in P19 cells, RNAi against 
Papd5 and Zcchc8 was performed in N2a cells. qRT-PCR was used to verify knockdown 
efficiency, and Papd5 and Zcchc8 mRNA levels were each reduced by 85% and 55%, 
respectively (Fig. 3.8, p-values< 0.05). Following RNAi treatment, differentiation was 
measured as previously outlined.  
 Papd5 knockdown cells were visualized using the same neuron outgrowth 
staining kit, and increased neuronal cell morphology was observed, with a 10% increase 
in cells extending neuronal processes (two proportion Z-score=-8.3, p-value< 0.05, Fig 
3.9a,b). The mRNA levels of differentiation markers were quantified using qRT-PCR 
(Fig. 3.9c). PAPD5 depletion resulted in a 2.5 fold increase in ChAT mRNA levels (p-
value< 0.02) and a 1.5 fold increase in Tubb3 mRNA levels (p-value< 0.001). These 
results appear to indicate that PAPD5 depletion replicated the phenotype observed with 
Skiv2l2 knockdown.   
However, Zcchc8 knockdown cells were also characterized by a slight but 
insignificant increase in ChAT, Tubb3, and TH (Fig 3.10a, p-values< 0.20, 0.06, 0.080, 
respectively), with a statistically significant 3.6 fold decrease in Sox2 and a 2.7 fold 
decrease in Nestin (Fig 3.10b, p-values< 0.002, 0.02). This led to the conclusion that 
either loss of the TRAMP complex or loss of the NEXT complex could trigger reduced 
pluripotency, but that loss of ZCCHC8 alone does not promote terminal differentiation 
into neurons to the same extent seen in Papd5 and Skiv2l2 knockdown cells. 
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Fig 3.8: Verification of Papd5 and Zcchc8 knockdown in N2a cells. A. qRT-PCR of 
Papd5. RNA isolated from N2a cells transfected with either non-targeting control 
siRNA or Papd5 siRNA was reverse transcribed and amplified. Papd5 expression was 
calculated from ΔCq values and normalized to ActB expression and control siRNA 
levels (error bars represent ±SD for n=3, p-value< 0.05). B. qRT-PCR of the Zcchc8. 
Zcchc8 expression was calculated from ΔCq values and normalized to ActB expression 
and control siRNA levels (error bars represent ±SD for n=3, p-value< 0.05). 
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Fig 3.9: Papd5 knockdown induces N2a cell differentiation. A. Fluorescent 
imaging. N2a cells stained with the neurite outgrowth staining kit, where green is 
a cell viability stain, orange is a cell membrane stain, and the overlay appears in 
yellow. Scale bar = 250 μm. Neuronal processes seen as red extensions were 
observed following Papd5 knockdown. B. Quantification of neuronal processes. 
Cells extending neuronal processes longer than twice the diameter of the cell 
were counted for both samples. C. qRT-PCR of differentiation markers ChAT 
and Tubb3. RNA isolated from N2a cells transfected with either non-targeting 
control siRNA or Papd5 siRNA was reverse transcribed and amplified. ChAT and 
Tubb3 expression were calculated from ΔCq values and normalized to ActB 
expression  and control siRNA levels (error bars represent ±SD for n=3, p-
values< 0.02, 0.001).  
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Fig 3.10: Zcchc8 knockdown reduces pluripotency in N2a cells. A. qRT-PCR of 
differentiation markers. RNA isolated from N2a cells transfected with either non-
targeting control siRNA or Zcchc8 siRNA was reverse transcribed and amplified. 
ChAT, Tubb3, and TH expression were calculated from ΔCq values and normalized 
to ActB expression and control siRNA levels (error bars represent ±SD for n=3, p-
values>0.05). B. qRT-PCR of pluripotency markers. Sox2 and Nestin expression 
were calculated from ΔCq values and normalized to ActB expression and control 
siRNA levels (error bars represent ±SD for n=3), p-values< 0.002, 0.02. 
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In an attempt to explain this result, the expression of Skiv2l2 was examined in 
Papd5 and Zcchc8 knockdown cells. Western blots demonstrated that Papd5 knockdown 
resulted in a 42% decrease in SKIV2L2 protein levels (p-value< 0.002, Fig 3.11a). In 
agreement with these results, Papd5 knockdown caused a 43% reduction in Skiv2l2 
mRNA levels (Fig.3.11b, p-value< 0.001). This reflects about a 50% destabilization of 
SKIV2L2 following PAPD5 depletion, a member of the TRAMP complex. Conversely, 
Papd5 mRNA levels remained stable following Skiv2l2 knockdown (p-value< 0.52). 
However, Zcchc8 knockdown caused a slight but insignificant 1.7 fold increase in 
SKIV2L2 levels (Fig 3.11a, p-value< 0.2). SKIV2L2 levels remain stable following 
Zcchc8 knockdown, suggesting that the expression of at least one NEXT complex 
component does not affect Skiv2l2 expression.   
 Given that both Zcchc8 and Papd5 knockdown impacted differentiation and 
multipotency, the differentiation phenotype associated with SKIV2L2 depletion cannot 
be directly attributed to its function in either the TRAMP or NEXT complexes. It is 
possible that SKIV2L2 could influence differentiation through either the TRAMP or 
NEXT complex, or neither, but the redundancy and intricate relationships between 
nuclear surveillance components make it difficult to decipher which complex is involved. 
One way to address this would be to look at phenotypes following knockdown of 
different combinations of nuclear RNA surveillance proteins. For example, a Papd5 and 
Zcchc7 double knockdown would target the TRAMP complex, while a Rbm7 and Zcchc8 
double knockdown would target the NEXT complex. Following both single and double 
knockdown experiments, the phenotype could be observed and compared to that seen 
with Skiv2l2 knockdown. Finally, RNA-sequencing would identify RNAs accumulating 
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under each condition to see which RNAs are targeted by the NEXT complex, the 
TRAMP complex, or SKIV2L2 alone. 
 
 
 
 
 
 
 
 
A. 
Fig 3.11: Skiv2l2 expression decreases following Papd5 knockdown. A. Western blots 
against SKIV2L2 protein in cells transfected with non-targeting control siRNA, Skiv2l2 
siRNA Papd5 siRNA, or Zcchc8 siRNA. N2a cells transfected with siRNA were grown 
in 10% FBS or 2% FBS, 20μM ATRA. SKIV2L2 protein levels (118 kD) were 
normalized to β-actin protein levels and control siRNA levels (42 kD). Experiment was 
run on two separate gels. B. qRT-PCR of Skiv2l2 mRNA from cells transfected with 
non-targeting control siRNA or Papd5 siRNA. Skiv2l2 expression measured via ΔCq 
values was normalized to β-actin expression and control siRNA levels. Error bars 
represent ±SD for n=3, p-value< 0.001. 
 
B. 
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3.3 Discussion 
 Through these experiments, it was demonstrated that RNAi knockdown of Skiv2l2 
is sufficient to trigger the loss of pluripotency and induce differentiation in both P19 and 
N2a cells. Seeing as SKIV2L2 depletion promoted differentiation into both neurons and 
cardiomyocytes, this differentiation is not restricted to a single cell fate. In N2a cells, 
Skiv2l2 knockdown resulted in both cholinergic and dopaminergic neurons, further 
supporting the conclusion that this effect on differentiation is not specific to a single 
differentiation pathway. Papd5 knockdown alone enhanced differentiation, and Zcchc8 
knockdown reduced the expression of pluripotency markers. However, the complicated 
nature of the relationship between the NEXT and TRAMP complex components muddled 
any conclusion about whether the differentiation phenotype observed following 
SKIV2L2 depletion is due to either the TRAMP complex or the NEXT complex. It is 
possible that multiple SKIV2L2 target RNAs are responsible for the increased 
differentiation observed with SKIV2L2 depletion. These RNAs may each be targeted by 
a different complex, making the loss of one complex insufficient to drive differentiation. 
In addition, Papd5 and Zcchc8 may complex with SKIV2L2 but may not be essential to 
the turnover or processing of these specific RNAs.  
 These findings indicate that not only is decreased Skiv2l2 expression indicative of 
differentiated cells, but SKIV2L2 depletion is sufficient to induce cell differentiation. 
This directly links RNA surveillance with differentiation and suggests that high 
SKIV2L2 levels impede differentiation. Pluripotent cells may require high levels of 
nuclear RNA surveillance. Similar to how autophagy pathways are upregulated in stem 
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cells due to increased translation (Phadwal, 2012), stem cells may also upregulate nuclear 
RNA surveillance pathways in response to the high levels of transcription and protein 
synthesis required for pluripotency and cell division (Boisvert, 2007). During 
differentiation, nuclear RNA surveillance mechanisms may be downregulated to change 
the steady-state levels of certain RNAs, leading to decreased pluripotency and allowing 
for differentiation to proceed.  
 While the differentiation phenotype could not be definitively linked to the 
TRAMP or NEXT complexes, the experiments did reveal insight into nuclear RNA 
surveillance. PAPD5 appears to be necessary for the stability of SKIV2L2 in the TRAMP 
complex. Differentiation following Papd5 knockdown could be attributed to 
downregulation of SKIV2L2, loss of the TRAMP complex, or loss of PAPD5 function 
outside the TRAMP complex. Because Zcchc8 knockdown alone reduced the expression 
of pluripotency markers but did not induce terminal differentiation, it is possible that the 
reduction in ZCCHC8 was not sufficient to replicate the differentiation associated with 
SKIV2L2 depletion, or that the differentiation seen following Skiv2l2 knockdown is a 
complex phenotype resulting from the loss of both TRAMP and NEXT complex 
functions. The finding that Papd5 knockdown led to a consistent 40% decrease in 
SKIV2L2 levels has two implications. First, differentiation seen in Papd5 knockdown 
cells could be attributed to lower levels of SKIV2L2. Second, SKIV2L2 levels seem to be 
regulated based on its function in the TRAMP complex because loss of another TRAMP 
complex component, but not a NEXT complex component, led to Skiv2l2 
downregulation.  
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 While these results definitively indicate that SKIV2L2 is necessary to maintain 
pluripotency in murine cancer cell lines, it is unclear whether differentiation is directly 
inhibited by SKIV2L2 or differentiation results indirectly from decreased pluripotency or 
increased cell stress. It is worth noting that N2a and P19 cell growth depends on 
confluency and contact inhibition. Plate overcrowding can lead to detachment, apoptosis, 
and cell death. Also, cells grown at increased confluency cannot differentiate due to 
contact inhibition (Zhi, 2012). Because cells were not grown past confluency, 
overcrowding did not occur. However, Skiv2l2 knockdown plates were not as confluent 
as control plates, meaning that decreased contact inhibition could contribute to increased 
levels of differentiation. One way to address this would be to closely look at changes in 
gene expression and cell confluency over time to see if decreased confluency is the cause 
or result of differentiation.   
Therefore, while these experiments established SKIV2L2 as necessary to maintain 
multipotency in cancer cell lines, they do not offer conclusive proof that SKIV2L2 
directly represses differentiation pathways, as opposed to maintaining proliferation and 
indirectly blocking differentiation. On the contrary, the seemingly poised status of N2a 
cells to undergo differentiation into either cholinergic or dopaminergic neurons following 
Skiv2l2 knockdown implicates SKIV2L2 in maintaining proliferation and pluripotency as 
opposed to repressing a single differentiation pathway. The next chapter addresses this 
hypothesis in further detail. Nevertheless, the conclusion that loss of SKIV2L2 leads to 
cell differentiation offers unique insight into the role of RNA surveillance in stem cell 
maintenance. Coupled with the downregulation of Skiv2l2 during differentiation, 
discovering that this downregulation is sufficient to induce differentiation gives a better 
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understanding of how and why RNA surveillance changes upon cell differentiation. 
Focusing on specific RNA surveillance targets that are necessary to maintain 
pluripotency will not only expand knowledge of RNA surveillance mechanisms but also 
will help advance understanding of stem cell maintenance. Given that many anti-cancer 
drugs focus on triggering apoptosis or differentiation, and stem cell therapy requires cell 
differentiation, the downregulation of Skiv2l2 can be potentially utilized to enhance cell 
differentiation in future cancer and stem cell research. 
 
Fig 3.12: Model depicting the relationship between SKIV2L2 and differentiation. 
Decreases in SKIV2L2 levels are correlated with increased differentiation. This decrease 
in SKIV2L2 can be accomplished through chemically induced differentiation, which 
leads to decreased growth signaling, or through RNAi. Higher levels of SKIV2L2 
maintain pluripotency and proliferation in cancer cell lines. 
76 
 
CHAPTER IV: SKIV2L2 DEPLETION INDUCES A SLIGHT BUT 
SIGNIFICANT MITOTIC ARREST IN MURINE CELL LINES 
 
4.1 Introduction 
Hypothesis: SKIV2L2 depletion via RNAi results in reduced proliferation in murine cell 
lines. 
In the previous chapter, experiments demonstrated that Skiv2l2 knockdown via 
RNAi enhanced differentiation in N2a and P19 cells and that the differentiation resulting 
from reduced SKIV2L2 levels was not restricted to one cell type or one differentiation 
pathway. Because differentiation and cancer stem cell maintenance are affected in 
multiple cell types, it is unlikely that RNA surveillance specifically represses one cell 
fate, which would be more likely result in ectopic expression of lineage-specific genes 
with loss of SKIV2L2. The maintenance of stem cells and cancer stem cells depends on 
both the expression of pluripotency genes and high levels of proliferation. With no 
evidence that SKIV2L2 represses specific differentiation pathways, it was hypothesized 
that SKIV2L2 instead enhances proliferation to maintain pluripotency. In support of the 
hypothesis that SKIV2L2 enhances cell proliferation, studies in zebrafish found that 
SKIV2L2 is necessary to maintain stem cell pools and colocalizes with PCNA, a marker 
of cells in S phase (Yang, 2007; Hultman, 2010). Skiv2l2 mutant zebrafish not only have 
underdeveloped brains and immune systems, but the mutants also cannot regenerate 
melanocytes or tails normally derived from stem cell pools (Yang, 2007; Iwanami, 2009).  
While the experiments outlined in Chapter 3 demonstrated that SKIV2L2 depletion 
results in reduced expression of pluripotency markers, such as Sox2 and Nanog, it was 
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necessary to also investigate how Skiv2l2 knockdown influences cellular proliferation to 
understand the effect of SKIV2L2 on cancer stem cell maintenance.  
SKIV2L2’s localization to the nucleoplasm and nucleolus bolsters the hypothesis 
that SKIV2L2 functions as a regulator of cell division (Osman, 2011; Lubas, 2011). In 
particular, the nucleolus regulates certain stages in cell growth and division, and other 
nucleolar proteins have been shown to be downregulated during differentiation (Boisvert, 
2007; Tsai, 2014; Yang, 2011). DNA helicases in the nucleolus influence the timing of S 
phase, and the nucleolar sequestration of different proteins like HDM2 regulates growth 
arrest (Boisvert, 2007; Phillips, 2006). Because SKIV2L2 functions in nucleolar RNA 
surveillance, and the nucleolus helps regulate cell division (Boisvert, 2007; Tsai, 2014; 
Yang, 2011), SKIV2L2 may also play a role in cell division. Interestingly, ZCCHC8, a 
NEXT complex member, is phosphorylated during the G2/M phase spindle assembly 
checkpoint, suggesting RNA surveillance is regulated in a cell cycle dependent manner 
(Gustafson, 2007). Overall, the cellular location of SKIV2L2 and the G2-specific 
phosphorylation of ZCCHC8 lend credence to the hypothesis that RNA surveillance is 
necessary for cell proliferation.  
Differentiation and proliferation are often viewed as antagonistic processes 
because cells proliferate prior to differentiation, but cells arrest in G1 phase just before 
differentiation (Liu, 2013b). Therefore, proliferative cells usually do not differentiate, and 
differentiation requires proliferation to halt. The majority of terminally differentiated 
cells lose the ability to divide, with new cells coming only from a stem cell pool. 
Additionally, many cancer cell lines, including N2a cells, differentiate following serum 
starvation, indicating that the growth factors that keep cancer cells proliferating are 
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necessary to prevent differentiation (Phillips, 2006).  Slowed cellular proliferation could 
result in the increased differentiation seen with Skiv2l2 knockdown, as SKIV2L2 
depletion caused reduced confluency, which could induce differentiation by relieving 
contact inhibition. Because N2a and P19 cells are immortalized cell lines derived from 
cancer cells, it was also possible that differentiation could result from cell cycle stress 
(Smith, 1998). Genetic mutations in cancer cells can prevent apoptosis that would be 
triggered in healthy cells experiencing cell cycle arrest (Freije, 2014). This phenomenon 
often leads to “slippage” through cell cycle checkpoints, followed by cellular senescence, 
necrosis, or differentiation (Freije, 2014; Dikovskaya, 2015; Sato, 1994; Rieder, 2004). 
This occurs as cells cannot hold the spindle assembly checkpoint indefinitely, as cyclin B 
is degraded over time.  This causes the cell to progress through mitosis, generating a 
tetraploid cell. Tetraploid cells then either exit the cell cycle, followed by senescence or 
differentiation, or continue through the cell cycle, ultimately dying through necrosis 
(Freije, 2014; Dikovskaya, 2015; Sato, 1994; Rieder, 2004). In light of this, it was 
hypothesized that reduced SKIV2L2 levels impede progression through the cell cycle, 
ultimately causing cellular differentiation. To investigate this hypothesis, multiple 
experiments were performed to see how SKIV2L2 depletion affects cell proliferation (Fig 
4.1). 
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4.2 Approach and Results 
4.2.1 SKIV2L2 depletion reduces the total number of proliferating cells by 
approximately 30% 
 
To test the hypothesis that SKIV2L2 maintains cell proliferation in cancer stem 
cells, MTT assays were used to quantify the proliferation of both N2a and P19 cells 
transfected with either control or Skiv2l2 siRNA. MTT assays estimate the relative 
amount of proliferating cells. The mitochondrial reductases in proliferating cells reduce 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to the purple 
formazan crystal, making formazan production a readout of metabolic activity (Xie, 
Fig 4.1: Experimental method to determine how Skiv2l2 knockdown via RNAi influences 
proliferation. Three major experiments were performed: MTT assays, propidium iodide 
staining, and H3 phospho-S10 immunofluorescence. MTT assays gave a colorimetric 
readout of overall proliferation, propidium iodide staining monitored the percent of cells in 
G1, S, and G2/M based on DNA content, and H3 phospho-S10 immunofluorescence 
measured the amount of cells undergoing mitosis. 
80 
 
2010; Gui, 2014). Lower levels of MTT reduction into the purple formazan product 
correspond to a decrease in the number of proliferating cells, which could be due to cell 
death, cell differentiation, or slower progression through the cell cycle (Xie, 2010; Gui, 
2014). MTT reduction is easily quantified using a spectrophotometer to measure the 
absorbance of the formazan crystal, with higher absorbance correlating with both 
increased formazan production and more proliferating cells. Cell proliferation was 
measured by comparing the absorbance at 570 nm of the dissolved formazan from 
Skiv2l2 knockdown cells to control cells.  
In both N2a cells and P19 cells, SKIV2L2 depletion resulted in a decrease in 
formazan production. Transfection of N2a cells with Skiv2l2 siRNA resulted in a 38% (p-
value< 0.0001, Fig.4.2a, b) overall decrease in formazan reduction. Capturing this in a 
time course experiment revealed that proliferation of both retinoic acid treated cells and 
Skiv2l2 knockdown cells slowed similarly over time when compared to control cells (Fig. 
4.2c). Twenty-eight hours following transfection, Skiv2l2 siRNA resulted in a 22% (p-
value< 0.002) reduction in proliferation, and at thirty-two hours, Skiv2l2 knockdown cell 
proliferation was 27% less than that seen in control cells (p-value< 0.002). The 
experiment was repeated following Skiv2l2 siRNA transfection of P19 cells, with P19 
cells showing a similar 30% decrease in formazan production after 32 hours (p-value< 
0.0001, Fig. 4.2d). This result demonstrates a 22-38% reduction in the number of 
proliferating cells following SKIV2L2 depletion. 
  
C. 
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Fig 4.2: MTT assays demonstrated reduced overall proliferation following 
Skiv2l2 knockdown. A. MTT Assay in N2a cells. Cells were treated with MTT 
48 hours following transfection of N2a cells with non-targeting control siRNA 
or Skiv2l2 siRNA. Cuvette 1 contains N2a cells that were not treated with 
MTT as a negative control, cuvettes 2-4 contain control siRNA cells treated 
with MTT, and cuvettes 5-7 contain Skiv2l2 siRNA cells treated with MTT.  
B. Quantification of formazan absorbance from MTT assay in A. Background 
absorbance at 630nm was subtracted from 570nm formazan absorbance to 
determine the total level of MTT reduction (error bars represent ±SD for n=9, 
p-value< 0.0001). C. MTT Time point Assay in N2a cells. Absorbance of 
formazan was recorded at 6 hour time points before harvesting cells 
transfected with non-targeting control siRNA or Skiv2l2 siRNA (n=4 for each 
time point, * represents p-value< 0.05 compared to control cells). D. MTT 
Assay in P19 cells. MTT Assay performed in P19 cells as stated in A and B, 
where p-value< 0.0001. 
D. 
* 
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4.2.2 Skiv2l2 knockdown does not induce cell death in cancer cell lines 
Because the MTT assay measures overall proliferation, the reduced proliferation 
of Skiv2l2 knockdown cells could be due to cell death. To examine this possibility, N2a 
cells were stained with propidium iodide, which passes through the compromised 
membranes of dead cells and binds to DNA. This allows cells to be sorted through 
fluorescent activated cell sorting (FACs) and quantified based on cell viability: dead or 
dying cells stain with propidium iodide, while live cells do not (Lima, 2008).  In addition 
to propidium iodide staining, FACs analysis sorts cells based on forward scatter and side 
scatter. Forward scatter measures size, allowing smaller cellular debris and larger clumps 
to be excluded from the cell population to be analyzed. Side scatter measures the 
granularity of the cells, and apoptotic, necrotic, and dead cells generally have increased 
side scatter (Lima, 2008). Measuring the proportion of cells with increased side scatter 
serves as a way to both confirm the percentage of dead cells measured via propidium 
iodide staining and measure the percentage of apoptotic cells with intact cellular 
membranes that do not stain with propidium iodide.  
Because P19 cells grow in clusters as myocytes or embryoid bodies, it was 
impractical to subject these cells to FACs analysis as the large clumps of cells would 
make data analysis difficult. Instead, N2a cells were stained with propidium iodide to 
investigate cell viability following Skiv2l2 knockdown (Fig 4.3a). Quantifying the 
percentage of total cells staining with propidium iodide revealed that transfection of N2a 
cells with control siRNA and differentiation with all-trans retinoic acid resulted in 
identical 14% cell death rates (p-value< 0.7, n=3). SKIV2L2 depletion, however, 
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significantly decreased the number of dead cells, as only 5% of Skiv2l2 knockdown cells 
stained with propidium iodide (p-value< 0.0001, n=3, Fig 4.3b). This denotes that the 
reduced levels of proliferation following SKIV2L2 depletion seen in the MTT assay 
could not be attributed to increased cell death. To confirm this result, side scattering was 
examined through FACs analysis (Fig 4.4). Control cells and Skiv2l2 knockdown cells 
exhibited comparable proportions of cells with increased side scatter (7.6% and 4.9%, 
respectively, p-value< 0.2). Retinoic acid treatment had a higher proportion of cells 
exhibiting side scatter (13.9%, p-value< 0.01), suggesting that a higher proportion of 
chemically differentiated cells undergo apoptosis. Seeing as SKIV2L2 depletion did not 
increase the proportion of granule cells, it was concluded that loss of SKIV2L2 does not 
result in increased cell death or trigger apoptosis.  
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Fig 4.3: Skiv2l2 knockdown does not trigger cell death according to dead/live 
staining. A. Propidium Iodide Viability Staining. N2a cells stained with propidium 
iodide were excited at 488nm and sorted using the Accuri C6. Fluorescing cells 
(dead or apoptotic) detected by the FL-2 filter are circled, and the Accuri C6 
software was used to quantify the percent of control, retinoic acid treated, and 
Skiv2l2 knockdown cells staining with propidium iodide per 50,000 cells analyzed. 
B. Quantification of propidium iodide dead/live staining in N2a cells. The 
procedure cited in A was repeated for three biological replicates to calculate the 
percentage of cells staining with propidium iodide for control, retinoic acid treated, 
and Skiv2l2 knockdown cells (p-values< 0.72, 0.00001 repectively). 
 
B. 
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A. 
Fig 4.4: Skiv2l2 knockdown does not trigger cell death according to side 
scattering. A. FACs analysis of side scatter. N2a cells stained with propidium 
iodide were excited at 488nm and sorted using the Accuri C6. Cells were 
initially sorted based on forward scatter (FSC-A) vs. side scatter (SSC-H). 
Cells with increased side scatter are in quadrant (1), with debris in quadrant 
(2).  Single live cells ideal for analysis are circled. B. Quantification of dead 
cells based on side scatter. To approximate the percentage of dead, apoptotic, 
and necrotic cells, cells in quadrant (1) were selected using the Accuri C6 
software. No significant change was observed with Skiv2l2 siRNA (p-value< 
0.2), while retinoic acid increased apoptotic cells (p-value< 0.01). 
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4.2.3 SKIV2L2 depletion triggers a modest but statistically significant increase in 
G2/M phase cells 
 
Because SKIV2L2 depletion results in increased differentiation, it was 
hypothesized that loss of SKIV2L2 would first cause G1 arrest and then differentiation 
like that seen in N2a cells treated with ATRA (F Zhi, 2012; Wesley, 2015). To test this 
hypothesis, the cell cycle was examined through FACs analysis of fixed N2a cells stained 
with propidium iodide. Propidium iodide passes through the permeabilized membranes of 
fixed cells and binds to DNA. Gating based on forward and side scatter allows cell 
debris, cell clumps, and dead cells to be excluded from the analysis. The amount of 
propidium iodide fluorescence correlates to DNA content, and FACs sorts the cells based 
on the intensity of propidium iodide fluorescence (Krishan 1975). Given that DNA 
content is replicated in S phase, cells in G1 phase possess half the DNA content of cells 
in G2 phase and therefore half the intensity of propidium iodide fluorescence. For 
example, ATRA treatment induces G1 phase arrest followed by cell cycle exit and 
differentiation (F Zhi, 2012), which would lead to the majority of cells staining with 
propidium iodide at a lower intensity. If SKIV2L2 depletion induced differentiation in a 
similar manner, the cell cycle profile would be similar to ATRA treated cells and indicate 
G1 phase arrest. A different landscape would suggest that SKIV2L2 depletion disrupts 
the cell cycle in a way distinct from natural or chemically induced differentiation. 
For N2a cells transfected with negative control siRNA, the majority of cells were 
found to be in G1 phase, with smaller proportions of cells observed in S phase and G2/M 
phase. As expected, differentiation of N2a cells with ATRA induced a small but 
significant 11% increase in the proportion of cells in G1 phase compared to control cells 
A. 
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(p-value< 0.003, Fig 4.5). Low levels of G1 differentiated cells were most likely due to 
the use of ATRA alone with 10% FBS, which is less effective at inducing differentiation 
but does not induce changes in Skiv2l2 expression. Surprisingly, SKIV2L2 depletion did 
not cause G1 arrest as expected. Instead, the highest proportion of Skiv2l2 knockdown 
cells appeared to have doubled their DNA content, indicative of G2/M phase. This 
modest but statistically significant 23% increase (p-value< 0.00001, Fig 4.6a) in G2/M 
phase cells implies that SKIV2L2 depletion hinders the progression of cells through 
G2/M phase. Additionally, when compared to control cells, Skiv2l2 knockdown cells 
showed a marked 23% reduction in G1 phase cells (p-value< 0.000001, Fig 4.5). The 
increase in G2/M phase cells following SKIV2L2 depletion indicates impaired cell cycle 
progression distinct from the G1 phase arrest seen in chemically differentiating N2a cells. 
FACS analysis of propidium iodide-stained cells implicates SKIV2L2 in G2/M phase 
progression, as reduced SKIV2L2 levels cause an increase in the percent of cells in G2/M 
phase. This finding hints that while SKIV2L2 is necessary to prevent cell differentiation, 
the differentiation that occurs following Skiv2l2 knockdown is an indirect effect of loss of 
RNA surveillance. With direct induction of differentiation pathways, G1 arrest would be 
expected, similar to that seen with ATRA treatment. Because Skiv2l2 knockdown does 
not increase the number of G1 phase cells, differentiation is not likely to occur in the 
same manner.  
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Fig 4.5 SKIV2L2 depletion induces a modest but significant G2/M phase arrest. A. 
Cell Cycle Analysis with Propidium Iodide Staining of Fixed N2a Cells. N2a cells 
transfected with non-targeting control siRNA, Skiv2l2 siRNA, or all-trans retinoic 
acid were fixed in ethanol and stained with propidium iodide. Cells were excited at 
488 nm, and sorted using FL-2 on the Accuri C6 based on propidium iodide 
fluorescence. The sorted cells corresponded to G1, S, and G2/M phase as denoted. B. 
Quantification of Cell Cycle Profile. Based on the cell cycle landscapes generated in 
D, the Accuri C6 software was used to calculate the percentage of cells in G1, S, and 
G2/M phase, where n=3 sets of 50,000 cells from each treatment. Comparison of the 
percentage of cells in each phase was performed, with statistically significant 
differences compared to control siRNA treated cells (p-value< 0.003) denoted with an 
asterisk (*). 
B. 
A. 
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4.2.4 SKIV2L2 depletion results in mitotic arrest as demonstrated through 
increased H3 phospho-S10 levels 
 
Following the observance of a modest G2/M phase arrest following Skiv2l2 
knockdown (Fig 4.6a), further experiments were aimed at deciphering whether SKIV2L2 
depletion impaired G2 phase or mitosis. Phosphorylation of serine 10 on histone H3 is a 
well-accepted marker of mitosis that increases with mitotic chromosome condensation 
(Crosio, 2002). The H3 phospho-S10 marker was monitored in two ways to determine 
whether Skiv2l2 knockdown causes mitotic arrest. First, cells were stained with the H3 
phospho-S10 antibody, which was then detected using a secondary anti-rabbit antibody 
conjugated to AlexaFluor488. The cells were sorted based on green fluorescence using 
the Accuri C6, and the percentage of cells immunostained with H3 phospho-S10 were 
quantified. A larger proportion of stained cells would indicate mitotic arrest following 
Skiv2l2 knockdown. Second, western blots to detect phosphorylated H3 (H3 phospho-
S10) were performed on histones acid-extracted from control and Skiv2l2 knockdown 
cells. This results in a measurement of the total amount of H3 phospho-S10, which 
correlates to the proportion of cells in M phase.  
The number of cells in G2/M phase (Fig. 4.6a) was compared to the number of 
cells in mitosis (Fig. 4.6b). Following treatment with control siRNA, 6.8% of cells 
stained with H3 phospho-S10, and ATRA treatment resulted in a similar percentage of 
H3 phospho-S10 positive cells (8.4%, p-value< 0.4, Fig 4.6b). This suggests that 
approximately 20% of G2/M phase cells detected by propidium iodide are in mitosis. 
15.5% of Skiv2l2 knockdown cells were positive for H3 phospho-S10 as measured 
through FACs analysis (p-value< 0.007, Fig 4.6b). This correlates to approximately 40% 
* 
* 
* 
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of the cells detected as G2/M phase cells using propidium iodide are undergoing mitosis. 
Western blots were used to detect overall H3 phospho-S10 levels, with β-actin as a 
loading control. Skiv2l2 knockdown cells exhibited an average 2.5 fold increase in H3 
phospho-S10 compared to control cells (n=8, p-value< 0.007, Fig 4.7a). Figure 4.7a 
demonstrates one such Western blot for H3 phospho-S10 depicting a 1.9 fold increase in 
cells treated with Skiv2l2 siRNA. The experiment was replicated in P19 cells, where an 
80% reduction in SKIV2L2 resulted in a 4-fold increase in H3 phospho-S10 (p-value< 
0.04, Fig 4.7b). With both a 2.5 fold increase in overall H3 phospho-S10 levels and a 1.8 
fold increase in the total number of cells staining with H3 phospho-S10, it was concluded 
that an approximate doubling in H3 phospho-S10, which corresponds to more cells in 
mitosis, characterizes Skiv2l2 knockdown cells. 
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Fig 4.6: Skiv2l2 knockdown cells arrest in M-phase. A. Quantification of G2/M phase 
N2a cells based on propidium iodide staining. Fixed N2a cells stained with propidium 
iodided were excited at 488 nm, and 50,000 cells per sample were sorted using FL-2 on 
the Accuri C6 based on propidium iodide fluorescence. The percentage of cells in G2/M 
phase was averaged for three biological replicates with statistically significant 
differences (p-value< 0.00001) denoted by an asterisk. B. FACs analysis of H3 
phospho-S10 cells. Fixed N2a cells were incubated with primary antibody against H3 
phospho-S10 and anti-rabbit conjugated to AlexaFluor®-488. Cells were excited at 488 
nm, and 50,000 cells per sample were sorted using the FL-1 filter on the Accuri C6 
based on AlexaFluor fluorescence. The percentage of cells fluorescing over background 
(no primary antibody control) was quantified for three biological replicates to determine 
the percentage of cells positive for the mitotic marker H3 phospho-S10. Statistically 
significant differences (p-value< 0.007) denoted by an asterisk. 
A. 
B. 
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A. 
B. 
Fig 4.7: Skiv2l2 knockdown causes increased levels of the mitotic marker H3 
phospho-S10. A. Western blot against histone H3 phosphorylated at serine 10 
(H3pS10) in N2a cells. Proteins were acid extracted from N2a cells following 
knockdown with control or Skiv2l2 siRNA, and Western blotting was used to 
visualize the mitotic marker H3pS10 (17kD). H3pS10 protein levels were 
normalized to β-actin protein levels from the cytoplasmic fraction of the protein 
extraction (run on a separate gel) and control siRNA levels. Proteins were 
quantified using ImageJ software. B. Western blot against H3pS10 in P19 cells. 
Proteins were acid extracted from P19 cells following knockdown with control or 
Skiv2l2 siRNA, and Western blotting was used to visualize the mitotic marker 
H3pS10 (17kD). H3pS10 protein levels were normalized to β-actin protein levels 
from the cytoplasmic fraction of the protein extraction (run on a separate gel) and 
control siRNA levels. Proteins were quantified using ImageJ software. 
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4.2.5 Binuclear cells were detected following SKIV2L2 depletion 
To confirm the increased H3 phospho-S10 levels observed with SKIV2L2 
depletion, the H3 phospho-S10 mitotic marker was also utilized to visualize N2a cells 
using immunofluorescence microscopy. Cells immunostaining with H3 phospho-S10 
were counted to determine if reduced SKIV2L2 levels increased the proportion of mitotic 
cells. Visualization of the cells allowed for observation of the intensity of H3 phospho-
S10 staining and verified the nuclear colocalization of the mitotic marker with propidium 
iodide. Because FACs analysis gates out binuclear cells and clumps, visualization also 
captured a more complete picture of the cell population. However, once again, 
immunostaining of P19 cells was not practical due to the formation of embryoid bodies 
and myocytes. 
Viewing and counting N2a cells immunostained for H3 phospho-S10 on the 
Nikon Eclipse E600 microscope confirmed that more Skiv2l2 knockdown cells stained 
positive for H3 phospho-S10 compared to control cells (Fig 4.8). Images were obtained 
from control siRNA and Skiv2l2 siRNA treated cells stained with both propidium iodide 
and H3 phospho-S10 antibody. In control cells, cells densely staining with H3 phospho-
S10 appeared most often as mononucleated cells. Approximately 10.7% (± 4.3% SD) cell 
nuclei staining with propidium iodide also expressed H3 phospho-S10 in control siRNA 
treated samples (Fig 4.7b). Comparatively, SKIV2L2 depletion resulted in 20.1% (± 
4.3% SD) of cell nuclei staining with the mitotic marker H3 phospho-S10 antibody (Fig 
4.8). This represents nearly a 2 fold increase in cells expressing H3 phospho-S10 
following Skiv2l2 knockdown (n=four biological replicates, 150 nuclei counted per 
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replicate, p-value< 0.01), which correlates to the observed 2.5 fold increase seen via 
Western blotting. Interestingly, binucleated cells were observed in Skiv2l2 knockdown 
samples (Fig 4.8a), denoted by arrows, while no binucleated cells were observed among 
control cells. These observed binucleated cells depict a failure to undergo cytokinesis 
following SKIV2L2 depletion (Rieder, 2004). Together, reduced SKIV2L2 levels 
increased both the number of mitotic cells, suggesting mitotic arrest, and resulted in 
binucleation in a subset of cells expressing the mitotic marker H3 phospho-S10.  
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A. 
Fig 4.8: Skiv2l2 knockdown results in mitotic arrest and binuclear cells detected via 
H3 phospho-S10 immunostaining. A. Immunofluorescent staining of H3 phospho-
S10 in N2a cells. N2a cells were stained with propidium iodide for nuclei 
visualization. Incubation with H3 phospho-S10 antibody followed by anti-rabbit 
AlexaFluor488 stained mitotic cells green. Scale bar is 15 µM for the four leftmost 
panels and 20 µM scale bar for the four rightmost panels. B. Quantification of H3 
phospho-S10 staining nuclei. Nuclei densely staining with H3 phospho-S10 were 
divided by the number of nuclei staining with propidium iodide to obtain the 
percentage of nuclei undergoing mitosis. 150 propidium iodide-stained nuclei were 
counted for control and Skiv2l2 siRNA transfected N2a cells in two distinct 
knockdown experiments (* marks p-value< 0.05). 
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4.2.6 Cell cycle genes are dysregulated following SKIV2L2 depletion 
To better understand this mitotic arrest, RNA-seq data obtained from P19 cells 
following treatment with control or Skiv2l2 siRNA was probed to identify changes to the 
transcriptome indicative of proliferation defects. GO-ontology analysis of mRNAs 
dysregulated in Skiv2l2 knockdown cells revealed genes involved in positively regulating 
cell proliferation were downregulated (p-value< 0.03), while anti-apoptotic genes were 
upregulated (p-value< 0.001). Genes found to be dysregulated following SKIV2L2 
depletion included those involved in the DNA damage response, signaling-induced cell 
proliferation, mitotic cyclins, chromatin remodeling, and mitotic spindle assembly. 
Multiple protein-coding mRNAs that could cause changes in cells proliferation or 
indicate cell division defects were dysregulated with Skiv2l2 knockdown, including 26 
cytoskeletal and spindle genes, 125 known oncogenes, tumor suppressors, and 
differentiation markers, and 29 chromatin modification and remodeling genes. A subset 
of these genes is depicted in Fig 4.9, with a false discovery rate of less than 5%. Of 
particular interest, Skiv2l2 knockdown cells showed higher expression of cyclin-G1, 
which accumulates in G2/M phase arrested cells (Kimura, 2011), and lower expression of 
both the G1-S phase transition cyclin-D1 and the mitotic progression cyclin-B2 (Wu, 
2002; Matsuura, 2004). This result is consistent with fewer cells in G1 and more cells 
arrested in mitosis. Together, this affirmed that mRNA levels reflected the observed 
defects in cell proliferation, as genes involved with cell division were dysregulated. 
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4.3 Discussion 
 These experiments demonstrated that SKIV2L2 depletion results in decreased 
cellular proliferation, specifically attributed to failed progression through mitosis. The 
proliferation defect in Skiv2l2 knockdown cells was first identified through MTT assays, 
which reported that loss of SKIV2L2 causes an approximate 30% reduction overall 
Fig 4.9: Graph of select genes involved in cell cycle control with differential 
expression in Skiv2l2 knockdown cells. RNA-seq was performed in triplicate on 
control and Skiv2l2 siRNA transfected P19 cells. Upregulated and downregulated 
genes following loss of SKIV2L2 were found to be involved in cell cycle control, 
with an emphasis on cyclin, mitotic spindle assembly, and the DNA damage 
response. All changes in RNA levels depicted have a q-value of less than .05.  
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metabolic activity. This decrease in metabolically active cells was attributed to decreased 
proliferation and increased differentiation because FACs analysis showed no increase in 
dead cells as measured by propidium iodide staining and side scatter. Because SKIV2L2 
depletion resulted in increased differentiation and decreased proliferation similar to 
ATRA treated cells, it was hypothesized that SKIV2L2 depletion would cause the G1 
arrest characteristic of both natural and chemically induced differentiation (Zhi, 2012). 
However, FACs analysis of the cell cycle through the staining of fixed N2a cells with 
propidium iodide demonstrated an 8% increase in mitotic cells following Skiv2l2 
knockdown, with a sharp decrease in G1 cells and a slight increase in S phase cells. This 
suggests SKIV2L2 depletion triggers a G2/M phase block, with a slight impairment in 
DNA replication. Mitotic arrest was found to be responsible for this disruption in the cell 
cycle. Both the total amount of the mitotic marker H3 phospho-S10 and the number of 
cells staining with H3 phospho-S10 increased with Skiv2l2 knockdown. Coupled with the 
observance of binuclear cells that fail to undergo cytokinesis, this evidence suggests that 
SKIV2L2 depletion hinders progression through mitosis. 
 At first glance, the observance of mitotically arrested and binuclear cells 
following SKIV2L2 depletion appears to conflict with the differentiation phenotype 
originally observed, as cells usually arrest in G1 prior to differentiation, not in G2/M 
phase. However, mitotic arrest could trigger differentiation in two possible ways. First, 
the overall decrease in proliferation caused by mitotic arrest would relieve contact 
inhibition, resulting in the differentiation of neighboring cells in G1 phase. A second 
explanation for increased differentiation would be mitotic slippage. Mitotic slippage 
occurs as a result of activation of the spindle assembly checkpoint and temporary mitotic 
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arrest. If the cell fails to undergo apoptosis as a result of this mitotic arrest, the 
checkpoint cannot be maintained indefinitely, causing the cell to aberrantly continue 
through mitosis in a phenomenon termed mitotic slippage (Rieder, 2004; Dikovskaya, 
2015; Freije, 2014). Mitotic slippage can occur in N2a and P19 cells because the spindle 
assembly checkpoint is impaired. Failed cytokinesis following mitotic slippage generates 
one 4N G1 cell (binuclear or tetraploid) that can undergo apoptosis, enter S phase with 
significant genomic damage, or arrest in G1 to either senesce or differentiate (Freije, 
2014; Rieder, 2004; Dikovskaya, 2015; Zanet, 2010). One mediator of apoptosis, p53, is 
not expressed in N2a or P19 cells according to both our RNA-seq data and other sources 
(Chang, 2010). Given that p53 functions to trigger apoptosis in response to DNA damage 
following mitotic slippage, the lack of p53 in P19 and N2a cells could lead to cellular 
senescence, differentiation, or necrosis in tetraploid cells (Zanet, 2010; Freije, 2014).  
The gene expression patterns captured using RNA-seq in P19 cells following SKIV2L2 
depletion are consistent with induction of the spindle assembly checkpoint, followed by 
mitotic slippage and failed cytokinesis. Further experiments could be aimed at 
deciphering whether differentiated cells are binuclear to clarify how mitotic perturbations 
cause differentiation following SKIV2L2 depletion. 
 Overall, cell proliferation genes were downregulated following SKIV2L2 
depletion, and anti-apoptotic genes were upregulated. Genes involved with DNA damage 
and spindle assembly were dysregulated in Skiv2l2 knockdown cells. The mitotic arrest 
observed in Skiv2l2 knockdown cells could result from activation of the DNA damage 
response or the spindle assembly checkpoint. Kinetochores can fail to attach to the 
chromosomes as a result of DNA damage or improper chromatin compaction, and DNA 
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damage can result from errors in replication, chromatin packaging, or chromosome 
segregation (Smith, 1998; Rieder, 2004; Meeks-Wagner 1986; Singh, 2010). Gross issues 
in chromosome segregation or DNA damage could explain the presence of binuclear 
cells, as both would cause failed cytokinesis. In totality, the changes in gene expression 
following SKIV2L2 depletion support the hypothesis that loss of SKIV2L2 triggers 
mitotic arrest, probably due to DNA damage, followed by mitotic slippage, failed 
cytokinesis, and ultimately differentiation.  However, further investigation into this 
hypothesis would require looking at phosphorylation events indicative of the spindle 
assembly checkpoint.  
 Still, the results of these experiments are significant in that they show SKIV2L2 
to be necessary for proper mitotic progression in cancer cell lines. Because SKIV2L2 
depletion impairs mitotic progression, RNA surveillance may have an important role to 
play in development, stem cell maintenance, and proliferative diseases such as cancer. By 
demonstrating that SKIV2L2 depletion reduces cancer cell proliferation, this research 
reinforces previous RNAi screens that found SKIV2L2 necessary for breast cancer 
metastasis (Wang, 2012). Future research focusing on how SKIV2L2 and RNA 
surveillance may promote tumor growth and metastasis could have possible implications 
on cancer treatment. 
While previous studies have hinted at RNA surveillance supporting cell 
proliferation, these experiments validate these results in mammals and specifically 
implicate SKIV2L2 in mitosis. Extrapolating from the effect of Skiv2l2 knockdown on 
cancer cell lines, a model can be generated to explain a potential role for SKIV2L2 in 
development: SKIV2L2 is necessary to maintain efficient proliferation in stem cells. As 
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these stem cells differentiate, the cell cycle slows and eventually halts. During 
differentiation, SKIV2L2 is downregulated as high levels of proliferation no longer need 
to be sustained. In an effort to establish a definitive link between RNA surveillance and 
stem cell maintenance, the experiments outlined in the subsequent chapters focus on 
identifying RNAs that could be processed or turned over via SKIV2L2-mediated RNA 
surveillance to prevent mitotic arrest in stem cells. 
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CHAPTER V: SKIV2L2 TARGETS SPECIFIC NON-CODING RNAs FOR 
PROCESSING AND DEGRADATION 
 
5.1 Introduction 
Hypothesis: Unique RNA targets of SKIV2L2 can be identified among those transcripts 
accumulating upon Skiv2l2 knockdown. 
 To date, studies on mammalian nuclear RNA surveillance have focused on 
identifying which classes of RNAs are targeted by the TRAMP and NEXT complexes for 
processing and degradation. These studies generally use high throughput sequencing and 
have been successful in discovering key roles for RNA surveillance in ribosomal RNA 
processing, promoter upstream transcript (PROMPT) and enhancer RNA (eRNA) 
turnover, and snoRNA processing (Tiedje, 2014; Lubas, 2015; Dorweiler, 2014). While a 
list of putative target RNAs have been identified in different organisms, particularly yeast 
and humans, it is believed that many RNA surveillance targets remain to be discovered, 
as different RNAs are expressed under certain conditions and in different cell types. 
Additionally, the biological importance of processing and turnover of RNA surveillance 
targets has not been investigated in depth. This research aimed to expand on previous 
studies by characterizing RNA surveillance targets of the helicase SKIV2L2, which 
functions in both the TRAMP and NEXT complexes, in N2a and P19 cells.  
 Initially, RNA surveillance studies focused on identifying targets of the TRAMP 
complex in yeast, which functions in both the nucleus and nucleolus. In Saccharomyces 
cerevisiae, the TRAMP complex was found to degrade hypomodified tRNAi
MET
. 
Mutation of Mtr4p suppresses the temperature sensitive growth phenotype associated 
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with low tRNAi
MET 
following Trm6 mutation (Kadaba, 2004). This discovery allowed for 
characterization of the TRAMP complex. High throughput sequencing of targets 
accumulating following TRAMP complex depletion and methods crosslinking TRAMP 
proteins to RNAs have resulted in identification of other TRAMP targets in yeast, 
including 5.8s rRNA, the 7s rRNA precursor, snRNAs arising from splicing, snoRNAs, 
and cryptic unstable transcripts transcribed from heterochromatin (CUTs) (de la Cruz, 
1998; Callahan, 2009; Kong, 2013; Thiebaut, 2006). The TRAMP complex has been 
found to be important in gene expression, as degradation of antisense CUTs can impact 
transcriptional silencing and prevent loss of repeats during recombination (Thiebaut, 
2006). In Schizosaccharomyces pombe, the TRAMP complex prevents endogenous 
antisense RNAs from activating RNAi silencing pathways (Bühler, 2008). 
With the recent discovery of the mammalian homologs, the NEXT and TRAMP 
complexes, current research focuses on characterizing RNA surveillance targets in 
mammals as it is applicable to human disease. Currently, the NEXT complex is thought 
to function in the degradation of PROMPTs and eRNAs (Lam, 2014; Lubas, 2015; 
Tiedje, 2014). In the NEXT complex, Rbm7 was found to preferentially bind U-rich 
RNAs and target uridylated snRNAs for degradation (Lubas, 2015; Tiedje, 2014). This 
finding illustrates that the three distinct RNA binding domains found in the NEXT 
(Rbm7, ZCCCH8, and SKIV2L2) and TRAMP (PAPD5, ZCCHC7, and SKIV2L2) may 
each recognize and bind unique classes of RNAs, allowing for many types of RNAs to be 
processed and degraded via nuclear RNA surveillance. For example, the TRAMP 
complex has been found to target different snoRNAs and rRNA precursors for 3' end 
processing and degradation (Lubas, 2015; Schilders, 2007), while the NEXT complex 
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was thought to target PROMPTs for degradation (Tiedje, 2014; Lubas, 2015).  However, 
the discovery of certain PROMPTs adenylated by PAPD5 does hint at some overlap 
between TRAMP and NEXT complex targets (Preker, 2011). Indeed, the distinction 
between the two complexes might prove more complex. Understanding which RNAs are 
targeted by the TRAMP and NEXT complexes in mammals proves to be even more 
difficult due to certain members acting independent from the complex or being 
nonessential for targeting certain RNAs. For example, PAPD5 has been found to be 
necessary for the 3' end trimming of H/ACA box snoRNAs and involved in the 
processing of rRNA precursors in concert with the TRAMP complex (Berndt, 2012; 
Sloan, 2014; Schilders, 2007). However, PAPD5 adenylation is not necessary for the 
turnover of long non-coding RNAs via SKIV2L2, the nuclear exosome, and PABPN1 
(Beaulieu, 2012). While the yeast Trf4p lacks an RNA binding domain and therefore 
cannot function independent from the TRAMP complex (La Cava, 2005), PAPD5 
possesses an RNA binding domain and has been found to adenylate certain mature 
miRNAs to alter their stability (Rammelt, 2011; Boele, 2014). PAPD5 adenylates the 
oncogenic mir-21, resulting in poly (A) specific ribonuclease (PARN)-mediated turnover 
of mir-21, which ultimately prevents tumor formation (Boele, 2014).  Together, these 
suggest a layer of complexity in identifying RNA surveillance complex targets not seen 
in yeast. Because the relationships between the protein members of the TRAMP and 
NEXT complex are poorly understood, this research attempted to characterize RNA 
targets of SKIV2L2, which is presumed to be essential for both TRAMP and NEXT 
complex function because it is the only helicase in both complexes. Recently, human 
SKIV2L2 was shown to complex with PABPN1 and ZCF3H1 for the turnover of 
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adenylated RNAs (Beaulieu, 2012; Meola, 2016). Studies have also shown that SKIV2L2 
functions with MPP6 to degrade unidentified, nuclear RNAs adenylated by poly-A-
polymerase (Fujiwara, 2016). These preliminary studies hint at a role for SKIV2L2 in 
nuclear RNA surveillance independent from both the TRAMP and NEXT complexes as 
well, truly making it the cornerstone in nuclear RNA surveillance. 
Previous work in the Anderson laboratory has focused on sequencing RNA 
targets of SKIV2L2 in N2a cells. After Skiv2l2 knockdown, TRAMP targets are thought 
to be adenylated by PAPD5 but accumulate because they cannot be degraded by the 
exosome. Using oligo-dT to select for adenylated RNAs, the total RNA from Skiv2l2 
knockdown cells was reverse-transcribed and sequenced, and putative TRAMP targets 
were identified, including the 5' leader released by Drosha cleavage of primary miRNAs, 
the 5'ETS cleaved during ribosomal RNA processing, the small nucleolar RNA U3, and 
the mRNA VGF (Dorweiler, 2014). Following poly-A-seq, molecular techniques verified 
RNA targets to better understand processing and degradation via the TRAMP complex. 
In addition, it was necessary to repeat the high throughput sequencing of RNAs following 
Skiv2l2 knockdown to identify NEXT complex targets and potential TRAMP complex 
targets not detected in the original poly-A-sequencing data. The oligo-dT to reverse 
transcribe was thought to only capture TRAMP targets adenylated by PAPD5. However, 
the efficiency of oligo-dT priming off of the short A-tails added by PAPD5 (assuming 
PAPD5 efficiently adenylates TRAMP targets in the absence of SKIV2L2) calls this 
method into question. To combat this, RNA-sequencing was performed on both control 
siRNA and Skiv2l2 siRNA treated P19 cells to detect accumulating RNAs that could be 
either TRAMP or NEXT complex targets. In addition to detecting and classifying unique 
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RNA surveillance targets via high throughput sequencing, molecular techniques were 
again utilized to verify these targets in P19 cells (Fig 5.1). 
Finally, a system to verify RNA binding to SKIV2L2 was instituted based on UV-
crosslinking of RNA and proteins followed by immunoprecipitation of endogenous 
SKIV2L2 (Fig 5.2). Previous CLIP (Cross-linked immunoprecipitation) and CRAC 
(Cross-linking and analysis of cDNA) methods depend on overexpression of the target 
protein fused to a tag (Tiejde, 2014; Bohnsack, 2012). Both protein overexpression and 
fusion tags can affect RNA binding, calling the validity of these results into question. In 
this chapter, RNA immunoprecipitation (RIP) was performed on endogenous SKIV2L2 
to detect RNAs bound to SKIV2L2 and therefore confirm those RNAs as direct targets of 
SKIV2L2-mediated RNA surveillance. 
Fig 5.1: RNA-seq and qRT-PCR identify and verify RNA targets of SKIV2L2. 
In cells treated with control siRNA, SKIV2L2 targets in red would be turned 
over. However, with Skiv2l2 knockdown, these targets would accumulate. 
These targets can be detected via qRT-PCR and RNA-seq. RNAs not targeted 
by SKIV2L2 (blue) would remain at similar levels under both conditions, while 
red target RNAs would accumulate in knockdown cells. 
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Fig 5.2:  RIP-qRT-PCR identifies RNAs binding to SKIV2L2. In RNA 
immunoprecipitation, RNAs associated with SKIV2L2 (red) are covalently 
bound through UV crosslinking. Cell lysates are then applied to magnetic 
Dynabeads coated with either negative control anti-goat Ig or anti-SKIV2l2 
antibodies. SKIV2L2 with its bound target RNAs would immunoprecipitate 
with anti-SKIV2L2. Using qRT-PCR, these bound RNAs (red) would be 
detected at higher levels in samples immunoprecipitated with anti-SKIV2L2 
compared to anti-goat Ig. However, unbound RNAs (blue) would be 
immunoprecipitated at similar rates with both anti-SKIV2L2 and anti-goat Ig 
antibodies. 
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5.2 Approach and Results 
5.2.1 TRAMP complex RNA targets possess short 3' tails consisting of three to six 
adenosines 
 
 The Anderson laboratory previously conducted a poly-A-seq experiment to detect 
polyadenylated RNAs that accumulate in Skiv2l2 knockdown cells (Dorweiler, 2014). 
The rationale behind this experiment was that becauseSKIV2L2 aids in RNA turnover via 
the nuclear exosome, RNAi against SKIV2L2 would prevent the turnover and cause the 
accumulation of RNAs targeted for degradation by the TRAMP or NEXT complex. 
Given that PAPD5 adenylates TRAMP target RNAs, but the NEXT complex lacks a 
poly-A-polymerase (Lubas, 2011), oligo-dT primed reverse transcription would detect 
accumulating TRAMP target RNAs. Indeed, analysis of the resulting poly-A-seq data 
from N2a cells treated with either control siRNA or Skiv2l2 siRNA revealed certain RNA 
classes as putative TRAMP targets. In particular, misprocessed U3 was found to be 
elevated in Skiv2l2 knockdown cells. U3 undergoes 3' end trimming to form the mature 
snRNA, and the data suggests that aberrant U3 RNAs are degraded via SKIV2L2. 
Additionally, the poly-A-seq data from Skiv2l2 knockdown cells detected an 
accumulation of 5' leader sequences of specific miRNAs (Fig 5.3). As the primary 
miRNA transcript is cleaved by Drosha, a 5' and 3' fragment are released to generate the 
pre-miRNA hairpin (Bartel, 2004). A subset of miRNA 5’ leader sequences, including 
mir-322, accumulates in Skiv2l2 knockdown cells, suggesting that SKIV2L2 may aid in 
their turnover.  
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 Given that the rationale behind the poly-A-seq data rests on the premise that 
PAPD5 adenylates TRAMP target RNAs, two questions were asked regarding the 
miRNA 5' leader and U3 snRNA transcripts. The first question asked was whether the 
RNAs were adenylated. Detecting adenylated miRNA 5' leader and U3 snRNA 
transcripts would not only verify that the poly-A-seq experiment selected for adenylated 
RNAs, but it would also suggest that these RNAs could be TRAMP complex targets. The 
second question addressed the length of the poly-A-tails on these transcripts. Because the 
yeast Trf4p adds three to five adenosines (Wlotzka, 2011; Jia, 2011), it was hypothesized 
that the mammalian homolog PAPD5 would add short poly-A-tails as well. However, 
with in vivo and in vitro experiments offering conflicting data on the length of poly-A-
tails added by Trf4p (Schmidt, 2013; Nag, 2012; Jia, 2011), and the experiments never 
having been performed in mouse cells, the exact length of poly-A-tails in mice could not 
be estimated. Therefore, measuring the length of the poly-A-tails on TRAMP targets in 
mouse was important because it would reveal insight into whether oligo-dT is the best 
method to detect these RNAs, as priming efficiency would decrease for poly-A-tails less 
than 19 adenosines in length and structured 3' ends can interfere with oligo-dT primer 
hybridization (Bustin, 2004).  
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 To detect poly-A-tails added to the 3' end of the mir-322 5' leader and U3, total 
RNA was isolated from Skiv2l2 knockdown cells to enrich for these RNAs. RNA extracts 
were digested using RNaseH and primers specific to the 5' most end (first red X) of 5' 
leader of mir-322 and U3 (Fig.5.3). This digested both RNAs into similar sized fragments 
approximately 150-200 base pairs in length, which is the length at which RNAs undergo 
circular ligation with the most efficiency (Shore, 1981). These short RNAs were then 
treated with RNA ligase to circularly ligate the 3' and 5' ends to each other. This would 
fuse any adenosines at the 3' end to the 5' end. The circularly ligated RNA was then 
reverse transcribed into cDNA using a gene specific primer, and the cDNA was amplified 
across the 5'-3' junction. This technique resulted in an amplicon that was cloned into 
bacteria and sequenced to detect any untemplated adenosines between the 5' and 3' ends 
of the RNA.  
This experimental method proved difficult due to low efficiency and low levels of 
the target RNA in respect to total RNA. The majority of cloned U3 was not adenylated, 
Fig 5.3: Processing of miRNAs such as mir-322 leads to the release of a 5' leader 
sequence. A diagram of the primary transcript containing the cluster of mir-322, mir-
503, and mir-351 denotes two distinct polyadenylation events: adenylation at the 3' end 
of the primary transcript and adenylation at the 5' most Drosha cleavage site generated 
to release the mir-322 hairpin. Red Xs flank the amplicon cloned via circular ligation to 
count the number of untemplated A’s on the 5' leader sequence. 
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which was expected given that only misprocessed U3 was elevated in the sequencing 
data. However, three U3 transcripts were found to be adenylated of the approximately 
thirty clones sequenced (Table 5.1). These three transcripts each had different defects in 
processing, including errors in 3' end trimming and an internal deletion. The number of 
untemplated adenosines spanning the 5'-3' junction ranged from three to six in number. 
For one of the transcripts, it was unclear whether the tail was four to six adenosines in 
length as two adenosines were predicted to occur at that position based on the U3 
sequence.  This suggests that misprocessed U3 is adenylated with three to six adenosines. 
Sequencing of the 5' leader of mir-322 yielded only one adenylated transcript. The 
majority of the thirty clones were retroelements expressed elsewhere in the genome with 
extensive sequence similarity to the mir-322 primary transcript. The one adenylated 5' 
leader sequence had an A-tail that was three adenosines in length. While four adenylated 
transcripts is not definitive proof, it does suggest that the A-tail of putative TRAMP 
targets is three to six adenosines in length. Indeed, two laboratories have confirmed that 
Trf4p, when acting with Mtr4p, adds three to five adenosines in yeast (Jia, 2011; 
Wlotzka, 2011). It is of note that this short tail that would not be as efficiently primed 
using oligo-dT as a longer poly-A-tail, suggesting that certain TRAMP targets might not 
be represented in the poly-A-seq data.  
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Table 5.1: Potential RNA targets of SKIV2L2 have three to five untemplated 
adenosines at their 3' end. U3 and the 5' leader of mir-322 RNAs were cleaved at the 5' 
end using RNAse H to generate 150-200 bp fragments. These fragments were 
circularly ligated to fuse the 5' and 3' ends and reverse transcribed. The resulting cDNA 
was cloned and sequenced, and the number of untemplated adenosines between the 5' 
and 3' ligation junction were counted. Four transcripts were found to be adenylated at 
the 3' end, and these A-tails ranged from three to five adenosines long. 
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5.2.2 The 5' leader of mir-322 is a definitive TRAMP target 
After detecting putative TRAMP targets using the poly-A-seq data, it was 
necessary to verify that these miRNA 5' leader sequences accumulate using another 
method. To do this, qRT-PCR was employed to detect the levels of the 5' leader sequence 
of mir-322 in control, Skiv2l2, and Papd5 knockdown cells. A series of primers were 
designed to detect the 5' leader of mir-322. Total RNA from all three cell treatments was 
reverse transcribed using either a primer specific to miRNA 5' leader sequence or oligo-
dT. By using two primers for reverse transcription, both adenylated 5' leader and total 5' 
leader levels could be detected and compared among the control, Skiv2l2, and Papd5 
knockdown cells. A single amplicon within the 5' leader sequence was amplified using 
qPCR to quantify the amount of mir-322 5' leader in each sample. Because NEXT 
complex targets are not adenylated, this experiment was designed to confirm SKIV2L2 
depletion impairs mir-322 5' leader turnover while also deciphering whether PAPD5 and 
the TRAMP complex are responsible for mir-322 5' leader turnover.  
The experiment was performed under two conditions. First, control cells were 
compared to Skiv2l2 knockdown cells alone using ActB as an RNA loading control.  
Then, control cells were compared to both Skiv2l2 and Papd5 knockdown cells using 
CyphB as an RNA loading control. When comparing the overall mir-322 5' leader levels, 
there was a 5 fold increase following Skiv2l2 knockdown (p-value< 0.04, Fig 5.4a). In the 
second set of experiments, overall levels of 5' leader were found to accumulate 11 fold in 
Skiv2l2 knockdown and 6 fold in Papd5 knockdown cells. Additionally, adenylated 5' 
leader transcripts were elevated 5 fold in Skiv2l2 knockdown cells but were not 
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significantly detected in Papd5 knockdown cells (Fig 5.4b). This data verifies that mir-
322 is a direct TRAMP target, as it accumulates in both Skiv2l2 and Papd5 knockdown 
cells. The loss of adenylated 5' leader in Papd5 knockdown cells confirms that PAPD5 is 
the poly-A-polymerase responsible for the observed adenylation. In addition to validating 
mir-322 5' leader as a direct TRAMP target, these experiments also established an 
experimental method that could be applied to other putative TRAMP target RNAs.  
5.2.3 SKIV2L2 is necessary for processing snoRNA Z18 from the long non-coding 
RNA Gas5 
 
In addition to identifying U3 and the 5' leader sequence of specific miRNAs as 
putative TRAMP targets, the poly-A-Seq data suggested an accumulation of the long 
non-coding RNA Gas5 following Skiv2l2 knockdown. However, it was not clear whether 
SKIV2L2 targeted a portion or the entire transcript for degradation. Viewing the poly-A-
Seq data converted into BigWig format on the IGV genome browser suggested a 
significant proportion of the accumulating transcripts covered the 3' end of the first 
intron. Gas5 lncRNA harbors multiple snoRNAs in its introns, and the fate of the 
lncRNA transcript changes based on cell stress (Wang, 2005). Without stress, spliced 
Gas5 is turned over via nonsense-mediated decay. Under conditions that induce growth 
arrest, including starvation, Gas5 undergoes an additional splicing event, is retained in 
the nucleus, and sequesters glucocorticoid hormone receptors so that genes responsive to 
glucocorticoid are silenced (Wang, 2005; Tani, 2013). The differential splicing of Gas5 
releases certain introns containing snoRNAs, and the intronic snoRNAs are processed 
into mature snoRNAs. The first intron contains the snoRNA Z18, and it was 
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hypothesized that SKIV2L2 promotes the processing of the first intron to generate mature 
Z18 (Fig 5.5a).  
To test this hypothesis, qRT-PCR was again utilized to determine whether the 
entire Gas5 transcript accumulates following Skiv2l2 knockdown or if the accumulation 
is specific to the first intron containing Z18. Using total RNA extracted from control and 
Skiv2l2 knockdown cells, Gas5 was reverse transcribed using two distinct primers: one 
that annealed to the 3' end of the long non-coding RNA and one that annealed to the first 
intron downstream of Z18’s mature 3' end. After reverse transcription, qPCR was 
performed using one amplicon spanning the junction between exons 11 and 12 to detect 
full length Gas5 and a second amplicon detecting 3' extended Z18 (Fig 5.5a). SKIV2L2 
could affect the stability of spliced Gas5 (detected through the amplicon spanning exons 
11 and 12), unspliced Gas5 transcript (both exons and introns), or Z18 snoRNA (first 
intron). The use of multiple primer sets allowed each possibility to be explored. 
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A. 
Fig 5.4: qRT-PCR verifies mir-322 5' leader sequence as a TRAMP complex target. A. 
mir-322 5' leader accumulates in Skiv2l2 knockdown cells. Total RNA from control 
and Skiv2l2 knockdown cells was reverse transcribed using gene specific primers. 
qPCR was then performed to measure the abundance of the 5' leader of mir-322 
relative to ActB (n=3, * marks p-value< 0.05). B. Adenylated 5' leader of mir-322 
accumulates in Skiv2l2 knockdown cells but not Papd5 knockdown cells. Total RNA 
was reverse transcribed using either gene specific primers or oligo-dT. qPCR was then 
performed to measure the abundance of total and adenylated mir-322 5' leader relative 
to CyphB (* marks p-value< 0.05 compared to control siRNA cells).  
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A. 
Fig 5.5: qRT-PCR verifies the snoRNA Z18 is a SKIV2L2 target. A. The snoRNA Z18 
is processed from the first intron of the long non-coding RNA Gas5. Z18 is located in 
the first intron of Gas5. Primers for reverse transcription are in red, and primers for 
qPCR are in blue.  Two primer sets were used to amplify either full length Gas5 
(amplicon across exons 11 and 12) or 3' extended Z18 (forward primer within Z18, 
reverse primer downstream of the snoRNA). B. 3' extended Z18 accumulates in Skiv2l2 
knockdown cells. Control and Skiv2l2 knockdown RNA was reverse transcribed using 
gene specific primers (red in A). qPCR was then performed to measure the abundance of 
the full length Gas5 and 3' extended Z18 relative to ActB (n=3, * marks p-value <0.05).  
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When comparing the levels of Gas5 between control and Skiv2l2 knockdown 
cells, spliced Gas5 levels, detected at the exon11-exon12 junction, were equivalent 
between the two treatments. This demonstrated that Skiv2l2 knockdown does not 
upregulate Gas5 transcription or influence the stability of spliced Gas5. Instead, qRT-
PCR results demonstrated that the first intron containing Z18 accumulated nearly30 fold 
(p-value< 0.02, Fig 5.5b). Based on the use of two amplicons and location of the primers, 
this could not be attributed to an increase in Gas5 expression or an increase in mature 
Z18. Therefore, Skiv2l2 knockdown leads to an accumulation of only the first intron of 
Gas5. Seeing as the overall transcript does not change following SKIV2L2 depletion, but 
the first intron is elevated, the conclusion is that SKIV2L2 is necessary for processing of 
the first intron, likely to generate mature Z18.  
5.2.4 Forty seven non-coding RNAs accumulate in P19 cells following SKIV2L2 
depletion 
 
 In light of both the analysis of TRAMP targets in N2a cells and the proliferation 
defect observed following SKIV2L2 depletion, an additional RNA-seq experiment was 
conducted in P19 cells to identify targets of SKIV2L2-mediated RNA surveillance that 
could influence mitotic progression. This experiment addressed two concerns with the 
poly-A-seq data obtained from N2a cells. First, by performing the RNA-seq in P19 cells 
following Skiv2l2 knockdown, this experiment allowed for comparison between two cell 
lines and had the potential to reveal additional RNA transcripts as SKIV2L2-mediated 
RNA surveillance targets. Second, given that NEXT complex targets have no poly-A-
tails (Lubas, 2011), and the adenosine tails on TRAMP complex targets are short, using 
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total RNA-seq circumvented inefficiency in priming with oligo-dT and allowed RNAs 
without poly-A-tails to be detected as well.  
Similar to the poly-A-seq performed on N2a cells (Dorweiler, 2014), the purpose 
of this RNA-seq experiment was to identify potential RNAs that are turned over or 
processed via SKIV2L2. P19 cells were treated with control siRNA or Skiv2l2 siRNA, 
and RNA was harvested, quantified, and checked for quality. Three biological replicates 
for each treatment were sent to the University of Wisconsin-Madison for preparation and 
sequencing. Using the online Galaxy platform, the resulting sequencing data was mapped 
to the mm10 mouse genome with tophat, transcript abundance was quantified with 
cufflinks, and changes between control and knockdown cells were identified with 
cuffdiff. Comparing control P19 cells with Skiv2l2 knockdown cells detected changes in 
RNA steady-state levels between the two samples. For simplicity, transcripts that were 
detected at a higher rate in the Skiv2l2 knockdown cells compared to control cells were 
considered to be upregulated, elevated, or accumulating, while transcripts detected at a 
lower rate in Skiv2l2 knockdown cells were considered to be downregulated. In control 
cells, it was hypothesized that any RNA targets of SKIV2L2-mediated RNA surveillance 
would be turned over or processed. However, in Skiv2l2 knockdown cells, these RNAs 
would fail to be turned over or processed by the nuclear exosome, leading to either an 
accumulation of the full-length transcript or an accumulation of an aberrant transcript. In 
both cases, these transcripts would appear to be “upregulated” in Skiv2l2 knockdown 
cells based on the RNA-seq data. The list of “upregulated” genes in Skiv2l2 knockdown 
cells contains RNA transcripts that are either directly targeted by RNA surveillance to the 
nuclear exosome or indirectly affected by changes in RNA surveillance. Conversely, 
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SKIV2L2 is presumed to indirectly affect the downregulated transcripts through a 
mechanism that does not depend on the nuclear exosome.  
Based on the RNA-seq data obtained from P19 cells, 1473 RefSeq genes were 
misregulated in Skiv2l2 knockdown cells. Of these, 585 genes were elevated following 
Skiv2l2 knockdown, while 887 genes were downregulated with a false discovery rate of 
5%. 337 elevated genes and 428 reduced genes showing greater than a 1.5-fold change 
were probed in further detail (Table 9.1). These transcripts were identified and classified 
into one of three groups: non-coding RNAs, replication-dependent histone mRNAs, and 
other mRNAs. RefSeq genes elevated following SKIV2L2 depletion included 36 
replication-dependent histone mRNA transcripts, 47 non-coding RNAs, and 254 other 
mRNAs (Fig 5.6). Genes showing decreased steady-state RNA levels following 
SKIV2L2 depletion included 416 other mRNAs and only 10 non-coding RNAs and 2 
non-canonical histone mRNA transcripts (Fig 5.7). Additionally, 772 intergenic 
transcripts (RNAs transcribed from regions of the mouse genome containing no 
annotated genes) were significantly elevated following SKIV2L2 depletion, while only 
99 intergenic transcripts were downregulated (Table 9.2). 
Previous research has demonstrated that the yeast TRAMP complex and the 
mammalian TRAMP and NEXT complexes primarily function in the processing and 
turnover of non-coding RNAs via the nuclear exosome (Andersen, 2008). Expanding off 
this research, the 47 non-coding RNAs identified as elevated in Skiv2l2 knockdown cells 
were probed in further detail (Table 9.3). The non-coding RNAs were classified as 
miRNAs, snoRNAs, or lncRNAs. Twelve RNAs could not be grouped into these 
categories and are denoted as “other” in the pie chart showing the breakdown of non-
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coding RNAs elevated following SKIV2L2 depletion (Fig 5.8). These twelve “other” 
non-coding RNAs include six small non-coding RNAs of unknown function, two non-
coding pseudogenes, and the RNA components of two enzymes, ribonuclease P and 
mitochondrial RNA processing endoribonuclease. Additionally, the 45S ribosomal RNA 
precursor and the snRNA U12 were both elevated in Skiv2l2 knockdown cells.  
  
Intergenic regions
Non-coding RNAs
Histone mRNAs
mRNAs
Fig 5.6: Various classes of RNAs accumulate in P19 cells following SKIV2L2 
depletion. Following RNA-seq, sequences were mapped for three biological 
replicates using Tophat, and accumulating RNA sequences were sorted based in 
intergenic regions (no annotated genes) and annotated gene type (q<0.05, 
M>0.58).  
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Intergenic
regions
Non-coding
RNAs
Histone
mRNAs
mRNAs
Fig 5.7: Transcripts downregulated in P19 cells following SKIV2L2 depletion. 
As identified through RNA-seq, those RNAs downregulated in knockdown cells 
by 1.5 fold or greater with a q-value <0.05 were included in analysis. 
Downregulated RNAs were then classified as coding, non-coding, or intergenic 
(no annotated genes).  
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Fig 5.8: SKIV2L2 depletion leads to the accumulation of different types of non-coding 
RNAs. Annotated genes elevated in Skiv2l2 knockdown cells were looked at in-depth. 
The non-coding RNAs identified from Table 9.1 were further categorized into the 
following groups: lncRNAs, miRNAs, snoRNAs, or other, with other RNAs including 
RNA components of enzymes, snRNAs, and non-coding RNAs of unknown class. 
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Twenty-seven of the non-coding RNAs were classified as long non-coding RNAs, 
the majority with unknown function. However, lncRNAs with at least some 
documentation included Snhg7 (a snoRNA host gene similar to Gas5), miRNA host 
genes (Snhg20, Mir22hg, and E130102H24 Rik), antisense transcripts (5031425E22Rik, 
RAB26os, Gt(ROSA)26Sor, and Fam120aos), one miRNA sponge lncRNA (Btbd19), 
and one lncRNA derived from the intron of an immunoglobulin gene (D430020J02Rik). 
Two of these lncRNAs were probed in further detail by looking at the Sashimi plot, 
which graphs the RNA-seq reads on the mouse genome and puts both samples side by 
side. Increased RNA-seq reads correlate to a larger peak amplitude at a given point, 
representing an increase in transcript abundance. For the antisense transcript Fam120aos, 
Sashimi plots revealed that the first exon of the gene was not detected in P19 cells, while 
the first intron and second exon were found to accumulate in Skiv2l2 knockdown cells 
(Fig 5.9a). The slight upregulation of the Fam120 protein coding gene suggests that the 
expression and turnover of the coding and non-coding antisense transcripts may be 
linked. Conversely, the antisense transcript RAB26os appears to accumulate in Skiv2l2 
knockdown cells with little to no impact on the expression of the RAB26 protein coding 
gene (Fig 5.9b). Regardless, it is of note that SKIV2L2 depletion was found to impact 
three major types of lncRNAs: RNAs antisense to other genes, RNAs processed from 
host genes, and host genes that undergo post-transcriptional processing.   
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A. 
B. 
Fig 5.9: lncRNAs accumulate in Skiv2l2 knockdown cells. A. Sashimi plot 
for Fam120aos. Fam120aos accumulates in Skiv2l2 knockdown cells (blue) 
compared to control P19 cells (red) measured via RNA-seq analysis. 
Accumulation occurs over the first intron, second exon, and 3' end. B. 
Sashimi plot for Rab26os. Rab26os accumulates in Skiv2l2 knockdown cells 
(blue) compared to control P19 cells (red) as measured via RNA-seq analysis. 
Accumulation is most pronounced over the first and second exons. 
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Five snoRNAs were elevated following SKIV2L2 depletion. These included 
snora65, snora70, snora64, snora21, and snord22, representing four H/ACA box 
snoRNAs and one C/D box snoRNA. Looking at the Sashimi plot for snora64, which is 
processed from the second intron of the Rsp2 host gene, accumulation only occurs over 
Rsp2’s two introns, with the greatest increase in transcript abundance occurring over 
snora64 in Skiv2l2 knockdown cells (Fig.5.10a). This result suggests that Rsp2 splicing, 
intron turnover, and snora64 processing may all depend on SKIV2L2. Additionally, one 
lncRNA that functions as a snoRNA host-gene was elevated following SKIV2L2 
depletion. For the lncRNA Snhg7, the Sashimi plot shows that Skiv2l2 knockdown 
induces only the accumulation of the intronic region that contains the H/ACA box 
snora78 (Fig. 5.10b). This result further implicates SKIV2L2 in the processing and 
turnover of intronic snoRNAs.  
Attention was then focused on two “other” non-coding RNAs found to 
accumulate in Skiv2l2 knockdown cells: Gm6548 and Gm6623. Both Gm6548 and 
Gm6623 are annotated as processed pseudogenes (expressed retrogenes). In Gm6548’s 
Sashimi plot, only two small areas of the transcript are expressed in P19 cells, and the 
accumulating transcripts in Skiv2l2 knockdown cells only occur at the 3' most peak (Fig 
5.11a). According to the piRNABank database, this region is predicted to contain 
piRNAs, possibly implicating SKIV2L2 in piRNA turnover. The Sashimi plot for 
Gm6623 suggests expression of the entire predicted non-coding RNA, with the transcript 
accumulating in Skiv2l2 knockdown cells along the entire gene (Fig. 5.11b). The 
piRNABank predicted no piRNAs over this gene, which is consistent with the transcript 
coverage on the Sashimi plot.  Instead the predicted gene Gm6623 may be an example of 
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a longer non-coding RNA turned over via SKIV2L2 and the nuclear exosome. Probing 
into these two predicted genes further confirmed that SKIV2L2 functions in a wide range 
of non-coding RNA processing and turnover events.  
Of the twelve non-coding RNAs that were downregulated following SKIV2L2 
depletion, ten were lncRNAs, one was a non-coding transcript variant of Mphosph9 
(mitotic phosphoprotein), and one was a non-coding RNA with little information (Table 
9.3). The ten downregulated lncRNAs represented a broad range, with some being 
differentially expressed in cancer and others containing piRNAs and miRNAs. Because 
these non-coding RNAs were not predicted to be SKIV2L2 targets based on the 
experimental design, they were not investigated in greater detail. However, it is of note 
that the lncRNA Neat1 was downregulated following SKIV2L2 depletion. The observed 
downregulation of Neat1, which maintains paraspeckles, could be due changes in mitosis, 
as paraspeckles are not maintained during telophase (Wang, 2016). Seeing as Neat1 is 
upregulated in certain cancer cells (Wang, 2016), its downregulation with loss of 
SKIV2L2 offers some insight into the observed mitotic arrest phenotype and the 
SKIV2L2’s role in maintaining cancer cell proliferation. 
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A. 
Fig 5.10: H/ACA box snoRNAs accumulate in Skiv2l2 knockdown cells. A. 
Sashimi plot for snora64. Snora64 derived from the Rsp2 transcript 
accumulates in Skiv2l2 knockdown cells (blue) compared to control P19 cells 
(red) as measured via RNA-seq analysis. Accumulation is mostly limited to 
the snoRNA itself with a slight accumulation of the 3' extended snoRNA. B. 
Sashimi plot for snora78. Snora78 derived from Snhg9 accumulates in 
Skiv2l2 knockdown cells (blue) compared to control P19 cells (red) as 
measured via RNA-seq analysis. Accumulation only occurs over mature 
snora78. 
B. 
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A. 
B. 
Fig 5.11: Processed pseudogenes accumulate in Skiv2l2 knockdown cells. A. 
Sashimi plot for Gm6548. Gm6548 accumulates in Skiv2l2 knockdown cells 
(blue) compared to control P19cells (red) as measured via RNA-seq analysis. 
Accumulation only occurs at the most 3' peak. B. Sashimi plot for Gm6623. 
Gm6623 accumulates in Skiv2l2 knockdown cells (blue) compared to control 
cells (red) as measured via RNA-seq analysis in P19 cells. Accumulation occurs 
over the entire transcript but is most notable at the most 5' peak. 
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5.2.5 SKIV2L2 depletion results in the accumulation of transcripts expressed from 
intergenic regions 
 
The RNA-seq data revealed that SKIV2L2 depletion induces a strong, directional 
trend toward the upregulation of transcripts arising from regions with no annotated genes 
(Table 9.2). Of these 772 upregulated intergenic transcripts, a fraction were found to 
contain retrogenes annotated on the UCSC genome browser, while some of these 
intergenic regions fall upstream of promoters, possibly representing PROMPTs (promoter 
upstream transcripts), a known target of nuclear RNA surveillance (Lubas, 2015; Tiedje, 
2014). Interestingly, only 99 intergenic loci were reduced in Skiv2l2 knockdown cells, 
suggesting that SKIV2L2 depletion causes a substantial increase in intergenic transcripts.  
 Because PROMPTs are a known NEXT complex target, research focused on 
processed pseudogenes (retrogenes) that were upregulated in Skiv2l2 knockdown cells. 
Pseudogenes are defined as functional genes that have lost their protein-coding abilities. 
There are two types of pseudogenes: unprocessed, which are created due to gene 
duplication events followed by mutations, and processed pseudogenes. Processed 
pseudogenes, also called retrogenes, arise when mRNA from a functional gene is reverse-
transcribed and inserted into the genome at a different location. Because they are formed 
from mRNA, these retrogenes are missing some or all introns and lack promoters and 
regulatory elements necessary to drive their transcription. (Pink, 2011) The majority of 
pseudogenes upregulated in Skiv2l2 knockdown cells were found to be processed 
pseudogenes (retrogenes). Some of these processed pseudogenes are named as predicted 
genes (pseudogene Gm12611), while some are unnamed and referred to by their parental 
gene name (retro-Phgdh).  
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The Sashimi plot from processed pseudogene 9577 shows that only a small 
portion of the pseudogene is expressed (red block on the UCSC genome browser), with 
the accumulation in Skiv2l2 knockdown cells restricted to two peaks, each covering 
approximately 100 base pairs (Fig 5.12a). Similarly, retro-Phdgh (Fig 5.12b) accumulates 
in Skiv2l2 knockdown cells only at one 120 base pair region in the processed pseudogene. 
This result suggests that either SKIV2L2 is involved in the silencing of processed 
pseudogenes, the turnover and processing of small non-coding RNAs arising from these 
pseudogenes, or both.  
To confirm that these processed pseudogenes accumulate in Skiv2l2 knockdown 
cells, qRT-PCR was performed to look at the steady-state levels of the complete 
transcripts for retro-Phdgh and pseudogene Gm12611. These two processed pseudogenes 
were selected from the RNA-seq data because SKIV2L2 depletion triggered high levels 
of accumulation with minimal change in the expression of the original gene. Total RNA 
was reverse-transcribed using oligo-dT or gene specific primers to detect adenylated and 
unadenylated transcripts. A small segment was selected for amplification in qRT-PCR. 
This allowed for detection of processed pseudogenes, both unadenylated and adenylated, 
that accumulate following SKIV2L2 depletion.  
Attempts to amplify these processed pseudogenes in N2a cells were unsuccessful, 
suggesting that their expression is specific to P19 cells. This is not surprising given that 
processed pseudogenes typically are expressed in a tissue-specific manner (Pink, 2011). 
In P19 cells, both retro-Phgdh and Gm12611 were elevated 1.3 fold following SKIV2L2 
depletion (Fig 5.13a, p-values< 0.003 and 0.03, respectively). While adenylated retro-
Phgdh was unchanged following SKIV2L2 depletion, adenylated Gm12611 increased 1.4 
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fold (Fig. 5.13b, p-value< 0.03). This suggests that accumulating Gm12611 is adenylated, 
whereas retro-Phgdh is not.  The levels of retro-Phgdh and Gm12611 detected through 
qRT-PCR are significantly lower than those seen in the RNA-seq data. These low levels 
support the Sashimi plot data, which suggest that the accumulation occurs at small 
regions expressed from the processed pseudogene that are not efficiently detected 
through qRT-PCR.   
Finally, RNA immunoprecipitation was utilized to see if processed pseudogene 
transcripts associate with SKIV2L2 in vivo. In this experiment (Fig. 5.2), proteins were 
UV crosslinked to RNAs bound to them and loaded onto Protein A-conjugated beads. 
These beads were pre-incubated with antibodies either specific to SKIV2L2 or to goat Ig. 
SKIV2L2 and its bound RNAs would be pulled down with anti-SKIV2L2. The anti-goat 
Ig would not capture SKIV2L2, serving as a negative control to ensure that the RNAs 
detected were specifically bound to SKIV2L2 and not to the magnetic beads. The 
immunoprecipitated RNAs in both samples were then reverse transcribed using gene-
specific primers, and qRT-PCR was performed. RNAs bound to SKIV2L2 would be 
pulled down at a higher rate with anti-SKIV2L2 compared to anti-goat Ig. To ensure that 
the SKIV2L2 protein did not indiscriminately associate with RNA or DNA and skew the 
data, qRT-PCR values were normalized to Skiv2l2 and Tubb3 mRNA, which were not 
detected among the immunoprecipitate and served as background levels.  
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A. 
B. 
Fig 5.12: Specific segments of processed pseudogenes accumulate in Skiv2l2 
knockdown cells. A. Sashimi plot for Gm9577 shows an accumulation (red box on the 
UCSC genome browser) in the processed pseudogene. This accumulation occurs 
following Skiv2l2 knockdown (blue) when compared to control cells (red) as measured 
via RNA-seq analysis in P19 cells. B. Sashimi plot for retro-Phgdh. Accumulation in 
Skiv2l2 knockdown cells (blue) was limited to one small segment of retro-Phgdh, 
denoted by a red box on the UCSC genome browser. 
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Fig 5.13: qRT-PCR verifies slight accumulation of processed pseudogenes 
following SKIV2L2 depletion in P19 cells. A. Unadenylated processed 
pseudogenes accumulate slightly with SKIV2L2 depletion.  Total RNA 
extracted from control and Skiv2l2 knockdown cells was reverse-transcribed 
with gene specific primers, with a segment amplified using qRT-PCR and 
normalized to ActB and control siRNA levels (n=3, * marks p-values <0.05) 
B. Only accumulating Gm12611 is adenylated. Total RNA extracted from 
control and Skiv2l2 knockdown cells was reverse-transcribed with oligo-dT, 
with a segment amplified using qRT-PCR and normalized to ActB and 
control siRNA levels (n=3, * marks p-values <0.05). 
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Using this RNA immunoprecipitation protocol, qRT-PCR showed that retro-
Phgdh and Gm12611 did not efficiently immunoprecipitate with anti-SKIV2L2 (p-values 
> 0.05, Fig. 5.14). While Gm12611 levels doubled in anti-SKIV2L2 samples, this 
increase was neither statistically significant (p-value> 0.05) nor on par with the increase 
expected to occur based on the detection of other target RNAs bound to SKIV2L2. 
Together, these results indicate that SKIV2L2 is not directly involved in the turnover of 
full-length retrogene transcripts.  
Fig 5.14: RNA immunoprecipitation does not detect significant association 
between processed pseudogenes and SKIV2L2. RNAs that co-precipitate with 
anti-goat Ig and anti-SKIV2L2 in P19 cells were reverse transcribed with 
gene specific primers and a segment was amplified using qRT-PCR to 
measure its abundance. Processed pseudogene transcript levels were 
normalized to Skiv2l2 and Tubb3 mRNAs to account for background noise  
and then normalized to anti-goat Ig levels (n=3, p-values >0.05). 
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5.2.6 SKIV2L2 depletion impacts the steady state levels of certain mRNAs 
 The majority of genes downregulated upon SKIV2L2 depletion were mRNAs. 
GO Ontology analysis established that a significant proportion of these downregulated 
mRNAs are positive regulators of cell proliferation (p-value< 0.03), while anti-apoptotic 
genes were upregulated (p-value< 0.001). The Sashimi plot for one mRNA, Neurog1, 
shows that the entire Neurog1 transcript is expressed at a lower level in Skiv2l2 
knockdown cells (Fig 5.15).  
 
Interestingly, certain trends emerged among the classes of mRNAs that were 
dysregulated in the RNA-seq data. While previous research focused on non-coding RNA 
targets of nuclear RNA surveillance, at least three types of coding RNAs were noticeably 
Fig 5.15: Developmental mRNAs are downregulated in P19 cells following SKIV2L2 
depletion. The entire Neurog1 mRNA is downregulated following Skiv2l2 knockdown 
(blue) when compared to control cells (red) as measured via RNA-seq analysis in P19 
cells. Neurogenin1 triggers early stages of neuronal differentiation but is 
downregulated soon after.  
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dysregulated following SKIV2L2 depletion: imprinted genes, ribosomal protein mRNAs, 
and histone mRNAs (discussed in Chapter VI). First, imprinted genes were 
overrepresented among genes dysregulated following Skiv2l2 knockdown. Out of the 129 
imprinted genes in the mouse genome, 16 were found to change expression with 
SKIV2L2 depletion, which is statistically significant (p-value< 2.52E-06, Table 5.2). The 
majority of these genes were paternally expressed (maternally imprinted) and 
downregulated upon SKIV2L2 depletion. Grb10, Peg12, Inpp5f, Frat1, Igf2, and Gab1 
are related to cell growth and cancer (Madon-Simon, 2014; Akamatsu, 2015; Jonkers, 
1997; Montagener, 2005), and Lin28a and H19 are involved with the let-7 miRNA 
network (Piskounova, 2011; Kallen, 2014). While the nature of this trend is unknown, 
this finding at least alludes to a possible connection between imprinting and nuclear RNA 
surveillance.  
 In addition to imprinted genes, there also appeared to be a statistically significant 
change in ribosomal protein mRNAs in Skiv2l2 knockdown cells. Approximately one-
third of all ribosomal protein mRNAs accumulated in Skiv2l2 knockdown cells (twenty-
two mRNAs), with only six ribosomal protein mRNAs being downregulated  (Table 9.4) 
This represents a statistically significant link between SKIV2L2 depletion and ribosomal 
protein mRNA regulation (p-value< 4.59E-20). Ribosomal protein mRNAs found to 
accumulate included one-fourth of the small subunit (40S) proteins and almost two-fifths 
of the large subunit (60S) proteins. Only one mitochondrial ribosomal protein mRNA 
accumulated in Skiv2l2 knockdown cells. Sashimi plots for these upregulated ribosomal 
protein mRNAs (Fig 5.16) demonstrate that the exons accumulate in Skiv2l2 knockdown 
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cells when compared to control cells. This implies that SKIV2L2 either directly or 
indirectly impacts the steady-state levels of ribosomal protein mRNAs.  
Gene Expression 
log
2
 (fold 
change) 
chromosome 
location q-value 
Grb10 
Isoform 
Dependent 1.43 chr11 0.0014 
Impact Paternal 0.420 chr18 0.0026 
Snrpn Paternal 0.409 chr7 0.035 
Lin28a Paternal 0.373 chr4 0.020 
Peg12 Paternal -0.391 chr7 0.044 
Inpp5f Paternal -0.408 chr7 0.016 
Slc38a4 Paternal -0.450 chr15 0.014 
H19 Maternal -0.482 chr7 0.050 
Pigu Paternal -0.485 chr2 0.022 
Frat1 Paternal -0.521 chr19 0.39 
Ppp1r9a Maternal -0.544 chr6 0.0014 
Igf2 Paternal -0.578 chr7 0.0055 
Ocrl Paternal -0.844 chrX 0.0014 
Gab1 Paternal -0.909 chr8 0.049 
Plagl1 Paternal -1.17 chr10 0.0014 
Zdbf2 Paternal -1.38 chr1 0.039 
 
Table 5.2: Imprinted gene expression changes with Skiv2l2 knockdown. RNA-seq 
data demonstrated that a statistically significant number of known imprinted genes 
undergo changes in gene expression upon SKIV2L2 depletion. Genes with 
statistically significant changes in expression (q-value <0.05) included upregulated, 
downregulated, maternally expressed (pink), and paternally expressed (blue) genes. 
Genes highlighted in green are involved with growth signaling, and genes 
highlighted in orange are linked to the let-7 miRNA network. 
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B. 
Fig 5.16: Ribosomal protein mRNAs accumulate in Skiv2l2 knockdown cells. Sashimi 
plots for Rpl36 (A), Rps10 (B), and Mrps18a (C) show an accumulation of the entire 
mRNA in Skiv2l2 knockdown cells (blue) when compared to control cells (red) as 
measured via RNA-seq analysis in P19 cells.  
A. 
C. 
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  5.3 Discussion 
 Two RNA-seq studies were performed to identify potential SKIV2L2 target 
RNAs in mice. The first study in N2a cells relied on amplification with oligo-dT to detect 
only polyadenylated RNAs, which would include mRNAs and TRAMP complex targets. 
Non-coding RNAs found to accumulate following SKIV2L2 depletion were predicted to 
be potential targets of the TRAMP complex. However, these results needed to be verified 
at a molecular level. To accomplish this, qRT-PCR was employed to confirm the 
accumulation of these potential target RNAs, establish which part of the RNA was 
accumulating, and determine whether the TRAMP complex was involved. In addition to 
identifying U3, mir-322 5' leader, and the Z18 snoRNA as potential TRAMP targets, this 
method established a set protocol for verifying future targets of nuclear RNA 
surveillance. 
 In an effort to validate the poly-A-sequencing results, molecular cloning was 
performed to measure the length of A-tails on putative target RNAs. The finding that 
PAPD5 adds three to five adenosines to the 3' ends of target RNAs called into question 
the ability of oligo-dT to capture all potential TRAMP target RNAs (Wlotzka, 2011). For 
this reason, a second RNA-seq study was performed on total RNA to identify all potential 
SKIV2L2 target RNAs. By capturing the steady-state level of all RNAs, this RNA-seq 
study in P19 cells identified changes in gene expression and RNA accumulation 
following SKIV2L2 depletion. The resulting list of potential target RNAs included both 
targets of the TRAMP and NEXT complex, as polyadenylation was no longer required to 
detect target RNAs.  
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A significant number of non-coding RNAs were found among those RNAs 
accumulating in Skiv2l2 knockdown cells, confirming previous studies centered on the 
role of SKIV2L2 in non-coding RNA processing and turnover. Long non-coding RNAs 
represented the majority of accumulating non-coding RNAs.  lncRNAs have been linked 
to differentiation and pluripotency, with knockdown of 137 out of 147 lncRNAs inducing 
differentiation in mouse embryonic stem cells. These lncRNAs were found to regulate 
Nanog and Oct4 expression, repress specific cell-fates, and inhibit apoptosis (Guttman, 
2011). As studies continue to uncover more information about lncRNA function, the 
processing, turnover, and regulation of these lncRNAs is of particular interest. Many 
lncRNAs are not adenylated and function in the nucleus (Ghosal, 2013; Dey, 2010), 
making them potential targets of nuclear RNA surveillance. Given the mitotic arrest 
phenotype associated with SKIV2L2 depletion, it is possible that SKIV2L2 aids in the 
processing or degradation of lncRNAs to promote cell pluripotency and proliferation.  
Noticeably, many of the accumulating non-coding RNAs arise from introns or 
contain introns hosting smaller non-coding RNAs. For example both snoRNAs and 
miRNAs processed from lncRNAs, and the lncRNAs that contain such snoRNAs and 
miRNAs, were found to accumulate with SKIV2L2 depletion. This finding was not 
surprising, as the TRAMP complex promotes efficient pre-mRNA splicing in yeast  
(Kong KY, 2014), and human SKIV2L2 interacts with splicing factors (Lubas, 2011). 
Rbm7 proves necessary for splicing of intronic snoRNAs, possibly attributing the 
accumulation of intronic snoRNAs with SKIV2L2 depletion to the loss of NEXT 
complex function (Hrossova, 2015).  
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The majority of mRNAs dysregulated in Skiv2l2 knockdown cells are not 
expected to be direct targets of nuclear RNA surveillance. However, ribosomal protein 
mRNAs and histone mRNAs may represent unique instances of SKIV2L2-mediated 
degradation of mRNAs. The yeast TRAMP complex has been linked to the processing 
and turnover of specific mRNAs  (Milligan, 2005; Ciais, 2008), and Rbm7 binds pre-
mRNAs and 3' extended replication dependent histone mRNAs (Lubas, 2015). Given the 
previously established association between pre-mRNAs and nuclear RNA surveillance, it 
is not surprising that ribosomal protein mRNAs and histone mRNAs were found to 
accumulate in SKIV2L2 knockdown cells. However, this finding does represent a unique 
instance of nuclear mRNA turnover attributed to SKIV2L2, which was thought to mainly 
aid non-coding RNA turnover.  
The RNA-seq data also revealed a substantial change in the levels of intergenic 
transcripts. SKIV2L2 depletion resulted in the accumulation of over 700 transcripts 
arising from regions without annotated genes, while less than 100 were downregulated. 
This suggests that SKIV2L2 either directly or indirectly prevents the accumulation of 
spurious transcripts. Many of these regions contain processed pseudogenes containing 
repetitive elements. Because the RNA-seq data indicates only a subset of these regions 
accumulate, and the full-length pseudogenes do not bind SKIV2L2, it is hypothesized 
that piRNAs or other small RNAs arising from these regions might be processed or 
turned over through SKIV2L2-mediated RNA surveillance. Processed pseudogenes are 
known to harbor small regulatory RNAs (Pink, 2011), and the loss of SKIV2L2 may 
result in the accumulation of the small non-coding RNAs as opposed to the entire 
pseudogene. Small RNAs transcribed from processed pseudogenes in mouse oocytes 
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have been found to enter the siRNA pathway to regulate the expression of protein-coding 
genes. In addition, small RNAs that are antisense to pseudogenes regulate the expression 
of their protein-coding counterparts, particularly oncogenes such as Oct4 (Hawkins, 
2010). In light of these findings, SKIV2L2 may mediate the turnover of small regulatory 
RNAs, such as siRNAs, piRNAs, or antisense RNAs, and modulate the expression of 
protein-coding genes. Alternatively, changes in chromatin compaction could account for 
the upregulation of these intergenic regions. If SKIV2L2 depletion induces a more open 
chromatin environment, spurious transcription from intergenic regions could occur. 
While attempts to visualize global changes in chromatin compaction were inconclusive, 
previous studies agree that histone overexpression often induces changes in the chromatin 
structure only in specific regions (Eberle, 2015; Singh, 2010). While it is unclear whether 
SKIV2L2 depletion affects processed pseudogene processing, siRNA/piRNA turnover, or 
chromatin compaction, this RNA-seq experiment does casually associate nuclear RNA 
surveillance with the regulation of processed pseudogene transcripts.  
The two RNA-seq studies in N2a and P19 cells following SKIV2L2 knockdown 
established a pipeline for verifying SKIV2L2 target RNAs. This pipeline was used to 
identify multiple targets of SKIV2L2, both unique and previously known.  Of note, 
SKIV2L2 was linked to the turnover of 5' leader sequences of miRNAs, ribosomal 
protein mRNAs, snoRNAs, and lncRNAs. In addition, nuclear RNA surveillance appears 
to play some role in the regulation of intergenic transcripts. The resulting list of both 
accumulating and downregulated genes was probed in light of the mitotic arrest 
phenotype observed following SKIV2L2 depletion. In particular, ribosomal protein 
mRNAs and lncRNAs of unknown function could be responsible for mitotic arrest. On 
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the other hand, aberrant transcription from intergenic regions could cause mitotic arrest 
or be symptomatic of changes in chromatin structure that can lead to chromosome 
nondisjunction. These possibilities will be discussed further in Chapter VII.  
A. 
B. 
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CHAPTER VI: SKIV2L2 TARGETS HISTONE MRNAS FOR DEGRADATION 
IN THE NUCLEUS 
 
6.1 Introduction 
Hypothesis: SKIV2L2 targets histone mRNAs for degradation. 
 Studies on nuclear RNA surveillance have focused on the turnover of non-coding 
RNAs that function in the nucleus (Andersen, 2008). Even though some mRNA 
processing has been linked to the TRAMP complex in yeast (Nag, 2012; Kong, 2013; 
Hiriart, 2012; Milligan, 2005), the majority of mRNA turnover is thought to be coupled 
to translation in the cytoplasm (Chang, 2007). However, RNA-seq analysis of P19 cells 
revealed an accumulation of replication-dependent histone mRNAs following SKIV2L2 
depletion. Only two histone mRNAs were downregulated, both non-canonical, suggesting 
a strong connection between RNA surveillance and histone regulation. This finding led to 
further investigation into the role of SKIV2L2 in histone mRNA turnover.  
 Chromatin is composed of DNA wrapped around the nucleosome, an octamer of 
histones composed of two of each of the following histones: H2A, H2B, H3 and H4. The 
histone H1 binds to the linker DNA between nucleosomes. (Marzluff, 2008) Histone 
protein modifications change histone spacing and chromatin compaction, leading to areas 
of open euchromatin permissive to gene expression and closed heterochromatin 
containing transcriptionally silent genes (Bird, 2007). Because large quantities of histone 
proteins are necessary to package and maintain chromatin, mammalian genomes encode 
for over seventy-five replication-dependent histone genes (Marzluff, 2002). In mice, the 
replication-dependent histone genes are located in three genomic clusters containing 
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multiple genes encoding the H1, H2A, H2B, H3, and H4 histones. The Hist1 cluster 
contains over fifty histone transcripts, with additional histone genes found in the Hist2 
and Hist3 clusters. H4 and H2A genes are also located outside of the histone clusters, and 
certain histone variants, including H2A.X, H2A.Z, and H3.3, are expressed from distinct 
loci and regulated differently from the replication-dependent histones.  (Marzluff, 2002) 
The transcription of all these histone genes must be tightly regulated to ensure the correct 
stoichiometry of the histones in relation to each other and in relation to DNA (Gunjan, 
2005).  
 During S phase, the replication of DNA must be coordinated with its packaging 
into chromatin (Gunjan, 2005; Günesdogan, 2014). This requires increased histone 
protein production only during S phase, with lower levels of histones being generated 
throughout the cell cycle to replace histones already incorporated into chromatin 
(Marzluff, 2008). To accomplish this, histone levels are regulated at both the 
transcriptional and post-transcriptional level. At the onset of S-phase, the cyclinE-Cdk2 
complex phosphorylates the transcription factor NPAT located in Cajal bodies adjacent to 
the histone genomic clusters (Zhao, 2000). The phosphorylation of NPAT leads to its 
binding to the histone genes, enhancing histone transcription by 3-5 fold (Zhao, 2000). 
However, S phase requires 25-30 fold more histones than other phases of the cell cycle 
(Marzluff, 2008). This increase is accomplished through multiple post-transcriptional 
mechanisms that enhance the processing and translation of histone mRNAs.  
 Because replication-dependent histone mRNAs lack introns and poly-A-tails, 
their 3' end formation and translation require unique mechanisms (Marzluff, 2008). 
Histone mRNAs contain a 3' stem loop followed by a purine-rich histone downstream 
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element (HDE) (Zainer, 2002). Concurrent with transcription, SLBP, the major protein 
involved with histone mRNA processing and stabilization, binds to the stem loop and 
recruits the U7 snRNP (Zhao, 2004; Zhang, 2012). As U7 snRNA base-pairs with the 
HDE, multiple factors such as symplekin, CPSF100, and CPSF73 bind the histone 
mRNA and ultimately lead to cleavage of the 3' end of the histone mRNA via an 
unknown nuclease (Sullivan, 2009). This leads to the formation of the mature 3' end of 
the replication histones, which terminate in the stem loop. SLBP remains bound to the 
stem loop as it is required for export of the mRNA out of the nucleus (Sullivan, 2001; 
Zhang, 2002; Zhao, 2004; Marzluff, 2008). Circularization of the histone mRNA 
achieved through binding of the SLBP, SLIP, and EIF4G proteins then enhances the 
translation of the histone mRNA, making SLBP the key player in histone regulation 
(Ling, 2002). The downregulation of both SLBP and histone mRNAs at the end of S-
phase is necessary for cell cycle progression because the expression of histone proteins 
outside of S-phase negatively impacts chromosome segregation during mitosis and may 
titrate histone modifiers away from chromatin (Groth, 2005; Günesdogan, 2014; Gunjan, 
2005; Lanzotti, 2002; Meeks-Wagner, 1986; Singh, 2010). At the end of S phase, cyclin 
A-Cdk1 phosphorylates SLBP, leading to the proteolysis of SLBP (Koseoglu, 2008). 
Also, with the onset of G2 phase, histone mRNA stability decreases (Marzluff, 2008). 
 Previous research has shown that histone mRNA turnover is coupled to 
translation and nonsense mediated-decay proteins such as Upf1 (Kaygun, 2005ab). 
Cytoplasmic histone mRNA is uridylated by an unknown TUTase at the end of S phase 
or at the onset of DNA damage (Mullen, 2008; Schmidt, 2010). The poly(U) tail binds to 
Lsm proteins that recruit decapping enzymes (Kaygun, 2005ab; Mullen, 2008). This 
149 
 
ultimately results in the degradation of the histone mRNA in a 5' to 3' manner via the 
exonuclease Xrn1 (Kaygun, 2005ab; Mullen, 2008). However, in humans, the rapid 
degradation of histone mRNAs also depends on a different nuclease: PM/Scl100, the 
homolog of Rrp6 (Mullen, 2008). While Rrp6 in yeast is restricted to the nucle`ar 
exosome (Houseley, 2006), and initial studies on PM/Scl100 demonstrated its nuclear 
localization (Allmang, 2009), some researchers believe that a small fraction of 
PM/Scl100 functions in the cytoplasm in mammals (Lejeune, 2003). Initially, PAPD5 
was identified as the TUTase that uridylates histone mRNAs (Mullen, 2008), while 
further studies eliminated PAPD5 as the responsible TUTase (Schmidt, 2010). However, 
the link between PAPD5, PM/Scl100, and histone mRNA turnover hints that nuclear 
RNA surveillance may be involved in regulating histone levels during the cell cycle.  
The fact that Trf4p, the yeast homolog of PAPD5, and the TRAMP complex have 
been implicated in histone mRNA turnover in yeast (Reis, 2006) supports the possibility 
that SKIV2L2 mediates the degradation of mammalian histone mRNAs. In yeast, loss of 
Trf4p and the exosome component Rrp6 both lead to histone accumulation (Reis, 2006, 
Canavan, 2008). Similarly, knockdown of Rrp6 in Drosophila results in the accumulation 
of histone transcripts and inhibited cell cycle progression into M phase (Graham, 2009). 
In support of these studies, mature histone mRNAs accumulate following knockdown of 
human Rrp6 (PM/Scl100) but not Rbm7 in humans (Mullen, 2008). The RNA-seq 
experiment outlined in Chapter 5 identified replication-dependent mRNAs among RNAs 
accumulating following SKIV2L2 depletion. In regards to the mitotic arrest phenotype 
observed in Skiv2l2 knockdown cells, both reduction in and the accumulation of histone 
mRNAs and proteins have been shown to induce mitotic arrest in eukaryotes (Graham, 
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2009; Groth, 2005; Gunjan, 2003; Gunjan, 2005; Lanzotti, 2002; Meeks-Wagner, 1986; 
Murillo-Pineda, 2014; Zhao, 2004). This incriminates histone mRNAs as a potential 
candidate responsible for the observed mitotic arrest in Skiv2l2 knockdown cells. Indeed, 
Mtr4p depletion results in M phase arrest due to impaired microtubule spindle assembly 
(Smith, 2011), but it is unclear if this is due to a histone imbalance. The following 
research demonstrates that histone mRNAs are a unique mRNA target of the nuclear 
RNA surveillance in mammals. This finding is of significance for two reasons: it is the 
first finding of nuclear turnover of histone mRNAs, and histone mRNAs could be 
responsible for the activation of the spindle assembly checkpoint and resultant mitotic 
arrest following SKIV2L2 depletion.  
6.2 Approach and Results 
6.2.1 Histone mRNAs H1, H2A, H3, and H4 accumulate in P19 and N2a cells 
following SKIV2L2 depletion 
 
In addition to imprinted genes and ribosomal protein mRNAs, histone mRNAs were 
significantly overrepresented in the RNA-seq data (p-value< 1.85E-57). Over 75% of 
histone mRNAs were dysregulated in Skiv2l2 knockdown cells (Table 6.1). Of the sixty 
replication-dependent histone mRNAs, forty-six were found to accumulate following 
SKIV2L2 depletion, with greater than 1.5 fold accumulation occurring for 36 histone 
mRNAs. Multiple mRNAs encoding core histone proteins (H2A, H2B, H3, and H4) and 
the linker protein H1 accumulated with SKIV2L2 depletion, denoting a global change in 
histone regulation. Only two non-canonical histone mRNA transcripts, H2A.x and 
H2A.z, were downregulated. Notably, the spliced and polyadenylated mRNA encoding 
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the non-canonical histone H3.3 decreased slightly in abundance with SKIV2L2 depletion, 
although this downregulation was not statistically significant (q-value=.06). The 
replication-dependent histone mRNA accumulation seen with SKIV2L2 depletion 
suggests that nuclear RNA surveillance might influence histone mRNA turnover. 
To examine the accumulation seen at replication-dependent histone mRNAs, the 
sequencing data from P19 cells was plotted into Sashimi plots. The histone cluster 1 on 
chromosome 13 was examined in detail. Histone cluster 1 contains 45 histone mRNAs, 
thirty-seven of which were significantly elevated in Skiv2l2 knockdown cells. Histone 
cluster 1 consists of six H1 genes, nine H3 genes, five H2A genes, sixteen H2B genes, 
and nine H4 genes (Wang, 1996). Looking at the Sashimi plots, Hist1h1b accumulates in 
Skiv2l2 knockdown cells (blue) when compared to control knockdown cells (red, Fig 
6.1). In total, three out of six H1 histone mRNAs accumulate with SKIV2L2 depletion. 
The two non-canonical H1 histone mRNAs, H1f0 and Histh1t, do not change with 
Skiv2l2 knockdown. In cluster 1, all five H2A mRNAs and eleven out of sixteen H2B 
mRNAs accumulate with SKIV2L2 depletion. As seen in the Sashimi plots (Fig 6.2), 
H2A and H2B genes are often located in clusters, with the genes transcribed in divergent 
directions. In these cases, mRNAs arising from both the H2A and H2B gene accumulate 
in Skiv2l2 knockdown cells (blue) when compared to control knockdown cells (red). 
Similarly, all nine H3 and nine H4 mRNAs in cluster 1 accumulate with SKIV2L2 
depletion. The Sashimi plot of Hist1h3a shows higher levels of histone mRNA in Skiv2l2 
knockdown cells (Fig 6.3), as does the Sashimi plot of Hist1h4d (Fig. 6.4). 
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Histone Gene Name log2fold change q-value 
H3 Hist1h3e 3.422 0.0015 
H2A H2afj 2.8614 0.0015 
H4 Hist1h4j 2.4992 0.0055 
H2B Hist1h2bc 1.7225 0.0015 
H4 Hist1h4a 1.6044 0.0015 
H2B Hist1h2bn 1.5449 0.0015 
H2B Hist1h2bh 1.4328 0.0015 
H2A Hist1h2an 1.3952 0.0015 
H4 Hist1h4f 1.3176 0.0015 
H4 Hist1h4k 1.3143 0.0015 
H4 Hist1h4d 1.3043 0.0015 
H2B Hist1h2bk 1.2686 0.0015 
H3 Hist1h3i 1.1831 0.0015 
H2B Hist1h2bg 1.1672 0.0015 
H4 Hist1h4i 1.1225 0.0015 
H4 Hist1h4b 1.1002 0.0015 
H2A Hist2h2ac 1.0897 0.0015 
H2B Hist1h2bl 1.0895 0.0015 
H4 Hist2h4 1.0518 0.0015 
H4 Hist1h4h 1.0499 0.0015 
H2B Hist1h2bm 1.0281 0.0015 
H2A Hist3h2a 0.9981 0.0015 
H2A Hist1h2ah 0.9973 0.0055 
H2B Hist1h2be 0.9929 0.0015 
H3 Hist1h3f 0.9824 0.0015 
H2B Hist1h2bj 0.9806 0.0015 
H3 Hist1h3a 0.9728 0.0015 
H3 Hist1h3c 0.9416 0.0015 
H2A Hist1h2ak 0.9298 0.0015 
H4 Hist4h4 0.916 0.0015 
H2B Hist1h2bf 0.8984 0.0015 
H3 Hist2h3b 0.8816 0.0095 
H2B Hist3h2bb-ps 0.8594 0.0015 
H4 Hist1h4c 0.8594 0.0015 
H2A Hist1h2ai 0.8042 0.008 
H3 Hist1h3g 0.7957 0.0015 
H3 Hist1h3h 0.7068 0.0015 
H2B Hist1h2bp 0.6818 0.0015 
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H2B Hist3h2ba 0.6661 0.0015 
H3 Hist1h3d 0.5921 0.0015 
H2A Hist1h2ac 0.5881 0.02 
H3 Hist1h3b 0.5487 0.0015 
H1 Hist1h1b 0.5382 0.0015 
H1 Hist1h1c 0.4263 0.0036 
H2B Hist2h2bb 0.4164 0.0055 
H1 Hist1h1d 0.3362 0.0354 
H2A.X H2afx -2.398 0.0015 
H2A.Z H2afz -2.486 0.0015 
  
Fig 6.1: Hist1h1b transcripts accumulate in Skiv2l2 knockdown cells. Sashimi 
plots generated from RNA-seq data from P19 cells show higher levels of the 
entire Hist1h1b transcript in Skiv2l2 knockdown cells (blue) when compared to 
control cells (red). 
Table 6.1: Histone mRNA levels significantly change following Skiv2l2 
knockdown in P19 cells. RNA-seq identified a significant proportion of 
replication dependent histone mRNAs as accumulating in Skiv2l2 knockdown 
cells (q-value<0.05).  Log2fold change represents the fold change in Skiv2l2 
knockdown P19 cells compared to control P19 cells. Only two histone mRNAs 
are downregulated in Skiv2l2 knockdown cells, H2afx and H2afz, which are both 
non-canonical histone mRNAs. 
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B. 
A. 
Fig 6.2: Clusters of H2A and H2B transcripts accumulate in Skiv2l2 knockdown 
cells. A. Sashimi plots generated from RNA-seq data in P19 cells show higher 
levels of the entire Hist1h2ac and Hist1h2bc transcripts in Skiv2l2 knockdown 
cells (blue) when compared to control cells (red). B. Sashimi plot of the Hist1h2ah 
and Hist1h2bk loci shows a similar mRNA accumulation upon Skiv2l2 
knockdown.  
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Fig 6.3:Hist1h3a transcripts accumulate in Skiv2l2 knockdown cells. Sashimi plots 
generated from RNA-seq data in P19 cells show higher levels of the entire 
Hist1h3a transcript in Skiv2l2 knockdown cells (blue) when compared to control 
cells (red). 
Fig 6.4: Hist1h4d transcripts accumulate in Skiv2l2 knockdown cells. Sashimi 
plots generated from RNA-seq data in P19 cells show higher levels of the entire 
Hist1h4d transcript in Skiv2l2 knockdown cells (blue) when compared to control 
cells (red). 
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To verify the accumulation calculated in the RNA-seq data and visualized in the 
Sashimi plotting of that data, qRT-PCR was performed to measure the overall abundance 
of replication-dependent histone mRNAs. The sequence similarity between mRNAs 
makes distinguishing between individual transcript variants difficult, so primers were 
designed to probe for replication-dependent histone mRNA levels for total H1, H2A, 
H2B, H3, and H4 mRNAs. qRT-PCR verified that the replication-dependent histone 
mRNAs H1, H2A, H2B, H3, and H4 were significantly elevated in both N2a cells and 
P19 cells following SKIV2L2 depletion (Fig 6.5, d, n=3, p-values all < 0.05). In N2a 
cells, H1, H2A, H2B, and H4 mRNAs all accumulated approximately 3-fold, with a 
large, but highly variable 12-fold increase in H3 mRNA. SKIV2L2 depletion in P19 cells 
yielded a similar accumulation of the replication-dependent histone mRNAs, with 
approximately a 2 to 3-fold increase in H1, H2A, H2B, and H4 mRNAs. Attempts to 
detect histones following reverse transcription with oligo-dT were unsuccessful, 
suggesting that the accumulating histones lack long poly-A-tails that efficiently prime 
using oligo-dT. Overall, qRT-PCR and RNA-seq data both corroborate replication-
dependent histone mRNA accumulation following SKIV2L2 depletion. 
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A. 
B. 
Fig 6.5: Histone transcripts accumulate with SKIV2L2 depletion in N2a and P19 
cells. A. qRT-PCR of histone mRNAs in N2a cells. Expression levels of histone 
mRNAs were calculated using ΔCq values and normalized to ActB expression and 
control siRNA levels (error bars represent ±SD for n=3, p-values all <0.05). B. 
qRT-PCR of histone mRNAs in P19 cells. Expression levels of histone mRNAs 
were calculated using ΔCq values and normalized to ActB expression  and control 
siRNA levels (error bars represent ±SD for n=3, p-values all < 0.05).  
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6.2.2 Histone mRNAs accumulate slightly in Papd5 knockdown cells but not in 
Zcchc8 knockdown cells 
 
 Confident that SKIV2L2 depletion results in histone mRNA accumulation, the 
next experiment addressed whether the TRAMP or the NEXT complex could be involved 
in histone mRNA turnover. Both PAPD5 and ZCCHC8 were depleted via siRNA in N2a 
cells, and qRT-PCR was again utilized to measure the abundance of H4 mRNA. H4 was 
probed for because it moderately but consistently increased with Skiv2l2 knockdown. H4 
mRNA levels were normalized to ActB and compared to control siRNA-treated cells (Fig 
6.6). Papd5 knockdown cells showed a very slight increase in H4 mRNA (1.18-fold 
increase), while Zcchc8 knockdown cells had no detectable accumulation in H4 mRNA. 
This effectively demonstrates that ZCCHC8 is not essential for histone turnover. While 
the increase in H4 mRNA following PAPD5 depletion was statistically significant (p-
value< 0.0006), it did not replicate the 2-fold increase seen with SKIV2L2 depletion.   
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Fig 6.6: Histone H4 transcripts accumulate in Papd5 knockdown cells. qRT-
PCR measured histone H4 mRNAs in N2a cells following Papd5, Zcchc8, and 
control siRNA treatments. Expression levels of histone mRNAs were calculated 
using ΔCq values and normalized to ActB expression (error bars represent ±SD 
for n=3). A slight but statistically significant increase (denoted by asterisk, p-
value< 0.05) in H4 mRNA was observed in Papd5 knockdown cells but not 
Zcchc8 knockdown cells.  
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6.2.3 Histone transcript accumulation with SKIV2L2 depletion correlates to an 
increase in at least one histone protein 
 
Previous research in Drosophila found that histone mRNAs accumulate with loss 
of Rrp6, with no change in histone protein levels (Graham, 2009). To see if an increase in 
histone mRNA results in an increase in histone protein following SKIV2L2 depletion, 
total protein was recovered from control and Skiv2l2 knockdown cells. The total protein 
was fractionated into nuclear and cytoplasmic fractions, and the nuclear fraction was 
acid-extracted to release histones from DNA. Western blotting was then used to detect 
histone H4 in the acid-extracted fractions and ActB in the cytoplasmic fractions for 
normalization. Histone H4 protein levels increased by an average of 2.9 fold (n=3, p-
value< 0.03) in N2a cells and an average of 4.5 fold (n=3, p-value< 0.002) in P19 cells 
following Skiv2l2 knockdown (Fig 6.7). This demonstrates that the increase in histone H4 
mRNA transcripts following SKIV2L2 depletion correlates to an increase in H4 protein.  
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A. 
B. 
Fig 6.7: Histone H4 protein accumulates in Skiv2l2 knockdown cells. A. Western 
blot against Histone H4 in N2a cells. Acid extracted proteins from N2a cells 
transfected with either control or Skiv2l2 siRNA were probed for H4 (17 kD). 
Histone H4 protein levels were normalized to β-actin protein levels (42 kD) from 
the cytoplasmic fraction of the protein extraction that was run on a separate gel. 
B. Western blot against Histone H4 in P19 cells. Performed as stated in A on 
proteins extracted from P19 cells. 
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6.2.4 Histone accumulation with SKIV2L2 depletion may negatively impact 
chromatin compaction 
 
 Because both histone mRNAs and H4 protein were found to accumulate with 
SKIV2L2 depletion, it was hypothesized that these excess histones could affect 
chromatin compaction in Skiv2l2 knockdown cells. During prophase, chromatin becomes 
tightly compacted to prepare for the attachment of kinetochores during prometaphase and 
metaphase. Excess free histones have been shown to inhibit this chromatin compaction 
and trigger mitotic arrest, particularly if the histone dimer pairs (H2A-H2B and H3-H4) 
are not expressed with the correct stoichiometry (Meeks-Wagner, 1986; Singh, 2010). 
The observed histone imbalance with SKIV2L2 depletion could prevent the compaction 
of chromatin, leading to the observed mitotic arrest. To test this hypothesis, micrococcal 
nuclease assays were performed to measure the overall compactness of the chromatin in 
control and Skiv2l2 knockdown cells. Micrococcal nuclease cuts the DNA between 
histone octamers. When the chromatin is loose (euchromatin), the micrococcal nuclease 
will digest the DNA between histones, generating small fragments of DNA. If the 
chromatin is compact, histone octamers are spaced closer together, and the micrococcal 
nuclease cannot access the DNA. This leads to decreased digestion of the DNA, 
generating larger DNA fragments.  
The micrococcal nuclease assays performed on chromatin isolated from N2A cells 
treated with control and Skiv2l2 siRNA resulted in a qualitative assessment of overall 
chromatin compaction (Fig 6.8). As a control, isolated chromatin was digested with 
proteinase K to degrade histone proteins. The resulting naked DNA was then digested 
with micrococcal nuclease to verify that DNA digestion was complete in the absence of 
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histone proteins (Fig 6.8, lanes 2 and 3). No large DNA bands appeared on the gel, 
confirming that digestion was complete after 9 minutes of treatment with micrococcal 
nuclease. The intact chromatin from N2A cells was then digested in a similar manner 
(lanes 4-9). Each lane pair (4 and 5, 6 and 7, 8 and 9) represents a unique biological 
replicate. For chromatin extracted from control N2A cells, digestion generated mainly 
large DNA fragments and some small DNA fragments, generating a “smear” on the gel 
(lanes 4, 6, and 8). With SKIV2L2 depletion, chromatin digestion with micrococcal 
nuclease generates an increased number of smaller base pair fragments and fewer larger 
DNA fragments when compared to the control cells (lanes 5, 7, and 9). Lane 5 shows 
digestion to completion like with naked DNA, while lane 7 and 9 contain mainly smaller 
base pair fragments, effectively shifting the “smear” downward on the gel. This result 
suggests that the chromatin of control cells is compact, preventing the micrococcal 
nuclease from accessing the DNA and leading to increased distance between cut sites. 
This correlates to larger DNA fragments on the agarose gel. However, chromatin from 
Skiv2l2 knockdown cells is digested more completely, visualized as smaller base pair 
fragments on the agarose gel. While this qualitative analysis is not definitive proof, the 
result suggests that the chromatin could be less compact following SKIV2L2 depletion, 
leading to increased digestion with micrococcal nuclease. 
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     1      2       3        4        5       6        7       8       9 
Fig 6.8: Micrococcal nuclease assays suggest chromatin compaction defects  
following SKIV2L2 depletion. Chromatin was digested with micrococcal nuclease 
and run on an agarose gel. Lane 1- 100 bp ladder; 2- naked DNA digested with 
micrococcal nuclease from control N2A cells; 3- naked DNA digested with 
micrococcal nuclease from Skiv2l2 knockdown N2A cells; 4, 6, 8- chromatin 
digested with micrococcal nuclease from control N2A cells; 5, 7, 9- chromatin 
digested with micrococcal nuclease from Skiv2l2 knockdown N2A cells. Smaller 
DNA fragments, particular noticeable in lane 7, indicate more complete digestion. 
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6.2.5 Histone mRNAs are detected among RNAs bound to the SKIV2L2 protein 
In order to support the assertion that replication-dependent histone mRNA 
turnover requires SKIV2L2, experiments sought to demonstrate that SKIV2L2 binds 
histone mRNAs in vivo, thereby establishing a direct, physical link between SKIV2L2 
and histone mRNA. To demonstrate that histone mRNAs directly associate with the 
nuclear-localized SKIV2L2 (Norbury, 2011; Lubas, 2011; Osman, 2011), cross-linked 
immunoprecipitation was performed to detect histone mRNAs bound to SKIV2L2. Both 
N2a and P19 cells were irradiated with UV light to crosslink RNA to protein, and 
proteins were bound to beads coated with antibodies directed against either SKIV2L2 or 
a negative control goat IgG. Western blots demonstrated that anti-SKIV2L2 successfully 
pulled down approximately 10% of cellular SKIV2L2, while no SKIV2L2 was detected 
in the eluate from control IgG (Fig 6.9a, Fig 6.10a).  
RNAs immunoprecipitated with anti-SKIV2L2 were compared to those RNAs 
immunoprecipitated with the control antibody using qRT-PCR. Histone mRNA levels in 
immunoprecipitates were normalized against Skiv2l2 and Tubb3 mRNA, which both 
showed no binding to SKIV2L2. Compared to RNA immunoprecipitated with anti-goat 
IgG, replication dependent histone mRNAs (H1, H2A, H2B, H3, and H4) were elevated 
among RNAs immunoprecipitated with anti-SKIV2L2, as measured via qRT-PCR (Fig 
6.9b,6.10b, all p-values< 0.05). In N2a cells, H1, H2A,H2B,  and H4 were enriched 
among those RNAs pulled down with anti-SKIV2L2 by more than 5-fold, while H3 was 
found at levels 2-fold above the control (Fig 6.9b). Among those RNAs that 
immunoprecipitated with SKIV2L2, retro-Phgdh mRNA levels were not above those 
166 
 
seen in the control immunoprecipitate, suggesting that the protocol sufficiently 
distinguished between RNAs bound to SKIV2L2 and unbound RNA. P19 cells proved to 
yield a more dramatic result, with H1, H2A, and H3 being pulled down with anti-
SKIV2L2 at levels 20-fold or greater above those seen in control cells, and H2B and H4 
enriched in the immunoprecipitate approximately 10-fold about control levels (Fig 
6.10b).  Because close association is necessary to crosslink RNA to protein, these results 
demonstrate binding of SKIV2L2 to histone mRNAs in vivo in both N2a and P19 cells.  
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A. 
Fig 6.9: RNA immunoprecipitation demonstrates SKIV2L2 binding to histone 
mRNAs in N2a cells. A. Western blots against immunoprecipitated SKIV2L2. 
Lanes 1, 3-total cell lysate; lane 2-eluate following immunoprecipitation with 
anti-goat Ig; lane 4- eluate following immunoprecipitation with anti-SKIV2L2. 
Top band represents SKIV2L2, bottom band is the heavy chain of the antibody 
used for immunoprecipitation. B. qRT-PCR of histone RNAs bound to 
immunoprecipitated SKIV2L2 in N2a cells. Proteins were extracted from N2a 
cells irradiated with UV light, and SKIV2L2 was immunoprecipitated with its 
associated RNAs using anti-SKIV2L2. Anti-goat was used as a negative control, 
and RNA was isolated from both samples. Using qRT-PCR, RNA abundance 
levels of histone mRNAs immunoprecipitated in either sample were calculated 
using ΔCq values, and normalized for background noise based on the 
amplification of Skiv2l2 mRNA transcript, which was unbound in both samples 
(error bars represent ±SD for n=3). Immunoprecipitated retro-Phgdh represents 
an RNA precipitated equally by anti-goat and anti-SKIV2L2. 
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A. 
B. 
Fig 6.10: RNA immunoprecipitation demonstrates SKIV2L2 binding to histone 
mRNAs in P19 cells. A. Western blots against immunoprecipitated SKIV2L2. 
Lanes 1, 3-total cell lysate; lane 2-eluate following immunoprecipitation with 
anti-goat Ig; lane 4- eluate following immunoprecipitation with anti-SKIV2L2. 
Top band represents SKIV2L2, bottom band is the heavy chain antibody used for 
immunoprecipitation. B. qRT-PCR of histone RNAs bound to 
immunoprecipitated SKIV2L2 in P19 cells. Proteins were extracted from P19 
cells irradiated with UV light, and SKIV2L2 was immunoprecipitated with its 
associated RNAs using anti-SKIV2L2. Anti-goat was used as a negative control, 
and RNA was isolated from both samples. Using qRT-PCR, RNA abundance 
levels of histone mRNAs immunoprecipitated in either sample were calculated 
using ΔCq values, and normalized for background noise based on the 
amplification of Skiv2l2 mRNA transcript, which was unbound in both samples 
(error bars represent ±SD for n=3). Immunoprecipitated retro-Phgdh represents 
an RNA precipitated equally by anti-goat and anti-SKIV2L2. 
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6.2.6 The half-life of H4 mRNA increases following SKIV2L2 depletion 
Given that histone mRNAs were found to accumulate with loss of SKIV2L2, and 
SKIV2L2 was found to directly bind to histone mRNAs, it was hypothesized that 
SKIV2L2 is necessary for the turnover of these histone mRNAs. To confirm this, 
experiments aimed to establish that SKIV2L2 depletion leads to a reduction in histone 
mRNA turnover and an increase in histone mRNA half-life. This evidence would further 
support the notion of SKIV2L2-mediated turnover of replication-dependent histone 
mRNAs. Histone mRNA turnover was assessed using Northern blotting. Following either 
Skiv2l2 or control siRNA knockdown, N2a cells were treated with Dactinomycin, which 
inhibits RNA polymerase II transcription (Bensaude, 2011). At time points following 
Dactinomycin treatment, cells were harvested to isolate RNA, which was utilized in 
Northern blotting and probed for histone H4 mRNA. Since transcription was inhibited, 
any subsequent decrease in H4 mRNA would be due to turnover. RNA from Skiv2l2 and 
control knockdown cells that were not treated with Dactinomycin was also probed for H4 
mRNA. Northern blots confirmed the 1.9 fold increase (p-value< 0.04, n=3) in H4 
mRNA observed in Skiv2l2 knockdown cells (Fig 6.11). This demonstrated that Northern 
blotting was sensitive enough to discriminate differences in H4 mRNA levels after 
treatment with Dactinomycin. In a pilot experiment, H4 mRNA was not detected after 6 
hours of Dactinomycin treatment. Therefore, the time points were selected to measure H4 
mRNA for 4 hours after Dactinomycin treatment. In the first trial, samples were collected 
at 0, 1, 2, 3, and 4 hours. However, RNA yield was not of sufficient quality at the 0 and 1 
hour time points in Skiv2l2 knockdown cells, and no H4 mRNA was detected in control 
cells after 2 hours. Therefore, Northern blotting detected H4 mRNA at 0, 1, and 2 hours 
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in control N2a cells and at 2, 3, and 4 hours in Skiv2l2 knockdown cells. While H4 
mRNA was depleted after 2 hours in control cells, H4 mRNA remained in Skiv2l2 
knockdown cells at 4 hours (Fig 6.11a). While this did not allow for direct comparison at 
hour time points, the H4 mRNA levels were used to calculate mRNA half-life in both 
control cells and cells depleted of SKIV2L2.  
To correct for issues in RNA quality in the first trial of this experiment, a second 
trial was performed. In control cells, H4 mRNA was depleted to negligible levels four 
hours after Dactinomycin treatment (Fig 6.11b). However, at four hours post 
Dactinomycin treatment, Skiv2l2 knockdown cells retained higher levels of H4 mRNA 
(Fig 6.11b). This result was consistent with the first trial, suggesting that cells depleted of 
SKIV2L2 exhibit a decreased rate of H4 mRNA turnover. However, the second trial did 
reveal the appearance of two H4 mRNA bands. Both bands were found to decrease at 
identical rates in both control and Skiv2l2 knockdown cells, so it is possible that the lower 
band corresponds to degradation intermediates or a transcript variant. Using the data from 
the first and second trials, the half-life of H4 mRNA was calculated. In control cells, the 
mRNA half-life was 34 minutes, while the half-life increased to 72 minutes following 
SKIV2L2 depletion (p-value< 0.04, n=2). For trial two, both the upper and lower band 
had identical half-lives. Given that Dactinomycin inhibited transcription in these samples, 
a slower rate of mRNA decay must be responsible for the increase in H4 mRNA half-life.  
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Fig 6.11: Skiv2l2 knockdown impairs H4 histone mRNA turnover, doubling its mRNA 
half-life. Northern blots tracking H4 mRNA turnover following Dactinomycin 
treatment. RNA was extracted from control and Skiv2l2 knockdown N2a cells following 
application of Dactinomycin at 1 hour timepoints. Northern blotting detected H4 
mRNA, which was quantified and normalized to ActB mRNA levels to calculate half-
life. A and B represent two unique biological replicates. In A, RNA quality for control 
siRNA at 3 hr and 4 hr and Skiv2l2 siRNA 0 hr and 1 hr was low and excluded from 
analysis.  
 
A. 
B. 
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6.3 Discussion 
Initial analysis of the RNA-seq data from P19 cells revealed that replication-
dependent histone mRNAs accumulated with SKIV2L2 depletion. This accumulation was 
confirmed through qRT-PCR of histone mRNAs following SKIV2L2 depletion in both 
N2a and P19 cells. In light of this, replication dependent-histone mRNAs were 
hypothesized to be a potential SKIV2L2 target. To confirm histone mRNAs as a RNA 
surveillance target via SKIV2l2, experiments proved that SKIV2L2 depletion prevents 
histone mRNA turnover and that SKIV2L2 directly binds histone mRNAs. Because 
replication-dependent histone mRNAs immunoprecipitated with SKIV2L2 at high levels, 
these results conclusively demonstrate SKIV2L2 directly binds to histone mRNAs in 
vivo. Coupled with the doubling of H4 mRNA half-life following SKIV2L2 depletion, 
we conclude that SKIV2L2 directly aids in the turnover of replication-dependent histone 
mRNAs. 
Sequencing data established that the majority of replication-dependent histone 
mRNAs accumulated with SKIV2L2 depletion, while the loss of nuclear RNA 
surveillance triggered downregulation of certain non-canonical histone mRNAs. 
Identification of the human NEXT complex demonstrated that two histone proteins, 
H2Bn and H2A.X, co-immunoprecipitated with human SKIV2L2 (Lubas, 2011). 
Looking at the corresponding mRNAs in mouse P19 cells, SKIV2L2 depletion led to the 
accumulation of Hist1h2bn mRNA and the downregulation of H2Afx mRNA. 
Additionally, Skiv2l2 knockdown increased H4 protein levels, suggesting that 
SKIV2L2’s role in histone mRNA turnover affects histone protein abundance. While not 
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definitive, micrococcal nuclease assays suggest that this increase in histone protein with 
SKIV2L2 depletion may negatively impact chromatin compaction. These findings allude 
to a possible role for SKIV2L2 in regulating histone levels that includes physical 
association with both histone mRNAs and proteins.   
While results implicated SKIV2L2 in histone mRNA turnover, experiments could 
not definitively confirm the role of the TRAMP complex in this process. PAPD5 
depletion led to a slight but significant increase in H4 mRNA. However, it is unclear 
whether the accumulation is due to the loss of PAPD5 or reduced SKIV2L2 protein 
levels, which were discussed previously. Even though the TRAMP complex was not 
proven to participate in histone mRNA turnover, the NEXT complex is not essential to 
the process, seeing as ZCCHC8 depletion had no effect on histone mRNA levels. This 
result agrees with experiments that demonstrate no change in histone mRNA levels with 
knockdown of the NEXT complex component Rbm7 (Mullen, 2008) but conflicts with 
reports that Rbm7 binds 3' extended histone mRNAs (Lubas, 2015). This hints at the 
possibility of a more complicated model for nuclear histone mRNA turnover, which may 
include different turnover pathways for both mature and aberrant transcripts. Previous 
experiments show that PAPD5 is dispensable for TRAMP complex function on certain 
RNA targets (Rammelt, 2011; Beaulieu, 2012), which could explain why loss of PAPD5 
does not have a large effect on histone mRNA levels. Alternatively, the helicase 
SKIV2L2 could function independently to remove the 3' stem loop and proteins like 
SLBP that are bound to the stem loop. Indeed, other RNAs with highly structured 3' end 
require helicases to aid in turnover via the nuclear exosome (Schilders, 2007; Dominski, 
2003).   
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In yeast, the TRAMP complex regulates the turnover and 3' end processing of the 
signal recognition particle RNA (SRP RNA) scR1 (Leung, 2014). SRP RNA is highly 
structured, and the protein La family protein, Lhp1, protects the mature 3'end from 
degradation and further processing. TRAMP degrades a subset of SRP RNA, but Lhp1 
overexpression prevents this turnover, suggesting that TRAMP and Lhp1 compete for the 
3' end of SRP RNA. Histone mRNAs could be turned over in a similar manner (Leung, 
2014). SLBP binds to and protects the 3' end of histone mRNAs (Zhang, 2012). At the 
end of S-phase, SLBP is degraded through proteolysis (Koseoglu, 2008). In competition 
for the binding of the 3' end of histone mRNAs, SKIV2L2 might outcompete SLBP for 
histone mRNAs at the end of S phase, leading to mRNA turnover.  
 Overall, there is substantial evidence that SKIV2l2 aids in the turnover of 
replication-dependent histone mRNAs. Because all localization studies have documented 
SKIV2L2’s location as nuclear and nucleolar (Osman, 2011; Lubas, 2011), this 
represents the first reported instance of nuclear histone mRNA turnover. Previous 
research has implicated Rrp6 and PAPD5 in mammalian histone mRNA turnover 
(Mullen, 2008), but these results were either assumed to occur in the cytoplasm or 
dismissed. By confirming that SKIV2L2 is necessary for histone mRNA turnover, a new 
model for nuclear histone mRNA turnover has emerged, one that includes Rrp6, 
SKIV2L2, and possibly PAPD5. We hypothesize that SKIV2L2 binds to histone mRNAs, 
displaces SLBP and other stem-loop binding proteins, unwinds the stem-loop, and feeds 
the histone mRNA into the nuclear exosome. This could occur as histone mRNAs are 
being transcribed at the end of S phase to quickly degrade histone mRNAs in the nucleus, 
while cytoplasmic histone mRNAs are uridylated and degraded (Kaygun, 2005ab, 
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Kaygun, 2006; Mullen, 2008). This model and its influence on cell cycle progression will 
be discussed in depth in the next chapter.  
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CHAPTER VII: FINAL CONCLUSIONS 
In this dissertation, it was reported that SKIV2L2 is necessary to enhance 
proliferation and prevent differentiation in two murine cell lines. SKIV2L2 depletion in 
proliferative cells led to mitotic arrest, but it is unclear whether this phenotype is 
attributed to SKIV2L2 working independently or its function in the TRAMP complex. 
Given that SKIV2L2 targets RNAs for processing and turnover via the nuclear exosome, 
it was hypothesized that loss of SKIV2L2 leads to the accumulation of aberrant RNAs 
that trigger mitotic arrest. RNA-seq identified multiple RNAs targeted by SKIV2L2 for 
processing and degradation, including non-coding RNAs, intergenic RNAs, ribosomal 
protein mRNAs, and replication-dependent histone mRNAs. While the accumulation of 
many of these target RNAs could be responsible for the observed mitotic arrest with 
SKIV2L2 depletion, replication-dependent histone mRNAs were probed in further detail. 
It was found that SKIV2L2 directly binds histone mRNAs and that SKIV2L2 depletion 
doubles histone mRNA half-life. Together, this identified replication-dependent histone 
mRNAs as a definitive target of SKIV2L2-mediated RNA surveillance. Accumulation of 
histone mRNA and protein can hinder cell cycle progression, making histone mRNAs a 
viable SKIV2L2 target RNA capable of causing the mitotic arrest observed with 
SKIV2L2 depletion. 
7.1 SKIV2L2 and its role in differentiation and proliferation 
 The experiments presented in this dissertation highlighted the phenotype 
associated with SKIV2L2 depletion. Following Skiv2l2 knockdown via RNAi, cell 
proliferation slowed, pluripotency genes were downregulated, and differentiation genes 
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were upregulated. This phenotype occurred in both P19 and N2a cells, resulting in 
differentiation into both cardiac muscle and neurons. Neither knockdown of the TRAMP 
complex component PAPD5 nor the NEXT complex component ZCCHC8 could 
perfectly replicate the phenotype associated with SKIV2L2 depletion. This finding 
suggests that SKIV2L2 maintains cell proliferation and prevents differentiation through 
the turnover and processing of multiple RNA targets, either independently, in concert 
with the NEXT and TRAMP complexes, or a combination of these instances. 
 Because SKIV2L2 depletion led to decreased proliferation and increased 
differentiation, the cell cycle was examined to pinpoint a specific defect in cell growth or 
division. Increased cell death and apoptosis were not observed with SKIV2L2 depletion, 
which correlated well with the upregulation of anti-apoptotic genes according to the 
RNA-seq data. Usually, exit from the cell cycle at G1 precedes differentiation, which was 
visualized as G1 arrest in chemically differentiated N2a cells. Surprisingly, Skiv2l2 
knockdown reduced the percentage of cells in G1 phase. Instead, SKIV2L2 depletion 
triggered an accumulation of G2/M phase cells, mitotic arrest, and binucleation. A 
previous RNAi screen in HeLa cells corroborated this finding. Skiv2l2 knockdown cells 
were reported as being binucleated, with no delay in the onset of mitosis (Neumann, 
2010). Consistent with both datasets is a model where SKIV2L2 depletion primarily 
affects later stages of mitosis and cytokinesis, such as chromosome segregation, as 
opposed to regulating the timing of mitosis itself. 
 Interestingly, the study that identified the NEXT complex in humans lends insight 
into the role of SKIV2L2 in mitotic progression. Multiple proteins involved with 
proliferation and mitosis co-immunoprecipitate with SKIV2L2. SKIV2l2 associates with 
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the spliceosome and splicing factors for an unknown function (Lubas, 2011), and some of 
these splicing factors are necessary for mitotic progression. For example, ERH is required 
for proper splicing of the mRNA for the CENP-E gene, which encodes the kinesin motor 
protein localized to centromeres during mitotic chromosome segregation (Weng, 2013). 
In addition to ERH, the RNA processing gene Dhx9 also associates with SKIV2L2 
(Lubas, 2011). The helicase Dhx9 functions in complex with other proteins to protect 
Myc mRNA from cytoplasmic decay (Weidensdorfer, 2009), and loss of Dhx9 triggers 
premature cellular senescence through p53 (Lee, 2014). In immortalized cancer cells like 
P19 and N2a, senescence leads to differentiation, hinting that the differentiation observed 
with SKIV2L2 depletion may be similar to the senescence associated with Dhx9 
depletion and destabilization of Myc.  
Also similar to Dhx9, SKIV2L2 is connected to the transcription factor Myc, 
which regulates multiple genes involved in cell growth, proliferation, and differentiation 
(Hirsch, 2015). In many cancers, Myc is constitutively activated, leading to constant 
upregulation of the cyclin genes and enhanced cell cycle progression (Mateyak, 1999). 
Myc is necessary to reprogram mouse embryonic fibroblasts into induced pluripotent 
stem cells (Takanashi, 2006). This reprogramming depends on Myc, in complex with 
SAGA, upregulating cell cycle and RNA processing genes (Hirsch, 2015). Interestingly, 
the Myc-SAGA complex binds to and activates Skiv2l2 transcription during this 
reprogramming (Hirsch, 2015), further implicating SKIV2L2 as a factor necessary for 
stem cell formation and/or maintenance. The SAGA complex and Myc both are 
downregulated with differentiation through growth signaling (Hirsch, 2015), which could 
179 
 
account for the downregulation of Skiv2l2 following chemically induced differentiation in 
P19 and N2a cells.  
The downregulation of Skiv2l2 during differentiation further cements the role for 
SKIV2L2 in maintaining stem cell proliferation and pluripotency but also raises 
questions about nuclear RNA surveillance in differentiated cells. RNA-seq studies have 
demonstrated the developmental downregulation of Skiv2l2 as well (Cinghu, 2014), but 
the Human Protein Atlas documents medium to high SKIV2L2 expression levels in all 
human tissues, cell lines, and cancer cells (Uhlen, 2010). In zebrafish, Skiv2l2 mutations 
are embryonic lethal, presumably due to underdevelopment in the brain and immune 
system (Yang, 2007; Hultman, 2010; Iwanami, 2009). This suggests that high levels of 
SKIV2L2 are necessary for development, and differentiated cells may require lower 
levels of nuclear RNA surveillance. It is unclear whether Skiv2l2 is upregulated following 
differentiation or if differentiated cells function with less SKIV2L2 than stem cells 
despite how nuclear RNA surveillance is thought to be essential to cell health.  
However, the experiments in this dissertation definitively link SKIV2L2 to 
proliferation in mouse cell lines. The increase in mitotic cells following SKIV2L2 
depletion suggests that differentiation aberrantly occurs through a mechanism distinct 
from developmental or chemically-induced differentiation, particularly through mitotic 
slippage, followed by failed cytokinesis and the senescence and differentiation of 
binuclear 4N cells. Even though p53 does not regulate the spindle assembly checkpoint, 
p53-mediated apoptosis is activated when cells arrest in mitosis for prolonged periods of 
time (Orth, 2012). Without p53, these cells often undergo mitotic slippage and failed 
cytokinesis (Orth, 2012; Rieder, 2004). Because N2a and P19 cells lack p53, SKIV2L2 
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depletion results in mitotic arrest, binucleation following mitotic slippage, and possibly 
cellular senescence and differentiation. This phenotype could be unique to cancer cell 
lines, so further research must be conducted in primary cells, embryonic stem cells, and 
iPSCs to see how SKIV2L2 depletion affects proliferation when apoptotic pathways are 
intact.  
7.2 SKIV2L2 mediates the turnover and processing of multiple classes of RNAs 
 Understanding how SKIV2L2 functions in both nuclear RNA surveillance and 
stem cell maintenance requires identifying SKIV2L2 target RNAs. Expanding on 
previous research, this dissertation presented a pipeline for identifying and verifying 
SKIV2L2 target RNAs. First, RNA-seq identifies RNAs accumulating in Skiv2l2 
knockdown cells, representing putative target RNAs. Then, this accumulation is verified 
through qRT-PCR, which can also be used to detect poly-A-tails through oligo-dT 
priming in certain cases. Next, RNA immunoprecipitation demonstrates SKIV2L2 
binding to target RNAs. Performing qRT-PCR after RIP can monitor binding of 
individual putative target RNAs, while RIP followed by RNA-seq can be used to generate 
a list of all RNAs bound to SKIV2L2. Those RNAs found to both accumulate with 
SKIV2L2 depletion and bind to SKIV2L2 represent target RNAs. Finally, if the half-life 
of a particular target RNA increases with SKIV2L2 depletion and Dactinomycin 
treatment, then that RNA is a validated SKIV2L2 target whose turnover depends on 
SKIV2L2-mediated RNA surveillance. This pipeline can also be applied to PAPD5 and 
ZCCHC8 target RNAs to distinguish between TRAMP and NEXT complex targets.  
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 Target RNAs identified through RNA-seq included lncRNAs, snoRNAs, 
intergenic RNAs, ribosomal protein mRNAs, and replication-dependent histone mRNAs. 
Of these, only replication-dependent histone mRNAs represent validated SKIV2L2 target 
RNAs based on the experiments presented in this dissertation. However, other studies 
have established that SKIV2L2 mediates lncRNA (Beaulieu, 2012), PROMPT (Tiedje, 
2014), and snoRNA (Berndt, 2012; Lubas, 2015) processing and turnover. In the future, 
this pipeline can be used to validate unique SKIV2L2 target RNAs, such as ribosomal 
protein mRNAs and small RNAs arising from processed pseudogenes. Importantly, 
RNA-seq did highlight a previously established trend that links SKIV2L2 to the 
processing of spliced transcripts, such as snoRNAs and lncRNAs, and identify a novel 
role for SKIV2L2 in the turnover of two protein-coding RNAs: ribosomal protein 
mRNAs and replication-dependent histone mRNAs. While previous research attributed 
histone turnover to cytoplasmic NMD, this research has discovered a nuclear RNA 
surveillance pathway for histone mRNAs via the nuclear localized SKIV2L2 (Uhlen, 
2010; Osman, 2011). 
7.3 The accumulation and misprocessing of SKIV2L2 target RNAs may trigger 
mitotic arrest 
 
 Because SKIV2L2 depletion triggers mitotic arrest and leads to the accumulation 
of target RNAs, it reasons that one or a few of these targets RNAs cause the observed 
mitotic arrest. Intergenic RNAs, lncRNAs, snoRNAs, ribosomal protein mRNAs, and 
replication-dependent histone mRNAs all could contribute to slowed proliferation, and 
the accumulation of one or multiple RNAs could trigger mitotic arrest following 
SKIV2L2 depletion. In particular, spurious transcription from intergenic regions, 
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dysregulation of ribosome biogenesis, and increased free histone levels could lead to 
mitotic arrest in Skiv2l2 knockdown cells (Fig 7.1). 
 The TRAMP complex is located in the nucleolus (Lubas, 2011), where ribosome 
biogenesis occurs, so it is not surprising that SKIV2L2 and the TRAMP complex are 
linked to ribosome biogenesis. Ribosome biogenesis requires rDNA transcription by 
RNA pol I and rRNA processing directed by snoRNAs and cofactors. Ribosomal proteins 
are imported into the nucleolus where the ribosome is assembled before export to the 
cytoplasm (Boisvert, 2007). Previous research demonstrated that SKIV2L2 mediates the 
processing of ribosomal RNA (Schilders, 2007; Lubas, 2015). Additionally, SKIV2L2 
physically interacts with 61 out of 79 ribosomal proteins (Lubas, 2011). This dissertation 
presents a novel connection between SKIV2L2 and ribosome biogenesis. Ribosomal 
protein mRNAs were dysregulated with SKIV2L2 depletion. A substantial number of 
ribosomal protein mRNAs accumulate in Skiv2l2 knockdown cells, while a few are 
downregulated. Given that SKIV2L2 mediates the processing of rRNA, promotes the 
turnover of ribosomal protein mRNAs, and associates with ribosomal proteins, SKIV2L2 
plays an important role in ribosome biogenesis.  
 The ribosome is tightly linked to cell cycle control. As the cell grows, more 
ribosomes are assembled in the nucleolus to support increased translation. Before the cell 
can divide, it must double its number of ribosomes so that both daughter cells receive a 
sufficient number of ribosomes. (Boisvert, 2007) Proliferating cells require increased 
levels of rRNA transcription, and high levels of ribosomes prevent differentiation 
(Zhang, 2014). Therefore, ribosome biogenesis regulates the timing and progression of 
the cell cycle. For example, impaired ribosome biogenesis often triggers G1-S phase 
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arrest and apoptosis (Donati, 2012). In addition, the expression of certain ribosomal 
proteins like human L13a causes G2/M phase arrest and apoptosis (Chen, 1999). The 
transcription factor Myc serves as a master regulator of ribosome biogenesis and controls 
the transcription of multiple genes involved with the each step of ribosome biogenesis 
(van Riggelen, 2010), including Skiv2l2 (Hirsch, 2015). In addition to SKIV2L2’s 
function in rRNA processing and ribosomal protein mRNA turnover, the fact that Myc 
coordinates Skiv2l2 expression and ribosome biogenesis may indicate that nuclear RNA 
surveillance plays a central role in regulating ribosome biogenesis. With SKIV2L2 
depletion, ribosome biogenesis may be impaired, leading to cell cycle arrest, reduced 
proliferation, and ultimately differentiation. In support of this, replicative stress in stem 
cells leads to Skiv2l2 downregulation, slowed rRNA processing, and cellular senescence 
(Nishimura, 2015). 
 While impaired ribosome biogenesis could trigger cell cycle arrest and 
differentiation, spurious transcription and excess histones also could account for the 
proliferation defects seen in Skiv2l2 knockdown cells. Although not definitive in its 
conclusion, micrococcal nuclease digestion of chromatin following SKIV2L2 depletion 
suggests a defect in chromatin compaction may be responsible for the observed mitotic 
arrest. At the onset of mitosis, chromatin condenses, preventing certain transcription 
factors and RNA polymerase II from accessing the DNA (Chen, 2004).  Proper spindle 
assembly and chromosome segregation requires transcriptional activation and silencing at 
proper regions (Chan, 2012; Pastor, 2016). Chromatin modifiers and transcription factors 
that can access the condensed chromatin silence the majority of the genome (Chen, 
2004). Small areas of the genome are activated, particular genes necessary for mitosis, 
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such as cyclin-B1 (Sciortino, 2010) and small RNAs transcribed from the centromere to 
promote spindle attachment and activate the mitotic Aurora kinases (Chan, 2012). 
However, the majority of the genome is transcriptionally silenced. Spurious transcription 
from intergenic regions could either be responsible for or symptomatic of a more open 
chromatin environment. With SKIV2L2 depletion, small RNAs arising from intergenic 
regions accumulate. These intergenic RNAs, which include PROMPTs and processed 
pseudogenes, are transcribed from various regions on each chromosome, eliminating the 
possibility that these are RNAs at the centromere to promote mitosis. If spurious 
transcription occurs at these regions during mitosis, it could negatively impact spindle 
attachment and chromosome segregation. Analysis hints that a subset of the small RNAs 
transcribed from processed pseudogenes may be piRNAs, which play a role in 
transcriptional silencing and chromatin condensation during mitosis (Pek, 2011). 
SKIV2L2-mediated RNA surveillance may function in the turnover and transcriptional 
silencing of RNAs transcribed from intergenic regions, thereby promoting chromatin 
condensation and mitosis.  
 It is also probable that defects in chromatin condensation are result of histone 
imbalance. Replication-dependent histone mRNAs are a direct SKIV2L2 target whose 
accumulation could impair chromatin condensation and induce mitotic arrest. SKIV2L2 
depletion leads to both an accumulation in histone mRNAs and at least one histone 
protein, H4. Cell cycle progression is sensitive to the level of histones in the cell, with 
both histone depletion and accumulation triggering cell cycle arrest in G2 or M phase 
(Günesdogan, 2014; Sullivan, 2001; Groth, 2005). In both cases, the cell cycle arrest is 
attributed to defects in chromatin compaction during mitosis, which leads to impaired 
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spindle assembly, improper chromosome segregation, non-disjunction, and DNA damage 
(Meeks-Wagner, 1986; Sullivan, 2001).  In the case of excess histones, the positively-
charged free histones inappropriately bind to negatively-charged DNA and RNA (Singh, 
2010), which impairs proper chromatin compaction and leads to mitotic arrest (Meeks-
Wagner, 1986).  Additionally, excess histones titrate chromatin modifiers away from the 
chromatin (Singh, 2010). Without certain histone marks, the chromatin cannot condense 
during mitosis. For example, SIRT6 must deacetylate H3K18 to silence pericentric 
heterochromatin containing repetitive DNA (Pastor, 2016). In fact, histone deacetylase 
inhibitors replicate the phenotype seen with SKIV2L2 depletion: defects in chromatin 
condensation trigger mitotic arrest, mitotic slippage, and binucleation (Stevens, 2007). 
Fig 7.1: Hypothetical model for mitotic arrest phenotype observed with loss of 
SKIV2L2. Treatment with Skiv2l2 siRNA in mouse cell lines results in an observable 
phenotype that includes increased differentiation, mitotic arrest, and binucleation. At a 
molecular level, loss of SKIV2L2 inhibits nuclear RNA turnover, leading to impaired 
ribosome biogenesis, spurious transcription from intergenic regions, and histone 
accumulation.  
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Given that excess free histones are known to cause mitotic arrest, it is hypothesized that 
SKIV2L2 promotes mitotic progression by degrading replication-dependent histone 
mRNAs in the nucleus at the end of G2. The turnover of these mRNAs would ensure that 
excess free histones do not interfere with chromatin condensation during mitosis.  
7.4 Summary and significance of findings 
 This dissertation characterized the phenotype associated with the loss of 
SKIV2L2-mediated RNA surveillance, establishing a connection between RNA 
surveillance and cell cycle progression. With SKIV2L2 depletion triggering mitotic arrest 
and differentiation in two cell lines, it appears that SKIV2L2 is necessary for maintaining 
proliferation and pluripotency. While the exact function of SKIV2L2 in the cell cycle is 
unclear, an imbalance of SKIV2L2 target RNAs could be responsible for the defects in 
mitotic progression following SKIV2L2 depletion. Loss of SKIV2L2 prevents histone 
mRNAs from being efficiently degraded, and the presence of excess histone transcripts as 
the cell enters G2 phase could activate the spindle assembly checkpoint and trigger 
mitotic arrest. Alternatively, because SKIV2L2 facilitates the processing of mammalian 
pre-rRNAs and ribosomal protein mRNA turnover, SKIV2L2 may enhance the efficiency 
of rRNA processing and ribosome assembly, which are necessary to maintain cell 
proliferation in actively dividing cells. Experiments also implicated SKIV2L2-mediated 
RNA surveillance in snoRNA and miRNA biogenesis, lncRNA turnover, and degradation 
of transcripts arising from intergenic regions. Verifying and exploring these RNA 
surveillance targets will drive forward a better understanding of how RNA surveillance 
can influence RNA transcription and non-coding RNA biogenesis pathways on a more 
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global scale and lead to greater insight on the regulation of mammalian gene expression. 
The interconnectedness of SKIV2L2, RNA surveillance, and the cell cycle may lead to a 
greater understanding of SKIV2L2-associated diseases and stem cells. 
 
  
188 
 
CHAPTER VIII: MATERIALS AND METHODS 
8.1 Cell culture 
Neuro2A (N2a) cells were grown at 37°C in Dulbecco’s Modified Eagle Medium 
(Sigma Aldrich #D6429) supplemented with 10% fetal bovine serum (FBS, Sigma 
Aldrich #12306C). Cells were plated on Greiner Bio-One Advanced TC™ 35 or 60 mm 
plates. The cells were split at 1:5 or 1:10 every 48 hours, and incubator conditions were 
held at 5% CO2 and 95% humidity. N2a cell differentiation was initiated by plating the 
cells in Dulbecco’s Modified Eagle Medium supplemented with 2% FBS and 20μM all-
trans retinoic acid (Sigma Aldrich #R2625). Cells were harvested after 48 hours by 
simple pipetting.  
P19 cells were cultured in α-MEM growth medium (Sigma Aldrich # M8042) 
supplemented with 10% FBS (Sigma Aldrich #12306C). P19 cells were passaged every 
48 hours at 1:5 or 1:10 and grown under incubator conditions of 37°C, 5% CO2, and 95% 
humidity. P19 cells were differentiated using α-MEM growth medium supplemented with 
10% FBS and 0.1% dimethyl sulfoxide (Sigma Aldrich #D2438). Cells were harvested 
after 48 hours by simple pipetting. 
8.2 Kinase inhibitor treatment 
N2a and P19 cells were treated with various kinase inhibitors. Drugs were 
purchased from Cayman Chemical and dissolved in DMSO. Three replicate P60 plates 
were treated with each drug according to the concentrations listed in Table 2.1, with three 
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plates treated with 40 μL of DMSO as a vehicle control. Three hours after treatment, cells 
were harvested by simple pipetting for isolation of RNA and protein. 
8.3 RNAi 
Before RNAi knockdown, 3x10
5
 N2a cells or P19 cells were plated on 35 mm 
Advanced TC™ plates. When cells were at approximately 60% confluency (around 24 
hours after plating), cells were transfected with the appropriate siRNA. Skiv2l2 
knockdowns were performed by transfecting cells with either 67 nM Skiv2l2 Silencer® 
siRNA ID #177475 (ThermoFisher # AM16704/s90745), 3 nM PAPD5 Silencer Select® 
siRNA ID s103146, 67 nM ZCCHC8 Silencer® siRNA ID #163169, or 67 nM Negative 
Control Silencer® No. 1 siRNA by Ambion™ (ThermoFisher #AM4635). Knockdown 
was performed on five plates per siRNA. Delivery of siRNAs was accomplished with 1 
mL of Opti-MEM (Thermo Fisher #31985) and 0.1% Lipofectamine RNAiMax® by 
invitrogen™ (ThermoFisher #13778) for N2a cells or 0.1% Lipofectamine 3000® by 
invitrogen™ (ThermoFisher #L300008) for P19 cells according to manufacturer’s 
protocol. Cells treated with the siRNAs were grown for 48 hours at 37°C, 5% CO2, and 
95% humidity. The cells were then harvested following RNAi using simple pipetting. 
8.4 Neuronal Processes Quantification 
Following RNAi, N2a cells were viewed under a simple compound microscope at 
40x magnification. Random fields were selected on the plate, and the number of cells was 
counted in each field until 1000 cells were counted. In each field, individual cells that 
extended processes longer than twice the diameter of the cell body were counted as 
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differentiated. The number of cells extending processes longer than twice the diameter of 
the cell body was divided by the total number of cells to calculate the percent 
differentiated for each siRNA treatment. N2a cells were also counted in the same manner 
following treatment with the Neural Outgrowth Staining kit (Thermo Fisher # A15001) 
according to manufacturer’s protocol. Cells were viewed on the Leica DMI6000 B 
inverted microscope with excitation at 495 nM and 555 nM for visualization of the cell 
viability stain (green) and the cell membrane stain (orange). Random fields were again 
selected, and 900 cells were scored for each siRNA treatment. Cells staining red only 
were counted as dead. Cells staining both orange and green (yellow overlay) with 
processes extending longer than twice the diameter of the cell body were counted as 
differentiated. The numbers of dead and differentiated cells were then divided by the total 
number of cells counted to obtain the percentage of dead and differentiated cells. 
Population statistics were calculated using the two proportion z-score. As the z-score 
becomes more negative, the probability of observing a smaller difference between the 
two proportions becomes less.  
8.5 Protein Extraction 
Harvested N2a and P19 cells were lysed on ice for 15 minutes with protein lysis 
buffer containing 1% Triton-X, 150mM sodium chloride, 50 mM Tris-HCl pH 8, and 
cOmplete™ EDTA-free proteinase inhibitor tablet (04693132001 Roche). Cells were 
then spun down at 16,000g at 4°C for 15 minutes, and the supernatant containing the 
protein was collected. Bradford Assays were performed to quantify total protein using 
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Bradford Reagent (Sigma Aldrich #B6916). Histone proteins were isolated by incubating 
the nuclear pellet with 0.2N HCl overnight at 4°C.  
8.6 RNA Isolation 
Cells were lysed in 1 mL TRI Reagent® (Sigma Aldrich #T9424) by pipetting up 
and down and incubating at 21°C for 5 minutes. 200 μL of chloroform was added to the 
lysed cell mixture, and the organic and aqueous phases were separated through 
centrifugation at 12,000 g at 4°C for 10 minutes. The aqueous phase was collected, added 
to 500μL isopropanol, and incubated at 21°C for 20 minutes. The mixture was then spun 
down at 12,000 g at 4°C for 20 minutes to pellet the RNA. The supernatant was poured 
off, and the pellet was washed twice in 75% ethanol in DEPC-treated water. The RNA 
pellet was resuspended in 20 μL DEPC-treated water and quantified using the NanoDrop 
2000 instrument (Thermo Scientific) for RNA-40 values. The RNA was then DNase 
treated according to the TURBO DNA-free™ kit protocol (Ambion #AM1907) and re-
quantified using the NanoDrop 2000. RNA isolated from P19 cells for sequencing was 
tested for RNA integrity using the RNA 6000 Nano Kit (Agilent #5067-1511) on the 
Agilent 2100 Bioanalyzer according to the manufacturer’s protocol.  
8.7 Western Blotting 
Western blots were performed on the protein extracts from N2a and P19 cells to 
quantify SKIV2L2, ActB, Rrp6, H4, and H3 phospho-S10 protein levels. Laemmli buffer 
was added to total protein extracts, and the proteins were then run at 100V on a 10% 
acrylamide (37.5:1) SDS-PAGE gel. Proteins were then transferred onto BioTrace™ 
192 
 
nitrocellulose membrane, 0.2 μm pore size (Pall Corporation #66485) at 4°C and 15V for 
12 hours. The nitrocellulose membrane was blocked in 5% milk in PBS pH 7.5 with 0.1% 
NP-40 for one hour at 21°C. Following three 10 minute washes in PBS, 0.1% NP-40, the 
membrane was incubated in blotting milk containing polyclonal antibodies raised in 
rabbit against mouse SKIV2L2 (1:1000 dilution, Abcam® ab187884), beta-actin (1:50 
dilution, Thermo Fisher #PA5-16914), Histone H4 (1:500 dilution, Bethyl Laboratories, 
Inc. Catalog #A300-646A-T), or H3 phospho-S10 (1:500 dilution, Abcam® ab5176). The 
Rrp6 antibody produced by the Anderson laboratory was used at a dilution of 1:500. 
Primary antibody incubation occurred for 16 hours at 4°C and was followed by three 
washes in PBS, 0.1% NP-40. The secondary antibody, goat anti-rabbit conjugated to 
horseradish peroxidase (1:5,000 dilution, Abcam® ab6721) was applied to the membrane 
in blotting milk for 1 hour at 21°C. Protein was detected using luminol, ρ-coumaric acid, 
and hydrogen peroxide and capturing chemiluminescence with the UVP Biospectrum 
System. SKIV2L2, Rrp6, H4, and H3 phospho-S10 protein levels were quantified by 
normalizing to ACTB and control levels using the ImageJ software provided by the NIH. 
Statistics were calculated using the student’s t-test. 
8.8 Quantitative RT-PCR 
DNAse-treated RNA isolated from N2a and P19 cells was reversed transcribed 
using oligo-dT or gene-specific primers (primers listed in Table 8.1) according to M-
MLV reverse transcriptase protocol (Promega #M1705). PCR cleanup (IBI Scientific, 
VWR #95039) was then carried out according to manufacturer’s protocol, and the cDNA 
samples were diluted with DEPC-treated water by a factor of 10. Targets (primers listed 
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in Table 8.1) were amplified from the reverse transcription reactions using 12.5 μL of iQ 
SYBR® Green Supermix (BioRad #1708880) per 10 μL of target cDNA. Primers were 
added to a concentration of 60nM. Amplification was detected using the CFX Connect™ 
Real-Time PCR detection system, with annealing temperatures ranging from 52-58°C 
depending on primer melting temperature. Cycles 1-35 were analyzed using regression 
threshold analysis for samples with no amplification in control reactions without reverse 
transcriptase. Target expression was calculated using CFX Manager™ Software, where 
expression equals 2^(–(Cqtarget-CqActB) ) with targets normalized to beta-actin and 
control treatment. Statistics were calculated using the student’s t-test.  
Target Primer Application 
polyadenylated 
mRNAs 
TTTTTTTTTTTTTTTTTTTT oligo dT RT primer 
ActB TGAAGTGTGACGTTGACATCCG forward qPCR primer 
ActB GTACTCCTGCTTGCTGATCCAC reverse qPCR primer 
ActB 
GTA AAA CGC AGC TCA GTA ACA 
GTC CG 
RT primer 
H2An GTGCTGGAGTACCTGACGG forward qPCR primer 
H2An CTTGTTGAGCTCCTCGTCG reverse qPCR primer, RT 
Hist1h4d CAAAGTTCTGCGCGACAAC forward qPCR primer 
Hist1h4d AGGAACACCTTCAGCACAC reverse qPCR primer 
Hist1h4d CCAAGCGCAAGACCGTC RT primer 
Hist1h3a GTGCTCACCAGCTTGCTTTC forward qPCR primer 
Hist1h3a CTTTGGTGGCTAGCTGCTTG reverse qPCR primer 
Hist1h3a AGAGCCTTTGGTTAATTCCG RT primer 
Hist1h1b CAAGAGTCTGGTGAGCAAGG forward qPCR primer 
Hist1h1b GTTAAGCTTGAAGGAACCAGAG reverse qPCR primer, RT 
Nestin TGAGAACTCTCGCTTGCAGACAC forward qPCR primer 
Nestin GGTATCCCAAGGAAATGCAGC reverse qPCR primer 
ChAT GAGCCACCTGAGATGTTCATG forward qPCR primer 
ChAT CAGCAGAACATCTCCATGGTC reverse qPCR primer 
MAP2 GCTCACTTGACAATGCTCACCACG forward qPCR primer 
MAP2 GGGCCTTTGCATGCTCTCTGAAG reverse qPCR primer 
Fabp3 ACTCATCCATGTGCAGAAGTG forward qPCR primer 
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Fabp3 CCTTCTCATAAGTCCGAGTGC reverse qPCR primer 
Desmin GGGTTCTGAAGTCCATAC forward qPCR primer 
Desmin CACTGAATTCCTGGCTTAC reverse qPCR primer 
GATA4 GCTGTCATCTCACTATGGGC forward qPCR primer 
GATA4 GGAGATGCATAGCCTTGTGG reverse qPCR primer 
Pax7 ACTGGCTACAGTGTGGACCCTG forward qPCR primer 
Pax7 CTTCATACGGCGCTGTGTGG reverse qPCR primer 
Sox2 CATGGGCTCTGTGGTCAAGTCC forward qPCR primer 
Sox2 TGCTGATCATGTCCCGGAGGTC reverse qPCR primer 
Tubb3 ACACCTATTCAGGCCCGACAAC forward qPCR primer 
Tubb3 CCGCACGACATCTAGGACTGAG reverse qPCR primer 
Skiv2l2 CAGTTGAAGGCTGCACACAT forward qPCR primer 
Skiv2l2 CACTGAATGGCTTCTCTTTGG reverse qPCR primer 
Nkx2.5 GACAGGTACGGCTGTTGCTT forward qPCR primer 
Nkx2.5 AGCCTACGGTGACCCTGAC reverse qPCR primer 
Nanog AAAGGATGAAGTGCAAGCG forward qPCR primer 
Nanog GGATGCTGGGATACTCCACT reverse qPCR primer 
Table 8.1: List of primers used in study. Annealing temperature was Tm−5°C for each 
qPCR primer and 42°C for each RT primer. 
 
8.9 MTT Assay 
Immediately following transfection of N2a or P19 cells with negative control 
siRNA or Skiv2l2 siRNA, cells were harvested and transferred to a 96- well plate. 100 μL 
of cells were added to each well, and cells were grown at 37°C, 5% CO2, and 95% 
humidity. Thiazolyl blue tetrazolium bromide (MTT, Sigma Aldrich #M5655) was 
dissolved in 1X PBS to a concentration of 5 mg/mL and filtered through a .2 μm filter. 10 
μL of 5 mg/mL MTT was added to each well at various time points, and the cells were 
incubated at 37°C for three hours. Media was removed, and cells were resuspended in 
100 μL of isopropanol:DMSO. Absorbance of the suspension was measured at 570 nm 
(absorbance of purple formazan) and 630 nm (background protein absorbance) using a 
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spectrophotometer. 100 μL of isopropanol:DMSO was used as a negative control. 
Formazan absorbance was calculated by subtracting the absorbance at 630 nm from the 
absorbance at 570 nm for 10 wells per time point. Formazan absorbance was then used to 
calculate cell proliferation by dividing any given formazan absorbance by the initial 
formazan absorbance at the time of transfection.  
8.10 Fluorescent Activated Cell Sorting 
Following RNAi, knockdown cells were harvested and washed in PBS 
supplemented with 2% FBS and resuspended in 1 mL of PBS. For viability staining, cells 
were then incubated with 1 U RNaseA for 1 hour at 37° C. 100 μL of 1 mg/mL 
propidium iodide (Thermo Fisher # P3566) was added to the cells 20 minutes before cell 
sorting on the BD Accuri™ C6 cell sorter. Cells were excited with the 488 nm blue laser, 
and the filter was set to FL-2 to detect propidium iodide fluorescence. 50,000 cells were 
sorted for each sample on slow fluidics, debris and clumps were gated out, and the 
percentage of stained cells was calculated using the CFlow® Plus software.  
For cell cycle analysis, cells were fixed in ice cold ethanol for 30 minutes, washed twice 
in PBS, and re-suspended in 1mL PBS. The fixed cells were then incubated with 1 U 
RNaseA for 1 hour at 37° C. 100 μL of 1 mg/mL propidium iodide (Thermo Fisher # 
P3566) was added to the fixed cells 20 minutes before cell sorting on the BD Accuri™ 
C6 cell sorter as stated above. The percentage of stained cells in G1, S, and G2/M phase 
was calculated using the CFlow® Plus software based on FL-2 detection (DNA content) 
and cell count. 
196 
 
For H3 phospho-S10 detection, fixed cells were incubated with the primary 
antibody against H3 phospho-S10 (1:1000 dilution, Abcam® ab5176) for 1 hour at 21°C. 
Cells were washed twice in PBS, 0.1% NP-40, pH 7.5 before incubation with the 
secondary antibody anti-rabbit conjugated to AlexaFluor® 488 (1:500 dilution, Thermo 
Fisher #A-11034) and 1 U RNaseA for 30 minutes at 37°C. Cells were then washed in 
PBS and treated with 100 μL of 1 mg/mL propidium iodide before analysis on the BD 
Accuri™ C6 cell sorter as stated above, with excitation at 488nm and detection using the 
FL-1 filter. The percentage of cells fluorescing was normalized to negative controls with 
primary antibody only and secondary antibody only, with the percentage of cells 
fluorescing calculated by the CFlow® Plus software. 
8.11 Immunofluorescence Cell Imaging 
Following RNAi treatment, harvested cells were washed in PBS, 2% FBS and 
fixed for 30 minutes in ice-cold ethanol. After washing in PBS, 0.1% NP-40, pH 7.5, 
cells were blocked for 60 minutes at 21°C in PBS, 2% FBS. Cells were then incubated 
with the primary antibody against H3 phospho-S10 (1:500 dilution, Abcam® ab5176), 
Rrp6 (1:100 dilution), or SKIV2L2 (1:100 dilution, ab187884) for 14 hours at 4°C. Cells 
were again washed before incubation with the secondary antibody anti-rabbit conjugated 
to AlexaFluor® 488 (1:500 dilution, Thermo Fisher #A-11034) for two hours at 21°C. 
Cells were washed and resuspended in 100 μL PBS and 100 μL of propidium iodide 
before viewing 100 μL of cells on slides. Cells were excited at 488nm and brightfield 
images, FL-1 filtered images, and FL-3 filtered images were captured on the Nikon 
Eclipse E600 microscope. For H3 phospho-S10 staining, one hundred cells per sample 
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were scored based on fluorescence intensity, with three biological replicates. For 
SKIV2L2 and Rrp6 staining, images were captured to detect protein localization relative 
to propidium iodide staining of nuclei. 
8.12 RNA-seq 
RNA was harvested from P19 cells as previously described on three biological 
replicates of control siRNA and Skiv2l2 siRNA treated cells. Paired-end sequencing was 
performed at University of Wisconsin-Madison. FASTQ reads were trimmed and filtered 
to improve mapping quality before mapping to mm10 genomic build using Tophat, with a 
maximum of 2 mismatches allowed. Galaxy web based tools were used to perform 
cufflinks, and cuffdiff was run to determine differential transcripts, using the mm10 
reference annotation as a guide. Transcripts either upregulated or downregulated 1.5 fold 
with a q-value less than 0.05 were considered to be differentially expressed in the Skiv2l2 
knockdown cells.  
8.13 RNA-seq analysis 
Go-Ontology was performed on the differentially expressed transcripts using the 
GO Enrichment Analysis online platform at http://geneontology.org/page/go-enrichment-
analysis. Intergenic regions were identified using the UCSC genome browser on the 
mm10 genome build (http://genome.ucsc.edu/). The NCBI nucleotide database was used 
to identify genes names and their function. Significantly upregulated and downregulated 
mRNAs were then sorted by hand based on function specified at the NCBI database, with 
categories including: proliferation, DNA damage, chromatin remodeling, histones, 
ribosome, and RNA processing and turnover. Each category was then divided into 
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subcategories to identify genes involved with different aspects of the cell cycle. The 
phypher function in R was used for probability calculations. 
8.14 Protein-RNA immunoprecipitation 
After 48 hours of cell growth, untreated P19 and N2a cells from three P100 plates 
were irradiated at 254 nm (150 mJ/cm2) two times to crosslink proteins and RNA using 
the UVP Crosslinker CL-1000 model. Protein A conjugated Dynabeads® were prepared 
according to manufacturer’s protocol using the Dynabeads® Protein A 
Immunoprecipitation Kit (Thermo Fisher # 10006D). Dynabeads were incubated with 
12μL rabbit polyclonal antibody against SKIV2L2 (Abcam #ab70552) or incubated with 
12 μL anti-goat Ig as a negative control. Cells from three plates were combined into one 
biological sample and were lysed as described previously. 500μL of cellular lysate 
prepared from UV irradiated cells was loaded onto the Dynabeads® and incubated 
according to kit protocol. Immunoprecipation of SKIV2L2 according to kit protocol was 
performed, and the protein-RNA complexes were eluted off the Dynabeads®. Eluate was 
treated with DNase and proteinase K. Samples were taken for Western blotting to verify 
recovery of SKIV2L2 protein, while RNA was isolated from eluate using Trizol 
extraction with chloroform as previously described. cDNA was prepared using reverse 
gene specific primers in Table 8.1 or oligo-dT, and qPCR reactions were performed on 
the prepared cDNA as mentioned previously.   
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8.15 3'UTR pMirGlo Assay 
The 3'UTR of Skiv2l2 (200 bp) was amplified from N2a cell DNA isolated 
through Trizol extraction and cloned into the pMirGlo Dual Luciferase miRNA target 
expression vector (Promega #E1330). A 200 bp sequence from the 5' end of yeast Mtr4 
was amplified from yeast genomic DNA and cloned into a second pMirGlo vector as a 
negative control. This resulted in the firefly luciferase gene being fused to either the 3' 
UTR of Skiv2l2 or yeast genomic DNA. Using 0.1%  Lipofectamine 3000, N2a cells 
were transfected with either 20 ng of the pMirGlo vector containing the 3'UTR of Skiv2l2 
or 20 ng of the control vector containing yeast genomic DNA. Cells were then either 
grown in 10% FBS or 2% FBS with 20 μM retinoic acid. The cells were harvested after 
24 hours and diluted in DMEM. The cells were lysed using the Dual-Glo® Luciferase 
Assay System kit (Promega #E2920). Using the Lumat LB tube luminometer, firefly 
luciferase luminescence was measured first followed by measurement of background 
Renilla luciferase luminescence according to manufacturer’s protocol. Firefly luciferase 
expression was calculated by subtracting Renilla luciferase luminescence from the firefly 
luciferase luminescence.  
8.16 RNA Decay Assay 
Following 24 hours of control and Skiv2l2 RNAi as previously described, N2a 
cells were treated with Actinomycin-D (Sigma #A1410) to a concentration of 5 μg/mL. 
Cells were harvested for RNA extraction at 0, 1, 2, 3, and 4 hours. RNA was quantified 
and 8μL of identical amounts of RNA (approximately 8 μg) were run on a 1.4% agarose 
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gel at 90V. RNA was transferred to a blotting membrane overnight in 20X SSC before 
being crosslinked to the membrane. The Northern blot was probed using primers against 
H4 and ActB labeled with ATP, [γ-32P]- 3000Ci/mmol 10mCi/ml EasyTide Lead (Perkin 
Elmer) ATP-using T4-polynucleotide kinase (NEB #M0201) according to manufacturer’s 
protocol. Radiolabeled probes were incubated with the blot at 42°C for 16 hours and 
developed using phosphorimaging screens and the Storm™ PhosphorImager from GE 
Healthcare. Peak quantification for ActD and H4 mRNA was performed on Image J 
software, and H4 mRNA levels were normalized to ActD or rRNA levels as appropriate. 
The decay constant was calculated using the equation ln(C/C0)=-kdecayt, where t= time, 
kdecay=decay constant, C=RNA level at t, and C0= RNA level at t=0. H4 half-life (t1/2) was 
found by solving for t at ln(.5). The student’s t-test was performed on the H4 half-life 
calculated for three distinct trials.   
8.17 Poly-A-tail Length Assay 
RNA was isolate from N2A cells following Skiv2l2 knockdown as previously 
described. RNA was digested using RNAseH (NEB #M0297), and primers annealing to 
the 5' end of the RNA according to manufacturer’s protocol. 150-200 bp RNA fragments 
were extracted with phenol-chloroform according to laboratory protocol to remove 
RNAseH. RNA was circularly ligated with T4 RNA ligase according to manufacturer’s 
protocol (NEB #M0204). Circularly ligated RNA was reverse transcribed with a gene 
specific primer for 2 hours at Tm-5°C. DNA was then amplified with PCR using Taq 
DNA polymerase in ThermoPol® Buffer according to manufacturer’s protocol (NEB 
#M0267). DNA fragment was cloned into pGEM®-T Easy using the Promega kit 
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(Promega #A1360). BL21 Escherichia coli were then transformed with the pGEM®-T 
Easy vector with insert according to chemically competent BL21 protocol (NEB 
#C2530H) and plated on ampicillin plates with X-Gal for 16 hours at 37°C. White 
colonies were selected, and plasmids were purified using the Wizard® Plus SV 
Minipreps DNA Purification System according to manufacturer’s protocol (Promega 
#A1330). 
8.18 Micrococcal Nuclease Assay 
Nuclei were isolated from P19 and N2A cells lysed with 0.1% Triton X-100 after 
control siRNA or Skiv2l2 siRNA transfection. The nuclei were then treated with 
micrococcal nuclease (Sigma Aldrich N3755) and digested for 9 minutes at 20°C. Nuclei 
were digested with Proteinase K and RNase A for one hour at 37°C to remove proteins 
and RNA from DNA fragments. Hi-Lo loading buffer was added to reactions and DNA 
was run on 1% agarose gels with .001% ethidium bromide at 100V for 1 hour. DNA was 
detected using the UVP™ GelDoc-IT2 310 Imaging System.
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CHAPTER IX: RNA-SEQ DATA TABLES 
9.1 RefSeq genes dysregulated following Skiv2l2 knockdown in P19 cells 
Gene ID Gene Symbol Locus M q 
NR_015517 5930412G12Rik chr5:128579129-128600687 -0.85177 0.005539 
NM_001013608 Ercc6l2 chr13:63815319-63900301 -0.79391 0.001451 
NR_015601 Fam120aos chr13:48968111-48969905 0.839344 0.002615 
NM_178182 Hist1h2ai chr13:21716411-21716859 0.804162 0.007984 
NM_175656 Hist1h4i chr13:22040959-22041362 1.12245 0.001451 
NM_026821 Lurap1l chr4:80910685-80954301 -1.19847 0.001451 
NM_009538 Plagl1 chr10:13090787-13131695 -1.16881 0.001451 
NM_144912 Rad9b chr5:122325507-122354195 -0.73071 0.023577 
NR_028515 Snora78 chr17:24719530-24719965 1.65325 0.001451 
NM_026738 Card19 chr13:49202950-49216026 0.623596 0.001451 
NM_001033145 1190002N15Rik chr9:94517863-94538081 -1.09564 0.001451 
NR_015476 1500011K16Rik chr2:127791376-127792488 0.749772 0.023031 
NR_029432 1500015A07Rik chr18:61726389-61728253 1.13436 0.001451 
NR_029440 2010320M18Rik chr8:70776861-70777606 0.736332 0.006305 
NM_001001881 2510009E07Rik chr16:21649044-21694665 -2.04653 0.001451 
NR_028428 2610005L07Rik chr8:20385781-20424814 -0.61171 0.012253 
NM_183287 2610318N02Rik chr16:17113397-17125106 0.738631 0.001451 
NM_029818 2700049A03Rik chr12:71136847-71243303 -1.3526 0.001451 
NR_033780 2810001G20Rik chr11:64079483-64083259 0.608595 0.035448 
NR_045268 2810013P06Rik chr8:123042574-123044602 1.08102 0.001451 
NR_029441 2810454H06Rik chr6:134897960-134900785 0.678476 0.007984 
NR_033215 3000002C10Rik chr9:109830153-109831431 0.730317 0.046147 
NR_015510 4632427E13Rik chr7:92740705-92741459 0.638455 0.002615 
NM_028934 4930452B06Rik chr14:8431171-8666290 -0.85158 0.001451 
NR_033601 4930519F09Rik chr10:28921962-28923507 0.968532 0.031973 
NM_026296 4930548H24Rik chr5:31485858-31488262 0.955223 0.029723 
NR_015555 4933404O12Rik chr5:136919145-136937109 -0.67445 0.001451 
NR_036602 4933421O10Rik chr4:33027138-33031323 1.09842 0.001451 
NR_040469 5031425E22Rik chr5:23431807-23434353 0.665507 0.001451 
NR_015552 5330434G04Rik chrX:105372993-105391754 0.776201 0.004643 
NM_001162537 9330159F19Rik chr10:29211642-29230779 -0.76028 0.001451 
NM_001081963 9430020K01Rik chr18:4634928-4682869 -0.59852 0.001451 
NR_027446 A230072C01Rik chrX:20951664-20987349 1.02958 0.023031 
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NM_001160370 A830018L16Rik chr1:11414104-11975902 -1.00424 0.001451 
NR_002142 Rpph1 chr14:50807446-50807771 1.04795 0.001451 
NR_015488 A930003A15Rik chr16:19876567-19884274 -1.38304 0.001451 
NR_028376 A930004D18Rik chr2:18025188-18037741 0.891504 0.045018 
NM_172961 Abat chr16:8513428-8621567 -1.36166 0.001451 
NM_011075 Abcb1b chr5:8798146-8866314 -0.66127 0.001451 
NM_001033336 Abcc4 chr14:118482691-118706219 -0.58801 0.007984 
NM_013790 Abcc5 chr16:20331303-20426394 -0.66933 0.001451 
NM_007435 Abcd1 chrX:73716596-73738287 -0.79438 0.001451 
NM_011994 Abcd2 chr15:91145870-91191807 -0.72012 0.001451 
NM_009593 Abcg1 chr17:31057693-31117981 -1.08434 0.001451 
NM_145421 Abhd17a chr10:80583648-80590341 0.676096 0.008818 
NM_025341 Abhd6 chr14:8002901-8056555 -1.0291 0.014141 
NM_009595 Abl2 chr1:156558786-156649619 -0.63119 0.005539 
NM_028037 Acad10 chr5:121621028-121660510 -0.59944 0.025833 
NM_025408 Acer3 chr7:98213659-98309527 -0.60026 0.004643 
NM_022816 Acot10 chr15:20665213-20666750 0.646105 0.011607 
NM_025590 Acot11 chr4:106733914-106799831 -0.76832 0.011607 
NM_015729 Acox1 chr11:116171882-116215318 0.589957 0.005539 
NM_207625 Acsl4 chrX:142317992-142390535 -0.72736 0.001451 
NM_080575 Acss1 chr2:150618110-150668932 -1.21089 0.001451 
NM_007392 Acta2 chr19:34240335-34255373 1.03603 0.001451 
NM_009609 Actg1 chr11:120345689-120348484 -0.58144 0.001451 
NM_007498 Atf3 chr1:191170296-191183333 0.851031 0.001451 
NM_001291890 Adam19 chr11:46054501-46147347 -1.09343 0.001451 
NM_009621 Adamts1 chr16:85793827-85803115 0.643524 0.001451 
NM_029967 Adamtsl1 chr4:86053914-86428382 -0.6252 0.013563 
NM_019822 Adrm1 chr2:180171587-180176283 1.20408 0.023918 
NM_026531 Aen chr7:78895926-78908833 0.724787 0.030628 
NM_133919 Aff1 chr5:103754161-103855322 -0.83578 0.001451 
NM_153403 Ago1 chr4:126435012-126468421 -0.78951 0.001451 
NM_016661 Ahcy chr2:155059311-155074497 -0.67955 0.007984 
NM_001162970 Aim1l chr4:134068451-134092504 0.897542 0.010258 
NM_001199270 Aldoart1 chr4:72850582-72852634 0.784181 0.001451 
NM_008537 Amacr chr15:10981755-10996624 -0.58883 0.018937 
NM_001164602 Amigo2 chr15:97244073-97385691 -1.3001 0.020957 
NM_173405 Amz1 chr5:140724126-140753312 1.1413 0.035448 
NM_001252193 Amz2 chr11:109425945-109438148 -0.89148 0.039437 
NM_019764 Amotl2 chr9:102717803-102733417 0.970163 0.001451 
NM_027480 Ankrd24 chr10:81628539-81647612 -0.71059 0.01595 
NM_008486 Anpep chr7:79821802-79842352 -1.11325 0.001451 
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NM_021492 Ap3b2 chr7:81460398-81493925 -0.98739 0.001451 
NM_018758 Apba3 chr10:81268171-81291581 0.769216 0.003645 
NM_007462 Apc chr18:34207774-34322190 -0.65079 0.001451 
NM_133237 Apcdd1 chr18:62922326-62953195 -0.98482 0.001451 
NM_001297554 Apela chr8:65028416-65037336 -0.86277 0.001451 
NM_013912 Apln chrX:48025145-48034852 -0.95207 0.001451 
NM_001289687 Arhgef3 chr14:27143992-27403911 0.964467 0.002615 
NM_025404 Arl4d chr11:101665540-101667832 -0.82126 0.005539 
NM_207231 Arl5c chr11:97989579-97996173 -0.78756 0.047777 
NM_001166379 Armcx1 chrX:134717937-134721912 -1.5474 0.006305 
NM_027560 Arrdc2 chr8:70835137-70839720 0.61483 0.031539 
NM_028710 Arsg chr11:109440077-109573329 -0.70753 0.032882 
NM_133346 Asb6 chr2:30823097-30828300 0.587319 0.017725 
NM_026937 Ascc1 chr10:59987908-60099990 -0.60955 0.040659 
NM_178662 Atcay chr10:81194690-81230779 0.743805 0.001451 
NM_178405 Atp1a2 chr1:172271708-172298064 -1.29012 0.001451 
NM_026094 Atp8b3 chr10:80519584-80539124 0.838981 0.004643 
NM_001289446 Atp9a chr2:168634437-168742136 -0.79311 0.005539 
NM_001033532 AW554918 chr18:25169019-25467321 -0.58659 0.001451 
NM_015732 Axin2 chr11:108920348-108950781 -0.94668 0.001451 
NR_028263 B130006D01Rik chr11:95723585-95726773 -0.93014 0.003645 
NM_001080935 B230217C12Rik chr11:97840779-97843043 0.82094 0.026781 
NR_030695 B330016D10Rik chr4:141546161-141548313 1.12611 0.001451 
NM_133234 Bbc3 chr7:16309582-16318334 1.0077 0.02001 
NM_001033328 Tmem185a chrX:70460055-70477043 -0.73287 0.001451 
NR_030677 BC025920 chr10:81606307-81609836 1.15783 0.001451 
NM_029410 Bcl2l12 chr7:44986899-44997579 0.804035 0.034184 
NM_177235 Bend6 chr1:33852051-33907621 -0.82651 0.023031 
NM_026512 Bphl chr13:34037640-34074074 -0.68139 0.008818 
NM_007557 Bmp7 chr2:172868011-172940321 -1.01801 0.001451 
NM_172870 Bnc2 chr4:84272541-84675086 -0.7047 0.010947 
NM_028055 Btbd17 chr11:114790668-114795892 0.819902 0.023577 
NR_024078 Btbd19 chr4:117119217-117125725 0.867965 0.001451 
NM_001037758 Btrc chr19:45363733-45533343 -0.63459 0.031973 
NR_027987 C030016D13Rik chr19:27430036-27432631 1.81803 0.001451 
NR_026848 C030034I22Rik chr17:69416446-69419192 0.784575 0.004643 
NM_013484 C2 chr17:34862601-34882100 -1.29889 0.001451 
NR_027923 C630043F03Rik chr4:72201243-72203930 0.994274 0.001451 
NM_001146287 Cables1 chr18:11821087-11945627 -2.04232 0.001451 
NM_027381 Cactin chr10:81321102-81326251 0.640942 0.002615 
NM_053199 Cadm3 chr1:173334253-173367695 -0.63969 0.011607 
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NM_144817 Camk1g chr1:193346345-193370282 -0.63039 0.022563 
NM_009800 Car11 chr7:45699966-45704661 -0.96743 0.007175 
NM_010828 Cited2 chr10:17723227-17725674 -0.84435 0.001451 
NM_001076789 Cbx5 chr15:103191545-103239816 -0.67472 0.001451 
NM_145970 Cc2d1a chr8:84132827-84147753 0.75623 0.001451 
NM_001293560 Kyat3 chr3:142701047-142744911 -0.58782 0.007175 
NM_026964 Ccdc124 chr8:70868226-70873490 0.728343 0.001451 
NM_172428 Ccdc134 chr15:82127921-82142202 0.596359 0.006305 
NM_001195672 Ccdc170 chr10:4509871-4561111 -0.86799 0.046988 
NM_028381 Ccdc94 chr17:55952622-55967951 0.811028 0.001451 
NM_025725 Ccdc96 chr5:36484587-36488171 0.983034 0.001451 
NM_146014 Ccm2 chr11:6546886-6596761 0.65293 0.001451 
NM_007630 Ccnb2 chr9:70407688-70421554 -0.63783 0.001451 
NM_009829 Ccnd2 chr6:127125708-127212419 -0.69289 0.001451 
NM_009831 Ccng1 chr11:40748551-40755286 0.640568 0.001451 
NM_001045530 Ccnjl chr11:43528748-43586999 -0.71086 0.002615 
NM_001039151 Cd44 chr2:102811141-102901665 -1.16429 0.001451 
NM_009865 Cdh10 chr15:18820328-19014234 -0.92773 0.001451 
NM_019707 Cdh13 chr8:118283754-119323448 -0.66781 0.016521 
NM_033037 Cdo1 chr18:46713204-46728342 -1.90239 0.022563 
NM_009734 Cep131 chr11:120064429-120086827 0.73183 0.001451 
NM_027559 Cfap43 chr19:47736856-47837361 -0.81559 0.001451 
NM_026929 Chac1 chr2:119351241-119354327 1.58486 0.001451 
NM_021350 Chml chr1:175662420-175692632 0.606073 0.001451 
NM_031258 Chrdl1 chrX:143285673-143394262 -0.77846 0.001451 
NM_015730 Chrna4 chr2:181022310-181039177 -0.75624 0.001451 
NM_018763 Chst2 chr9:95400925-95407270 -0.61947 0.001451 
NM_001033302 Ciart chr3:95871521-95891930 0.663316 0.026333 
NM_001085500 Cisd3 chr11:97685951-97688625 -0.75114 0.010947 
NM_028870 Cltb chr13:54592938-54611272 0.775639 0.029213 
NM_009131 Clec11a chr7:44303765-44306959 0.707745 0.029723 
NM_053109 Clec2d chr6:129180614-129186535 -0.58727 0.005539 
NM_172469 Clic6 chr16:92498146-92541241 -0.7698 0.002615 
NM_001039162 Clip2 chr5:134489382-134552434 0.638823 0.031973 
NM_001033175 Cln6 chr9:62838786-62875917 -0.59123 0.006305 
NM_001102471 Cnnm2 chr19:46761608-46878580 -1.379 0.038705 
NM_175651 Cnpy1 chr5:28205462-28237873 1.05426 0.017725 
NM_175275 Cntln chr4:84884308-85131921 -0.58761 0.007175 
NM_053185 Col4a6 chrX:141165402-141474076 -0.83748 0.001451 
NM_130449 Colec12 chr18:9707647-9877995 -0.80878 0.001451 
NM_147778 Commd3 chr2:18672461-18676216 0.612389 0.010258 
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NM_001039710 Coq10b chr1:55052769-55072702 0.835201 0.001451 
NM_009898 Coro1a chr7:126699773-126704816 0.92625 0.002615 
NM_146067 Cpped1 chr16:11803720-11930594 -0.67858 0.010947 
NM_176073 Cpq chr15:33083128-33653436 -0.64717 0.028252 
NM_021273 Ckb chr12:111669354-111672338 1.00512 0.001451 
NM_133930 Creld1 chr6:113483568-113493338 0.610899 0.001451 
NM_024223 Crip2 chr12:113140235-113145506 0.910495 0.001451 
NR_033641 Crnde chr8:92326030-92356120 -0.88086 0.024425 
NM_019922 Crtap chr9:114368323-114390712 0.811066 0.019402 
NM_007770 Crx chr7:15865946-15879955 0.913287 0.006305 
NM_009965 Cryba1 chr11:77718731-77725293 -1.19805 0.023918 
NM_153076 Crygn chr5:24751001-24757843 -0.7814 0.024857 
NM_027945 Csl chr10:99757704-99759658 -0.64491 0.002615 
NM_153409 Csrnp3 chr2:65845766-66031546 -1.88083 0.001451 
NM_145953 Cth chr3:157894247-157925063 0.646348 0.001451 
NM_007801 Ctsh chr9:90054266-90076095 -1.06494 0.035448 
NM_001291234 Cux1 chr5:136248134-136567490 -1.06126 0.017111 
NM_021704 Cxcl12 chr6:117168534-117181368 -0.85014 0.002615 
NM_001012477 Cxcl12 chr6:117168534-117181368 -1.13871 0.001451 
NM_013655 Cxcl12 chr6:117168534-117181368 -1.14089 0.002615 
NM_009911 Cxcr4 chr1:128588198-128592299 -0.61332 0.001451 
NM_001004367 Cxxc4 chr3:134236494-134262089 -1.07338 0.001451 
NM_007811 Cyp26a1 chr19:37697807-37701536 0.735006 0.001451 
NM_010516 Cyr61 chr3:145646970-145649985 0.859053 0.001451 
NR_028421 D430020J02Rik chr12:116401946-116405161 0.598397 0.001451 
NM_194061 D630045J12Rik chr6:38048482-38254009 -0.81213 0.001451 
NR_027958 D930048N14Rik chr11:51643088-51657681 0.939226 0.017725 
NM_001190474 Dapk3 chr10:81183006-81193197 0.675098 0.009538 
NM_027490 Dcp2 chr18:44380499-44424969 -0.77572 0.001451 
NM_026993 Ddah1 chr3:145758691-145894277 -0.79472 0.001451 
NM_030143 Ddit4l chr3:137623671-137628332 -0.6201 0.005539 
NM_172962 Ddr1 chr17:35681566-35704139 0.6732 0.001451 
NM_013932 Ddx25 chr9:35541847-35558470 -0.60009 0.001451 
NM_026500 Ddx59 chr1:136411915-136440220 -0.58886 0.003645 
NM_181324 Ddx6 chr9:44604891-44640731 -0.59378 0.045495 
NM_145470 Deptor chr15:55099916-55259273 -0.83282 0.001451 
NM_001037938 Dhrs4 chr14:55478757-55490340 -0.63668 0.002615 
NM_001033326 Dhrsx chr4_GL456216_random:15880-36213 -0.62977 0.039437 
NM_001033548 Dnaaf3 chr7:4522956-4532442 0.863737 0.001451 
NM_198412 Dnajc6 chr4:101496647-101642799 -2.27332 0.012963 
NM_133964 Dohh chr10:81384427-81388352 0.75188 0.001451 
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NM_025675 Dph6 chr2:114516417-114654928 -0.8041 0.001451 
NM_026767 Dpm3 chr3:89266460-89267079 0.907552 0.010947 
NM_033606 Dqx1 chr6:83057843-83067219 0.638118 0.014681 
NM_025853 Dsn1 chr2:156995061-157007075 -0.67744 0.001451 
NM_009342 Dynlt1b chr17:6430111-6436295 -0.79283 0.008818 
NM_025943 Dzip1 chr14:118875519-118925470 -0.67729 0.001451 
NR_040708 E130102H24Rik chr4:101346523-101399185 0.832681 0.001451 
NR_038037 E130307A14Rik chr10:39612933-39732007 -0.72414 0.034591 
NM_001291105 E2f1 chr2:154559399-154569892 0.989853 0.004643 
NM_033270 E2f6 chr12:16810964-16826752 -0.80704 0.014681 
NM_010023 Eci1 chr17:24426682-24439316 -0.60942 0.003645 
NM_001110331 Eci2 chr13:34977747-34994144 -1.01705 0.001451 
NM_010100 Edar chr10:58600787-58675696 -1.02699 0.009538 
NM_021519 Edf1 chr2:25557899-25562082 0.770002 0.001451 
NM_027974 Efhc1 chr1:20951625-20990841 -1.20103 0.001451 
NM_020578 Ehd3 chr17:73804840-73832093 -0.72624 0.001451 
NM_198425 Eid2 chr7:28267880-28269168 -0.70312 0.001451 
NM_001177427 Eid2b chr7:28277705-28280129 -0.72295 0.002615 
NM_144958 Eif4a1 chr11:69666935-69672423 -1.17147 0.01595 
NM_013506 Eif4a2 chr16:23107467-23127730 -1.41013 0.014681 
NM_010487 Elavl3 chr9:22015004-22052023 0.693958 0.001451 
NM_080288 Elmo1 chr13:20090506-20608356 -0.87566 0.001451 
NM_001253692 Elmod3 chr6:72565921-72598413 -1.0245 0.001451 
NM_001043336 Eml1 chr12:108371152-108702306 -0.70668 0.001451 
NM_199466 Eml4 chr17:83350930-83480359 -0.90435 0.036345 
NM_172573 Engase chr11:118476959-118489198 0.596771 0.014681 
NM_015744 Enpp2 chr15:54838678-54920146 -1.06961 0.001451 
NM_134005 Enpp3 chr10:24773813-24836195 -0.63271 0.001451 
NM_010139 Epha2 chr4:141301220-141329384 0.791182 0.001451 
NM_001122889 Epha7 chr4:28813130-28967503 1.35026 0.025833 
NM_030711 Erap1 chr13:74639871-74691875 -0.96831 0.001451 
NM_011843 Esyt1 chr10:128510249-128525859 0.590776 0.005539 
NM_008815 Etv4 chr11:101769741-101785310 0.943731 0.014681 
NM_145920 Evc2 chr5:37338477-37425054 -0.72143 0.043378 
NM_175399 Exosc4 chr15:76327396-76330670 0.690836 0.001451 
NM_010164 Eya1 chr1:14168957-14310199 -1.27045 0.049716 
NM_007970 Ezh1 chr11:101191114-101226463 -0.69164 0.001451 
NM_001166213 Fam129c chr8:71597645-71608149 -0.73895 0.046988 
NM_173395 Fam132b chr1:91366429-91374217 0.892481 0.001451 
NM_027342 Fam162a chr16:36043843-36071515 -0.72433 0.001451 
NM_199200 Fam171a2 chr11:102436980-102447663 0.588976 0.011607 
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NM_001114174 Fam189a2 chr19:23972749-24031019 -1.56449 0.001451 
NM_001025382 Fam196b chr11:34226820-34783905 0.850402 0.001451 
NM_177233 Fam19a4 chr6:96831208-97060411 -0.83872 0.035898 
NM_007991 Fbl chr7:28169747-28179269 -0.64919 0.012963 
NM_001033312 Fbxl18 chr5:142871788-142895238 0.835289 0.002615 
NM_025386 Fbxo36 chr1:84839840-84900486 -1.56789 0.001451 
NM_176982 Fbxo48 chr11:16951409-16954772 0.586972 0.018345 
NM_010203 Fgf5 chr5:98254183-98277033 1.81829 0.002615 
NM_008013 Fgl2 chr5:21292960-21424677 -0.76476 0.002615 
NM_001110329 Fiz1 chr7:5007055-5014728 1.42803 0.004643 
NM_008019 Fkbp1a chr2:151542482-151561691 -0.87757 0.001451 
NM_013902 Fkbp3 chr12:65036333-65073938 -0.88211 0.001451 
NM_201411 Flrt1 chr19:7056767-7198062 -0.71766 0.046988 
NM_001301375 Fst chr13:114452261-114458951 -0.8606 0.029723 
NM_010425 Foxd3 chr4:99656298-99658671 0.714189 0.009538 
NM_019739 Foxo1 chr3:52268336-52350109 -0.59029 0.003645 
NM_175473 Fras1 chr5:96373954-96784728 -0.66351 0.001451 
NM_145148 Frmd4b chr6:97286866-97617657 -0.71275 0.001451 
NM_172673 Frmd5 chr2:121545528-121807057 -0.70758 0.001451 
NM_001195284 Fsd1l chr4:53631470-53707009 -0.85621 0.001451 
NM_001301373 Fst chr13:114452261-114458951 -0.83147 0.001451 
NM_021356 Gab1 chr8:80764430-80880519 -0.90908 0.048741 
NM_008078 Gad2 chr2:22622326-22693877 -2.1367 0.001451 
NM_001081421 Galnt16 chr12:80518989-80603896 -0.74836 0.001451 
NM_008086 Gas1 chr13:60174404-60177535 -0.6767 0.001451 
NM_010258 Gata6 chr18:11042036-11085635 -1.01435 0.001451 
NM_013526 Gdf6 chr4:9844371-9862345 -1.82012 0.001451 
NM_201352 Gdpd5 chr7:99381548-99460984 0.876064 0.001451 
NM_027450 Glipr2 chr4:43957701-43979118 0.851218 0.001451 
NM_053108 Glrx chr13:75839885-75850151 -0.65482 0.001451 
NR_033595 Gm13498 chr2:50909683-50911846 1.30957 0.001451 
NR_004442 Gm15421 chr5:22486488-22550331 -0.78532 0.001451 
NM_001033248 Gm266 chr12:111484608-111485823 -1.43469 0.024857 
NR_033619 Gm6623 chr17:36178776-36181364 0.705313 0.04692 
NR_045618 Gm9958 chr5:90366996-90368488 1.34624 0.001451 
NM_198101 Gmip chr8:69808686-69821870 0.667856 0.032882 
NM_001113384 Gnao1 chr8:93810837-93969388 -0.78072 0.001451 
NM_010316 Gng3 chr19:8836928-8848683 0.581008 0.020957 
NM_010318 Gng5 chr3:146499835-146505543 1.53371 0.001451 
NM_145965 Gphn chr12:78226654-78684769 -0.58314 0.007175 
NM_010338 Gpr37 chr6:25668522-25689980 -0.79998 0.001451 
209 
 
NM_008160 Gpx1 chr9:108339079-108340344 0.999232 0.001451 
NM_001083628 Greb1l chr18:10325178-10562941 -0.63197 0.001451 
NM_016886 Gria3 chrX:41401300-41678601 -0.88117 0.049405 
NM_001291045 Grm4 chr17:27422387-27503533 -0.62935 0.031539 
NM_010345 Grb10 chr11:11930498-12037420 1.42927 0.001451 
NM_026672 Gstm7 chr3:107926333-107931745 -0.72887 0.001451 
NM_008185 Gstt1 chr10:75783812-75798584 -0.75688 0.039858 
NM_010363 Gstz1 chr12:87106865-87164723 -0.68513 0.020957 
NR_027009 Gt(ROSA)26Sor chr6:113046326-113077244 0.795253 0.04735 
NM_053266 Gtf2ird2 chr5:134184037-134218143 -0.74592 0.020957 
NM_001033322 Gucy1a2 chr9:3532348-3905787 -0.83139 0.001451 
NM_178747 Gulo chr14:65986786-66009210 -0.73376 0.011607 
NM_172670 Gyltl1b chr2:92365045-92371057 -1.0279 0.001451 
NM_177688 H2afj chr6:136808247-136810074 0.855991 0.001451 
NM_016750 H2afz chr3:137864486-137866922 -0.6071 0.001451 
NM_008216 Has2 chr15:56665626-56694546 -1.31155 0.001451 
NM_027382 Hdac8 chrX:102284639-102505148 -0.58885 0.022043 
NM_001163471 Hectd2 chr19:36554638-36689479 -1.52125 0.041324 
NM_022331 Herpud1 chr8:94386499-94395358 0.612819 0.001451 
NM_020259 Hhip chr8:79965850-80058008 1.94527 0.001451 
NM_145567 Hibadh chr6:52546229-52640300 -0.67793 0.001451 
NM_175454 Hid1 chr11:115347708-115367719 0.740602 0.027823 
NM_001162950 Hif3a chr7:17030992-17062427 -1.00065 0.003645 
NM_010433 Hipk2 chr6:38697839-38876190 -0.83333 0.015282 
NM_178189 Hist1h2ac chr13:23683472-23683959 0.588116 0.02001 
NM_175659 Hist1h2ah chr13:22035121-22035643 0.997338 0.005539 
NM_178183 Hist1h2ak chr13:21753376-21753912 0.929831 0.001451 
NM_178184 Hist1h2an chr13:21786771-21787218 1.39517 0.001451 
NM_001290380 Hist1h2bc chr13:23684198-23692480 1.72254 0.001451 
NM_001290530 Hist1h2be chr13:23583669-23621124 0.992899 0.001451 
NM_178195 Hist1h2bf chr13:23573759-23574190 0.898411 0.001451 
NM_178196 Hist1h2bg chr13:23571399-23571863 1.16721 0.001451 
NM_178197 Hist1h2bh chr13:23542922-23543444 1.4328 0.001451 
NM_178198 Hist1h2bj chr13:22043229-22043658 0.98064 0.001451 
NM_175665 Hist1h2bk chr13:22035820-22036320 1.26857 0.001451 
NM_178199 Hist1h2bl chr13:21715712-21716143 1.08947 0.001451 
NM_178200 Hist1h2bm chr13:21722043-21722526 1.02812 0.001451 
NM_178201 Hist1h2bn chr13:21754122-21754553 1.54492 0.001451 
NM_001290466 Hist1h2bp chr13:21787487-21789213 0.681751 0.001451 
NM_013550 Hist1h3a chr13:23761884-23762386 0.97277 0.001451 
NM_175653 Hist1h3c chr13:23745041-23745521 0.941578 0.001451 
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NM_178204 Hist1h3d chr13:23575762-23576266 0.5921 0.001451 
NM_013548 Hist1h3f chr13:23544051-23544954 0.982357 0.001451 
NM_013548 Hist1h3f chr13:23544051-23544954 0.982357 0.001451 
NM_145073 Hist1h3g chr13:23535417-23535909 0.795682 0.001451 
NM_178206 Hist1h3h chr13:21717627-21718115 0.706797 0.001451 
NM_178207 Hist1h3i chr13:21782914-21783397 1.18313 0.001451 
NM_178192 Hist1h4a chr13:23760794-23761249 1.60444 0.001451 
NM_178193 Hist1h4b chr13:23756936-23757386 1.10022 0.001451 
NM_178208 Hist1h4c chr13:23698083-23698458 0.859387 0.001451 
NM_175654 Hist1h4d chr13:23581601-23581969 1.30428 0.001451 
NM_175655 Hist1h4f chr13:23551285-23551643 1.31757 0.001451 
NM_153173 Hist1h4h chr13:23531043-23531478 1.04986 0.001451 
NM_178210 Hist1h4j chr13:21735095-21735407 2.49915 0.005539 
NM_178211 Hist1h4k chr13:21750144-21750553 1.31433 0.001451 
NM_175662 Hist2h2ac chr3:96220412-96220880 1.08966 0.001451 
NM_178215 Hist2h3b chr3:96268653-96269155 0.881644 0.009538 
NM_033596 Hist2h4 chr3:96262933-96263317 1.05178 0.001451 
NM_178218 Hist3h2a chr11:58954684-58955192 0.998117 0.001451 
NM_030082 Hist3h2ba chr11:58948910-58949372 0.666109 0.001451 
NM_175652 Hist4h4 chr6:136803992-136804431 0.915953 0.001451 
NM_206882 - chr11:58954047-58954512 0.859444 0.001451 
NM_010420 Hesx1 chr14:27000361-27002325 1.37467 0.001451 
NM_146256 Hpdl chr4:116819906-116821508 1.01682 0.012253 
NM_011828 Hs2st1 chr3:144431106-144570216 -0.59104 0.001451 
NM_153571 Hscb chr5:110829069-110839777 -0.95979 0.001451 
NM_013558 Hspa1l chr17:34972702-34979228 0.866197 0.006305 
NM_030704 Hspb8 chr5:116408490-116422864 -0.65297 0.002615 
NM_031166 Id4 chr13:48044230-48264036 -0.6833 0.001451 
NM_001112715 Ifitm1 chr7:140967428-140969827 -1.19295 0.001451 
NM_008988 Igdcc3 chr9:65141188-65185870 -0.75362 0.001451 
NM_010518 Igfbp5 chr1:72858064-72874865 -0.6407 0.001451 
NM_177591 Igsf1 chrX:49782536-49797745 -0.97211 0.002615 
NM_018738 Igtp chr11:58199555-58207592 -0.93694 0.001451 
NM_011772 Ikzf4 chr10:128632414-128645993 -0.98324 0.001451 
NM_008349 Il10rb chr16:91406234-91425834 -1.00229 0.010258 
NM_172786 Il20ra chr10:19712586-19760053 0.686806 0.013563 
NM_001164528 Ildr2 chr1:166254138-166316832 -0.89211 0.001451 
NM_011830 Impdh2 chr9:108560500-108565566 0.65436 0.010258 
NM_001136270 Inafm1 chr7:16272012-16273692 0.981794 0.008818 
NM_175515 Intu chr3:40540766-40704774 -0.69049 0.001451 
NM_008393 Irx3 chr8:91798510-91801654 -1.10608 0.001451 
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NM_018826 Irx5 chr8:92357795-92361456 -1.10616 0.001451 
NM_010588 Jag2 chr12:112908589-112929495 0.683042 0.003645 
NM_010591 Jun chr4:95049035-95052222 0.648298 0.001451 
NM_152923 Kcnq3 chr15:65994914-66286224 -0.77391 0.002615 
NM_001039472 Kif21b chr1:136131400-136178014 0.6251 0.001451 
NM_008447 Kif5a chr10:127225694-127263363 1.61143 0.001451 
NM_033563 Klf7 chr1:64035670-64121389 0.687312 0.001451 
NM_026167 Klhl13 chrX:23219270-23365082 -0.60127 0.001451 
NM_029436 Klhl24 chr16:20097553-20127744 -0.59553 0.001451 
NM_001163020 Klhl32 chr4:24617272-24851086 -1.02064 0.004643 
NM_001083322 Klrk1 chr6:129610322-129623864 -0.61138 0.009538 
NM_026412 Knstrn chr2:118814002-118836212 -0.63751 0.001451 
NM_024291 Ky chr9:102506137-102546239 0.991254 0.001451 
NM_026038 L3hypdh chr12:72073427-72085313 -1.07399 0.019402 
NM_008482 Lamb1 chr12:31265293-31329639 -0.58562 0.001451 
NM_177356 Lamp3 chr16:19653380-19706365 0.977188 0.001451 
NM_033521 Laptm4b chr15:34238025-34284295 -0.70194 0.001451 
NR_038063 Rplp2-ps1 chr12:75630593-75669537 0.588396 0.001451 
NM_153168 Lars2 chr9:123366939-123462664 0.712285 0.001451 
NM_001276402 Lef1 chr3:131110296-131224357 -1.26171 0.001451 
NM_134093 Letmd1 chr15:100469033-100479252 -0.69564 0.001451 
NM_008499 Lhx5 chr5:120431885-120441457 0.738453 0.001451 
NM_010720 Lipg chr18:74939321-74961263 1.06835 0.001451 
NM_145438 Llgl2 chr11:115824057-115855780 0.72233 0.023031 
NM_020295 Lmbr1 chr5:29229801-29378390 -0.8475 0.001451 
NM_028050 Lmntd2 chr7:141194129-141214080 -0.99499 0.047777 
NM_001142335 Lmo2 chr2:103957994-103981878 -0.66398 0.023918 
NM_010725 Lmx1b chr2:33564535-33640511 -0.98519 0.049405 
NM_033325 Loxl2 chr14:69609475-69695834 -0.67025 0.001451 
NM_008509 Lpl chr8:68880554-68906932 -0.90333 0.001451 
NM_146164 Lrch4 chr5:137629122-137642902 0.746265 0.008818 
NM_028886 Lrguk chr6:34029447-34134034 -0.96163 0.002615 
NM_029044 Lrrc48 chr11:60353379-60394333 -1.08917 0.013563 
NM_133897 Lrrc8c chr5:105519470-105608954 -0.61585 0.002615 
NM_017405 Lsr chr7:30957769-30973469 1.70253 0.023918 
NM_146006 Lss chr10:76531604-76562226 0.624592 0.001451 
NM_010756 Mafg chr11:120628350-120633547 0.621452 0.001451 
NM_010757 Mafk chr5:139791535-139802652 0.661288 0.004643 
NM_001013813 Maml2 chr9:13619988-13709533 -0.86023 0.001451 
NM_027288 Manba chr3:135485610-135571403 -0.58616 0.001451 
NM_022012 Map3k11 chr19:5689130-5702864 0.592452 0.005539 
212 
 
NM_001048167 Map6 chr7:99267446-99337137 1.00769 0.001451 
NM_198599 Map6d1 chr16:20233308-20241358 -0.65067 0.030178 
NM_001045483 Mapk1ip1 chr7:138835817-138846267 0.676809 0.004643 
NM_011841 Mapk7 chr11:61488811-61494266 0.701916 0.009538 
NM_011162 Mapk8ip1 chr2:92383675-92401263 0.596152 0.006305 
NM_016762 Matn2 chr15:34306680-34436240 -0.77468 0.001451 
NM_001306143 Mbd3 chr10:80392538-80399531 0.951823 0.007984 
NM_001025245 Mbp chr18:82475122-82585637 -0.74582 0.001451 
NM_001085374 Mcc chr18:44425059-44812182 -0.79696 0.008818 
NM_001024703 Mctp2 chr7:72077829-72306595 1.13506 0.001451 
NM_001033259 Mcu chr10:59446983-59616692 -0.62005 0.006305 
NM_010783 Mdfi chr17:47815327-47834691 0.866976 0.001451 
NM_010786 Mdm2 chr10:117688874-117710758 -0.60026 0.031973 
NM_001081979 Mecp2 chrX:74026591-74085690 -0.83667 0.016521 
NM_001045484 Mef2b chr8:70152777-70167488 0.89741 0.036345 
NM_145128 Mgat5 chr1:127204985-127482972 -0.72303 0.001451 
NM_019394 Mia chr7:27179740-27181149 -1.06465 0.046518 
NM_026524 Mid1ip1 chrX:10717364-10719702 0.786363 0.001451 
NR_030711 Mir22hg chr11:75461538-75466690 1.04915 0.017725 
NR_030451 Mir682 chr13:75645045-75645141 3.63846 0.001451 
NR_030484 Mir703 chr5:98329303-98802019 3.18442 0.001451 
NM_177595 Mkx chr18:6934965-7004779 -0.70546 0.022563 
NM_027326 Mllt3 chr4:87769924-88033407 -0.73479 0.001451 
NM_025962 Mmachc chr4:116702433-116708385 -0.62013 0.001451 
NM_175217 Mmd2 chr5:142563480-142608752 -1.02964 0.010258 
NM_011900 Mpdu1 chr11:69655036-69662649 -0.84261 0.001451 
NR_102690 Mphosph9 chr5:124250958-124327972 -0.89529 0.017111 
NM_008624 Mras chr9:99385419-99436712 -0.69322 0.041324 
NM_001005423 Mreg chr1:72159232-72212307 -1.09925 0.001451 
NM_013601 Msx2 chr13:53466880-53472780 -0.78201 0.012253 
NM_029104 Mss51 chr14:20482863-20496901 -0.67742 0.048741 
NM_008638 Mthfd2 chr6:83305703-83317604 0.916797 0.001451 
NM_001081285 Mup6 chr4:60003548-60006214 -1.1367 0.001451 
NM_133250 Mutyh chr4:116807733-116819431 0.669184 0.024857 
NM_138656 Mvd chr8:122433595-122443422 0.732202 0.001451 
NM_026280 Mxra7 chr11:116803399-116828046 -0.94294 0.001451 
NM_001198914 Myb chr10:21124929-21160984 -0.69304 0.024425 
NM_010848 Myb chr10:21124929-21160984 -1.17101 0.001451 
NM_010860 Myl6 chr10:128490860-128493825 0.900494 0.001451 
NM_148413 Myo3a chr2:22227502-22423370 -1.30699 0.002615 
NM_001177965 Naa10 chrX:73916869-73921944 0.601453 0.013563 
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NM_013608 Naca chr10:128035345-128048637 0.901187 0.005539 
NM_028016 Nanog chr6:122707488-122714633 -1.04467 0.001451 
NM_008671 Nap1l2 chrX:103184058-103186664 0.867887 0.004643 
NM_183276 Nbeal2 chr9:110624788-110654161 0.615838 0.015282 
NM_011986 Ncdn chr4:126743749-126753429 0.635131 0.001451 
NM_178772 Nceh1 chr3:27183003-27244911 -0.89574 0.001451 
NM_030729 Nckipsd chr9:108808379-108818366 1.02171 0.001451 
NM_172495 Ncoa7 chr10:30645581-30803107 -0.66906 0.001451 
NM_026614 Ndufa5 chr6:24518665-24527687 -0.67824 0.001451 
NM_025843 Ndufb7 chr8:83566757-83571623 0.754608 0.001451 
NR_131212 Neat1 chr19:5824709-5845480 -0.60987 0.009538 
NM_010896 Neurog1 chr13:56250497-56252163 -1.1792 0.003645 
NM_009719 Neurog3 chr10:62133089-62134763 -2.13204 0.035448 
NM_182716 Nfasc chr1:132564689-132741797 -0.63519 0.023031 
NM_013610 Ninj1 chr13:49187546-49196251 0.773791 0.001451 
NM_023456 Npy chr6:49822728-49829505 -0.85517 0.001451 
NM_008173 Nr3c1 chr18:39410544-39487245 -0.77515 0.001451 
NM_015743 Nr4a3 chr4:48045304-48086446 -0.62853 0.004643 
NM_001146031 Nrcam chr12:44328884-44601846 -0.69916 0.001451 
NM_008744 Ntn1 chr11:68209363-68386826 -0.68339 0.001451 
NM_182809 Ntrk3 chr7:78192113-78577838 -1.01237 0.001451 
NM_027722 Nudt4 chr10:95547006-95564167 -0.73383 0.001451 
NM_001136075 Numb chr12:83794033-83921934 0.898536 0.027823 
NM_001134457 Nxpe3 chr16:55839952-55895279 -0.66164 0.003645 
NM_177215 Ocrl chrX:47912455-47965866 -0.84414 0.001451 
NM_025909 Oma1 chr4:103313845-103366428 -0.6543 0.005539 
NM_026580 Otub2 chr12:103376893-103406350 0.679657 0.001451 
NM_130880 Otud7a chr7:63444771-63759027 1.1083 0.009538 
NM_144841 Otx2 chr14:48657676-48667644 -0.677 0.016521 
NM_007696 Ovgp1 chr3:105973801-105987423 -0.89346 0.001451 
NM_011035 Pak1 chr7:97842938-97912381 -0.59513 0.001451 
NM_181402 Parp11 chr6:127453722-127494239 -0.58677 0.001451 
NM_001291508 Pbx1 chr1:168119363-168432169 -0.78006 0.049158 
NM_025273 Pcbd1 chr10:61089330-61094329 -0.73705 0.036345 
NM_025835 Pccb chr9:100982037-101034875 -0.59621 0.013563 
NM_028994 Pck2 chr14:55540265-55550017 0.984571 0.001451 
NM_172832 Pcyox1l chr18:61696836-61707635 0.763693 0.001451 
NM_024229 Pcyt2 chr11:120610086-120617890 0.6282 0.001451 
NM_133667 Pdk2 chr11:95026257-95041371 -0.82151 0.006305 
NM_001114088 Pdlim7 chr13:55497486-55513446 0.614648 0.030178 
NM_018884 Pdzrn3 chr6:101149606-101377897 -0.64294 0.001451 
214 
 
NM_026441 Pef1 chr4:130107555-130128134 -0.60893 0.002615 
NM_011066 Per2 chr1:91415981-91459328 1.83775 0.001451 
NM_023418 Pgam1 chr19:41911870-41918665 -0.59915 0.001451 
NM_001161797 Phactr4 chr4:132355924-132422446 -0.60023 0.029213 
NM_001109691 Phf21a chr2:92184181-92364666 -0.77591 0.033356 
NM_027949 Phf7 chr14:31237695-31251218 -0.85642 0.001451 
NM_016966 Phgdh chr3:98313170-98339969 0.595831 0.001451 
NM_008832 Phka1 chrX:102513974-102644246 -0.74368 0.001451 
NM_021501 Pias4 chr10:81153965-81167720 0.678756 0.001451 
NM_001039485 Piezo2 chr18:63010212-63387183 -0.74156 0.001451 
NM_025662 Pigk chr3:152714099-152789013 -0.59899 0.001451 
NM_001039536 Pigl chr11:62458459-62513900 -0.82655 0.001451 
NM_027153 Pir chrX:164269430-164373013 -0.68056 0.01595 
NM_134117 Pkdcc chr17:83215282-83225069 0.645349 0.001451 
NM_013737 Pla2g7 chr17:43568450-43612201 -0.79687 0.001451 
NM_013829 Plcb4 chr2:135741829-136013068 -0.88177 0.001451 
NM_172285 Plcg2 chr8:117498290-117635142 -0.61934 0.001451 
NM_146030 Plekhh3 chr11:101162679-101171302 0.818677 0.011607 
NM_001033150 Plekhm2 chr4:141625733-141664115 0.709805 0.003645 
NM_013807 Plk3 chr4:117126812-117133952 0.583309 0.009538 
NM_026162 Plxdc2 chr2:16356303-16755839 -0.60575 0.001451 
NM_026784 Pmvk chr3:89459117-89469009 0.64029 0.001451 
NM_054088 Pnpla3 chr15:84167815-84189521 0.658739 0.003645 
NM_025593 Polr2l chr7:141471859-141475153 0.827479 0.007175 
NM_026398 Pop5 chr5:115235850-115240970 -0.60881 0.002615 
NM_029741 Ppfia3 chr7:45339125-45370564 0.831715 0.004643 
NM_001110218 Ppm1h chr10:122678761-122945793 -0.74186 0.001451 
NM_013636 Ppp1cc chr5:122158278-122175269 0.58589 0.028252 
NM_033371 Ppp1r16a chr15:76671679-76694915 0.667704 0.001451 
NM_199149 Ppp1r37 chr7:19530966-19562398 0.679085 0.003645 
NM_016854 Ppp1r3c chr19:36731730-36736604 -0.85818 0.001451 
NM_008924 Prkar2a chr9:108692142-108749511 -0.6269 0.001451 
NM_011158 Prkar2b chr12:31958478-32061279 -0.63597 0.001451 
NM_016979 Prkx chrX:77762029-77795960 0.720997 0.001451 
NM_011173 Pros1 chr16:62854333-62929340 -0.65183 0.002615 
NM_175485 Prtg chr9:72807273-72917307 -0.66621 0.001451 
NM_177698 Psd3 chr8:67689081-67974574 -0.60862 0.019402 
NM_013640 Psmb10 chr8:105935727-105938392 0.700649 0.020957 
NM_025604 Psmg3 chr5:139823593-139826843 0.947122 0.001451 
NM_133900 Psph chr5:129765557-129787253 0.61375 0.001451 
NM_022415 Ptges chr2:30889470-30903297 -0.6409 0.026781 
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NM_008982 Ptprj chr2:90429755-90580647 -0.86895 0.001451 
NM_008985 Ptprn chr1:75247040-75264208 0.683393 0.034591 
NM_001098233 Purg chr8:33386324-33417469 -0.70958 0.023918 
NM_011224 Pygm chr19:6384428-6398459 0.770995 0.046988 
NM_026111 Qpctl chr7:19140216-19149196 0.588919 0.036874 
NR_045289 Rab26os chr17:24528250-24528744 0.974891 0.001451 
NM_175122 Rab39b chrX:75572044-75578231 1.15471 0.001451 
NM_173781 Rab6b chr9:103112073-103185270 -0.77684 0.001451 
NM_013862 Rabgap1l chr1:160219173-160792938 -0.6667 0.023577 
NM_001038621 Rabgap1l chr1:160219173-160792938 -0.72522 0.015282 
NM_009014 Rad51b chr12:79297281-79814690 -0.62213 0.041698 
NM_019444 Ramp2 chr11:101246333-101248250 -0.77239 0.012963 
NM_028238 Rab38 chr7:88430272-88491572 -1.33228 0.001451 
NM_029182 Rasd2 chr8:75213943-75224113 0.666243 0.031539 
NM_001013386 Rasl10b chr11:83410071-83421038 -0.66979 0.039043 
NM_178045 Rassf4 chr6:116633007-116673836 -0.76871 0.001451 
NM_019711 Rbms2 chr10:128129469-128180297 -0.80459 0.001451 
NM_025654 Rdm1 chr11:101627948-101636081 -0.75331 0.001451 
NM_011261 Reln chr5:21884453-22344705 -0.61762 0.001451 
NM_177073 Relt chr7:100845847-100863413 0.585365 0.043378 
NM_080726 Rem2 chr14:54476099-54480434 0.762426 0.022563 
NM_001085492 Rere chr4:150281915-150621966 -0.73275 0.001451 
NM_001025388 Eno1b chr4:150237196-150248873 1.02201 0.001451 
NM_028713 Rftn2 chr1:55170159-55226782 -0.97699 0.001451 
NM_178615 Rgmb chr17:15806252-15826586 -0.59034 0.001451 
NM_001291210 Rgs19 chr2:181688418-181693977 -1.74472 0.048168 
NM_139228 Rhbdl3 chr11:80300911-80355986 -0.73955 0.001451 
NM_007483 Rhob chr12:8497758-8499985 0.984946 0.001451 
NM_182929 Rims3 chr4:120877868-120891560 0.690133 0.016521 
NM_009066 Ring1 chr17:34020791-34024680 0.677998 0.002615 
NR_001460 Rmrp chr4:43492784-43493059 0.839268 0.001451 
NR_046233 Rn45s chr17:39842996-39848829 1.4549 0.001451 
NM_207623 Rnf138 chr18:21001299-21028224 0.7866 0.006305 
NR_004432 Rnu12 chr15:83149644-83149794 0.767094 0.001451 
NM_013845 Ror1 chr4:100095790-100442545 -1.5786 0.001451 
NM_016738 Rpl13 chr8:123102349-123105242 -0.64125 0.001451 
NM_025586 Rpl15 chr14:18267822-18270986 -0.59677 0.001451 
NM_009077 Rpl18 chr7:45718070-45720835 0.833382 0.001451 
NM_026517 Rpl22l1 chr3:28805510-28807415 -0.66835 0.001451 
NM_022891 Rpl23 chr11:97777525-97782439 0.721106 0.001451 
NM_025592 Rpl35 chr2:38998308-39005131 1.50758 0.001451 
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NM_018730 Rpl36 chr17:56613394-56614246 1.89609 0.017111 
NM_019865 Rpl36a chrX:134585653-134588062 1.54295 0.041324 
NM_001271590 Rpl37rt chr5:115102921-115110268 0.779787 0.010258 
NM_001048057 Rpl38 chr11:114344525-114757886 2.22584 0.014681 
NM_023372 Rpl38 chr11:114344525-114757886 1.28024 0.026333 
NM_016980 Rpl5 chr5:107900527-107987077 -0.69064 0.001451 
NM_011290 Rpl6 chr5:121204500-121209241 1.13705 0.001451 
NM_018853 Rplp1 chr9:61913282-61914510 1.50091 0.001451 
NM_026020 Rplp2 chr7:141447649-141451342 0.899075 0.001451 
NM_026308 Rpp21 chr17:36255672-36257846 -0.66464 0.003645 
NR_024198 Rprl3 chr8:3803124-3803361 1.78531 0.001451 
NM_025963 Rps10 chr17:27630428-27635242 0.867204 0.005539 
NM_025587 Rps21 chr2:180257378-180258444 1.06018 0.001451 
NM_013765 Rps26 chr10:128624528-128626506 0.846086 0.001451 
NM_016959 Rps3a1 chr3:86137939-86142668 1.02828 0.019402 
NM_011300 Rps7 chr12:28630846-28635953 0.917797 0.006305 
NM_001039521 Rrn3 chr16:13780698-13814841 -0.70166 0.001451 
NM_145620 Rrp9 chr9:106477308-106485415 0.633676 0.001451 
NM_028351 Rspo3 chr10:29453106-29535867 -0.87311 0.001451 
NM_053076 Rtn3 chr19:7417624-7483291 -0.6637 0.001451 
NM_001083807 Rusc1 chr3:89083978-89093363 0.746244 0.045806 
NM_016924 Rwdd2b chr16:87433330-87440592 -0.90352 0.001451 
NM_001033288 Sbspon chr1:15853861-15892722 -1.05281 0.001451 
NM_172769 Sc5d chr9:42254176-42264300 0.599921 0.001451 
NM_133199 Scn4a chr11:106318592-106349390 -0.92056 0.001451 
NM_025468 Sec11c chr18:65800577-65817657 0.659179 0.006305 
NM_025483 Senp7 chr16:56075403-56190031 -0.85755 0.001451 
NM_028800 Stk40 chr4:126103956-126141029 0.782848 0.001451 
NM_144907 Sesn2 chr4:132492806-132510456 0.93953 0.001451 
NM_001204875 Set chr2:30061995-30072577 -0.61497 0.007984 
NM_013834 Sfrp1 chr8:23411501-23449632 -0.99608 0.001451 
NM_011361 Sgk1 chr10:21882183-21999902 -0.80874 0.001451 
NM_019989 Sh3bgrl chrX:109095406-109162467 -0.68736 0.001451 
NM_017400 Sh3gl3 chr7:82259907-82307420 -1.3727 0.003645 
NM_001135727 Sh3kbp1 chrX:159627271-159975920 -0.67971 0.001451 
NM_001033415 Shisa3 chr5:67607882-67613987 1.0298 0.001451 
NM_001034874 Shisa6 chr11:66211724-66526126 -0.65868 0.001451 
NM_011382 Six4 chr12:73100258-73113245 -0.61242 0.014141 
NM_028151 Skiv2l2 chr13:112800776-112927380 -1.71634 0.001451 
NM_009197 Slc16a2 chrX:103697413-103821988 -0.65199 0.001451 
NM_001033167 Slc22a23 chr13:34179157-34345182 -0.65022 0.001451 
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NM_020520 Slc25a20 chr9:108662097-108684641 -0.60862 0.026781 
NM_025877 Slc25a23 chr17:57043710-57059863 -0.6546 0.001451 
NM_011989 Slc27a4 chr2:29802679-29817522 -0.58183 0.002615 
NM_146257 Slc29a4 chr5:142702100-142722490 1.04559 0.001451 
NM_172659 Slc2a6 chr2:27021364-27027998 0.777258 0.043378 
NM_001033286 Slc30a10 chr1:185447115-185468761 -0.63632 0.038705 
NM_177732 Slc35d1 chr4:103171717-103214884 -0.63582 0.038244 
NM_029529 Slc35d3 chr10:19847916-19851459 0.705233 0.001451 
NM_153142 Slc35e4 chr11:3907021-3914664 0.752319 0.022043 
NM_001101483 Slc35g2 chr9:100552187-100571085 -1.65674 0.001451 
NM_172479 Slc38a5 chrX:8271380-8280176 -0.69201 0.04692 
NM_001135150 Slc39a8 chr3:135825278-135888572 -0.67724 0.041324 
NM_008577 Slc3a2 chr19:8706881-8723369 0.727574 0.001451 
NM_177388 Slc41a2 chr10:83231138-83337817 -0.6261 0.001451 
NM_001177628 Slc45a3 chr1:131962914-131982972 -0.82108 0.001451 
NM_027872 Slc46a3 chr5:147878440-147894802 -0.58904 0.003645 
NM_053248 Slc5a5 chr8:70882888-70892757 1.6118 0.010258 
NM_178703 Slc6a1 chr6:114282634-114317525 -0.85411 0.001451 
NM_008135 Slc6a9 chr4:117835257-117872470 0.753468 0.002615 
NM_011404 Slc7a5 chr8:121881145-121907686 0.908661 0.001451 
NM_177353 Slc9a7 chrX:20105754-20291764 -0.82088 0.014681 
NM_001161431 Slitrk2 chrX:66649317-66661402 1.08592 0.024857 
NM_198864 Slitrk3 chr3:73048124-73056943 1.80073 0.001451 
NM_025891 Smarcd3 chr5:24592621-24602002 -0.95324 0.031073 
NM_020618 Smarce1 chr11:99209047-99231017 -0.62992 0.001451 
NM_133214 Smco4 chr9:15505494-15545259 -0.84828 0.006305 
NM_138743 Smim11 chr16:92301302-92313041 -0.58627 0.031973 
NM_027885 Smug1 chr15:103153289-103163284 -0.63976 0.001451 
NR_027059 Snhg20 chr11:117076782-117078955 1.20416 0.001451 
NR_003270 Snhg3 chr4:132351932-132353686 0.669058 0.001451 
NR_024068 Snhg7 chr2:26637175-26640244 0.673014 0.001451 
NR_028078 Snora21 chr11:97777525-97782439 2.09124 0.001451 
NR_002897 Snora64 chr17:24720062-24721927 1.22966 0.001451 
NR_002899 Snora70 chrX:74270815-74273135 1.93401 0.001451 
NR_004445 Snord22 chr19:8723486-8726326 0.809997 0.026781 
NR_002898 Snora65 chr2:32961711-32964045 3.85619 0.001451 
NM_001291077 Snph chr2:151590548-151632593 -0.7538 0.012253 
NM_027246 Snrpf chr10:93540631-93605245 0.599943 0.023918 
NM_172951 Sntg2 chr12:30174556-30373375 -1.14183 0.001451 
NM_029655 Snx7 chr3:117781496-117868936 -0.89998 0.031973 
NM_175407 Sobp chr10:43002499-43174530 -0.67377 0.003645 
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NM_172752 Sorbs2 chr8:45507787-45827906 -1.40107 0.007984 
NM_009233 Sox1 chr8:12385770-12436732 -0.82657 0.001451 
NM_011440 Sox14 chr9:99874105-99876170 -1.41483 0.001451 
NM_011448 Sox9 chr11:112782209-112787757 -0.67911 0.002615 
NM_001033277 Spryd3 chr15:102116527-102136215 0.852993 0.001451 
NM_029035 Spsb1 chr4:149896283-149955006 0.671107 0.028252 
NM_013675 Sptb chr12:76580487-76710547 -0.6252 0.014681 
NM_177710 Ssh2 chr11:77216424-77460219 -0.91432 0.014681 
NM_020491 Sssca1 chr19:5730305-5731732 0.650989 0.011607 
NM_138744 Ssx2ip chr3:146404641-146440137 1.1569 0.001451 
NM_001252505 St6gal1 chr16:23224739-23360350 -1.29952 0.001451 
NM_011491 Stc2 chr11:31359440-31370061 0.598009 0.001451 
NM_011505 Stxbp4 chr11:90476492-90638108 -0.67637 0.001451 
NM_001198565 Sulf1 chr1:12692429-12860372 -0.74488 0.001451 
NM_178652 Supt3 chr17:44495986-45119284 -0.61936 0.009538 
NM_201639 Synm chr7:67730160-67759742 -1.12886 0.010258 
NM_021441 Taf1c chr8:119575234-119605240 0.650325 0.009538 
NM_145968 Tagap chr17:7925999-7934897 -0.59555 0.014141 
NM_178598 Tagln2 chr1:172500245-172507375 0.652271 0.001451 
NM_009317 Tal2 chr4:53779704-53786885 -0.92345 0.001451 
NM_001111304 Tbc1d9 chr8:83165351-83272940 0.817801 0.001451 
NM_134023 Tbc1d10a chr11:4186832-4215505 0.636033 0.007175 
NM_146236 Tceal1 chrX:136708064-136709866 0.638177 0.023918 
NM_013736 Tceb3 chr4:136003369-136021649 -0.67177 0.001451 
NM_183289 Tcerg1l chr7:138208971-138397730 -0.79542 0.041698 
NM_001253862 Tcf12 chr9:71844251-72111819 -0.67644 0.002615 
NM_001083967 Tcf4 chr18:69344491-69687967 -0.66943 0.049405 
NM_133986 Tcta chr9:108302957-108305951 0.674032 0.012253 
NM_001166585 Tead1 chr7:112679319-112906805 -0.6288 0.001451 
NM_029464 Tex26 chr5:149439705-149470620 -0.59801 0.009538 
NM_001113417 Thrb chr14:17660959-18038088 -0.69475 0.001451 
NM_001164805 Thsd7a chr6:12311607-12749253 -0.98561 0.001451 
NM_178646 Tigd5 chr15:75909734-75914535 0.782431 0.002615 
NM_013895 Timm13 chr10:80879815-80900969 0.720606 0.001451 
NM_011904 Tll2 chr19:41083980-41206774 -1.18843 0.001451 
NM_145439 Tmc6 chr11:117765984-117780683 0.619196 0.004643 
NM_028876 Tmed5 chr5:108121646-108132591 0.583891 0.001451 
NM_153776 Tmem121 chr12:113185902-113189522 0.975739 0.034184 
NM_026734 Tmem126b chr7:90468828-90475995 0.663002 0.001451 
NM_177735 Tmem130 chr5:144735914-144761578 -1.05168 0.009538 
NM_001034863 Tmem136 chr9:43108652-43116570 -0.58431 0.007175 
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NM_183311 Tmem145 chr7:25306107-25316195 -0.87128 0.014141 
NM_026938 Tmem160 chr7:16452778-16455490 0.935306 0.001451 
NM_177592 Tmem164 chrX:142681399-142843494 -0.69429 0.001451 
NM_025781 Tmem170 chr8:111864897-111876675 -0.61717 0.001451 
NM_001142647 Nemp2 chr1:52630704-52651919 -0.81575 0.043705 
NM_029881 Tmem200a chr10:25991185-26079447 -0.66308 0.001451 
NM_177344 Tmem203 chr2:25255438-25256352 0.729464 0.034591 
NM_001304267 Tmem265 chr7:127561222-127565270 -0.71667 0.004643 
NM_028053 Tmem38b chr4:53826044-53862018 -0.90875 0.001451 
NM_025284 Tmsb10 chr6:72957346-72958748 0.838554 0.001451 
NM_001164155 Tnfrsf19 chr14:60963833-61046855 -0.9432 0.001451 
NM_013869 Tnfrsf19 chr14:60963833-61046855 -1.4039 0.001451 
NM_011613 Tnfsf11 chr14:78277445-78308043 0.87577 0.001451 
NM_001163007 Tnik chr3:28263213-28670585 -0.65381 0.013563 
NM_001081260 Tnks1bp1 chr2:85050459-85073048 0.6225 0.001451 
NM_144812 Tnrc6b chr15:80711312-80941086 -0.93631 0.030178 
NM_024214 Tomm20 chr8:126930663-126945921 -0.58939 0.001451 
NM_016871 Tomm40 chr7:19701312-19715429 0.764291 0.001451 
NM_009423 Traf4 chr11:78158422-78165550 0.704985 0.001451 
NM_146140 Tram1l1 chr3:124321036-124323260 -1.05287 0.007175 
NM_175093 Trib3 chr2:152337424-152344060 1.29086 0.001451 
NM_053166 Trim7 chr11:48826137-48850195 1.02485 0.001451 
NM_001024920 Trp53i13 chr11:77508098-77513273 1.09228 0.024857 
NM_010286 Tsc22d3 chrX:140539528-140600522 1.54305 0.001451 
NM_183180 Tspan18 chr2:93201759-93334487 -0.6342 0.031073 
NM_030203 Tspyl4 chr10:34297420-34301320 0.683652 0.001451 
NM_028341 Ttc39c chr18:12643532-12737052 -0.69344 0.001451 
NM_023279 Tubb3 chr8:123411563-123422010 1.19427 0.001451 
NM_009450 Tubb2a chr13:34074279-34078008 1.19477 0.001451 
NM_001145162 Ube2ql1 chr13:69702831-69739897 -1.00183 0.003645 
NM_011670 Uchl1 chr5:66626494-66687234 0.917756 0.001451 
NM_001029873 Unc13a chr8:71626711-71671757 0.646161 0.001451 
NM_145628 Usp11 chrX:20703908-20720539 -0.67403 0.001451 
NM_009482 Utf1 chr7:139943855-139945112 1.24914 0.001451 
NM_020505 Vav3 chr3:109340682-109685694 -0.64204 0.015282 
NM_001039385 Vgf chr5:137030294-137033351 1.88523 0.046147 
NM_011701 Vim chr2:13574310-13582826 0.85631 0.001451 
NM_146168 Vopp1 chr6:57752263-57825125 -0.64819 0.001451 
NM_027906 Vwa8 chr14:78849177-79202310 -0.63111 0.04692 
NM_001159527 Wdr35 chr12:8974000-9028847 -0.63148 0.001451 
NM_146254 Wdr78 chr4:103038064-103114299 -0.65795 0.020957 
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NM_001163766 Wdr90 chr17:25838837-25861515 0.619682 0.005539 
NM_001037927 Wdr93 chr7:79743162-79785950 -0.68421 0.013563 
NM_011716 Wfs1 chr5:36966103-36988982 0.587721 0.014141 
NM_026582 Wls chr3:159839694-159935175 -0.6339 0.001451 
NM_009290 Wnt8a chr18:34542327-34548061 -1.10869 0.001451 
NM_177618 Wscd1 chr11:71750702-71789646 -0.66894 0.006305 
NM_023500 Xk chrX:9272783-9313245 -0.83567 0.001451 
NM_026940 Ydjc chr16:17139063-17148857 0.754508 0.015282 
NM_023871 Set chr2:30061995-30072577 0.944805 0.04735 
NM_001098723 Yy2 chrX:157547821-157598715 0.939965 0.001451 
NM_181412 Zbed4 chr15:88751710-88784516 -0.66661 0.001451 
NM_001098237 Zbtb3 chr19:8802495-8804854 0.828871 0.021454 
NM_001034907 Zc3h12b chrX:95711677-95927970 -0.77707 0.034184 
NM_172467 Zc3hav1l chr6:38287393-38299259 -0.98878 0.001451 
NM_028673 Zdbf2 chr1:63182570-63314575 -1.37526 0.038705 
NM_175358 Zdhhc15 chrX:104536969-104671064 -0.69514 0.001451 
NM_007496 Zfhx3 chr8:108714643-108961636 0.668829 0.001451 
NM_030708 Zfhx4 chr3:5177823-5415855 -0.86143 0.001451 
NM_172918 Zfp317 chr9:19622090-19649731 -0.60932 0.001451 
NM_172794 Zfp454 chr11:50872722-50887443 -0.58575 0.006305 
NM_024215 Zfp593 chr4:134243305-134245873 0.587058 0.003645 
NM_201609 Zfp652 chr11:95749066-95764713 -0.73182 0.001451 
NM_026521 Zfp706 chr15:36997026-37007402 -0.66711 0.001451 
NM_177747 Zfp711 chrX:112600525-112635062 0.589761 0.024857 
NM_001002008 Zfp948 chr17:21567045-21588682 0.609054 0.001451 
NM_009569 Zfpm1 chr8:122282140-122337247 1.00165 0.002615 
NM_001145778 Zkscan3 chr13:21387003-21402755 -0.92365 0.043017 
NM_001081329 Zkscan2 chr7:123478638-123500449 -1.07394 0.001451 
NM_009517 Zmat3 chr3:32334793-32367438 -0.64369 0.001451 
NM_177086 Zmat4 chr8:23669660-24063116 -0.71334 0.008818 
NM_013859 Znhit2 chr19:6061206-6062468 0.745141 0.025833 
NM_001290819 Zscan29 chr2:121158272-121171125 -0.61533 0.030178 
NM_172503 Zswim4 chr8:84210941-84237042 0.618329 0.001451 
NM_001029912 Zswim5 chr4:116877401-116989105 -0.71061 0.001451 
NM_001167936 Zyg11a chr4:108181933-108217922 -1.18457 0.001451 
Table 9.1: List of statistically significant changes in annotated genes following Skiv2l2 
knockdown in P19 cells. Cuffdiff results in were filtered based on log2(fold_change) , 
denoted as M in table, and q-value (q in table). Annotated genes with M greater than .58 
and q less than .05 were considered elevated. Annotated genes with M less than -.58 and 
q less than .05 were considered downregulated. 
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9.2 Intergenic transcripts dysregulated following Skiv2l2 knockdown in P19 cells 
gene locus log2(fold_change) q_value 
- chr1:72236944-72284314 -6.92682 0.001103 
- chr4:85940115-85940936 -2.83531 0.045344 
- chr12:74331503-74332640 -2.0956 0.038943 
- chr2:16759633-16761414 -1.99871 0.03405 
- chr2:26245805-26249369 -1.88393 0.001103 
- chr18:49795350-49796733 -1.85991 0.002761 
- chr17:27422387-27513691 -1.77807 0.021093 
- chr1:121548071-121549638 -1.63827 0.018943 
- chr19:23199179-23200177 -1.59595 0.029356 
- chr5:76699048-76700997 -1.55665 0.003497 
- chrX:135909349-135911190 -1.52527 0.015721 
- chr9:13536467-13537932 -1.41724 0.048434 
- chr5:104802304-104807950 -1.40667 0.03405 
- chrX:101462310-101465148 -1.38315 0.004143 
- chr3:83357207-83359846 -1.34998 0.005924 
- chr18:7338138-7339976 -1.31332 0.036002 
- chr2:78927085-78928702 -1.3122 0.030571 
- chr4:136137200-136138729 -1.30077 0.026277 
- chr15:43783713-43786070 -1.26752 0.012039 
- chrX:81100675-81104325 -1.24812 0.004143 
- chr14:67671034-67672764 -1.22511 0.028115 
- chr13:115103375-115105227 -1.18968 0.043906 
- chr3:83238886-83300566 -1.17063 0.003497 
- chr7:59933198-59935315 -1.1705 0.01449 
- chr4:85869533-85871458 -1.12941 0.045635 
- chr1:93985685-93986178 -1.12677 0.040415 
- chr8:112916362-112921968 -1.12226 0.001103 
- chr9:13312678-13324261 -1.11505 0.001103 
- chr11:110516272-110523201 -1.11125 0.001103 
- chr8:20122306-20151685 -1.08932 0.001103 
- chr5:76704312-76707514 -1.08093 0.009141 
- chr8:89045569-89058258 -1.07925 0.001103 
- chr9:13498556-13503668 -1.05382 0.001103 
- chr5:58961128-58966274 -1.0289 0.001103 
- chr14:77819895-77823557 -1.02431 0.015296 
- chr5:76691303-76695019 -1.00875 0.004143 
222 
 
- chr9:13453656-13463172 -1.00843 0.001103 
- chr17:75532137-75533053 -1.00482 0.033584 
- chr8:106867719-106870016 -1.00381 0.030839 
- chr6:28211588-28215374 -0.99831 0.003497 
- chr3:121823467-121827805 -0.995 0.001103 
- chr9:13423504-13427542 -0.99398 0.001103 
- chr9:13463643-13498457 -0.98166 0.001103 
- chr2:40557003-40557434 -0.97903 0.001103 
- chr6:90963979-90967574 -0.97659 0.020393 
- chr3:65393577-65396208 -0.97571 0.006501 
- chr1:17768830-17770890 -0.95537 0.038943 
- chr7:92839891-92843766 -0.95122 0.005364 
- chr5:109684721-109685869 -0.94966 0.047876 
- chr12:57498187-57499932 -0.93885 0.047044 
- chr14:18547759-18550506 -0.93634 0.018213 
- chr8:71823610-71842466 -0.91466 0.020734 
- chr8:112937820-112939230 -0.91045 0.045814 
- chr4:149143232-149143466 -0.9019 0.001103 
- chr15:59210894-59211169 -0.88609 0.001103 
- chr1:156424388-156425255 -0.88359 0.001103 
- chr9:32089863-32093108 -0.87011 0.0218 
- chr7:80706451-80709499 -0.85699 0.037903 
- chr1:59713908-59715219 -0.85512 0.001984 
- chr9:13296683-13312443 -0.85346 0.001103 
- chr5:58958633-58961039 -0.8479 0.022171 
- chr16:9567915-9571718 -0.83249 0.001984 
- chr5:58980552-58985853 -0.82958 0.001103 
- chr1:130232372-130253622 -0.82721 0.001103 
- chr13:119613525-119617644 -0.82568 0.001103 
- chr5:58974101-58980419 -0.82343 0.001103 
- chr7:39588901-39591534 -0.82267 0.008667 
- chr9:32074244-32076527 -0.82168 0.031428 
- chrX:134724023-134729224 -0.8089 0.002761 
- chr8:112939686-112944777 -0.80167 0.006501 
- chr3:121829800-121831333 -0.79054 0.013733 
- chr3:101306401-101307192 -0.78318 0.001984 
- chr11:17095521-17095680 -0.78278 0.030839 
- chr9:94541206-94546397 -0.75561 0.003497 
- chr9:92214270-92218587 -0.75489 0.001103 
- chr14:49678669-49679686 -0.75445 0.032233 
- chr18:63543929-63544365 -0.74615 0.001103 
223 
 
- chr5:76684917-76690903 -0.73507 0.008178 
- chr17:15826638-15830661 -0.70561 0.001103 
- chr3:96460501-96467513 -0.70027 0.022438 
- chr5:76658199-76662815 -0.68756 0.013733 
- chr13:106475760-106476824 -0.67866 0.034803 
- chr8:71520119-71525693 -0.67819 0.047044 
- chrX:61405480-61412540 -0.67624 0.01449 
- chr15:31627162-31630305 -0.6725 0.046815 
- chr7:39570671-39573988 -0.67168 0.005924 
- chr3:121833340-121836420 -0.66939 0.002761 
- chr5:76665484-76670185 -0.65429 0.025296 
- chr9:123930060-123934453 -0.63462 0.001103 
- chr6:76284241-76284931 -0.6302 0.016151 
- chr14:49674364-49678586 -0.62442 0.009618 
- chr10:35710554-35711559 -0.6171 0.012039 
- chr12:52570588-52572261 -0.61553 0.03674 
- chr3:104933331-104940758 -0.61469 0.020734 
- chr14:18494286-18514427 -0.61289 0.001103 
- chr3:49185483-49190564 -0.60892 0.039831 
- chr4:85424804-85429767 -0.60717 0.032517 
- chr9:7214760-7221282 -0.60148 0.004143 
- chr9:32058967-32067138 -0.6002 0.007069 
- chr3:49381283-49382579 0.582099 0.004796 
- chr6:122761082-122764642 0.587207 0.03115 
- chr13:83832510-83833263 0.595626 0.001103 
- chr17:17345127-17346199 0.595902 0.001103 
- chrX:60045344-60045916 0.597235 0.044427 
- chr10:37139015-37151953 0.601783 0.029046 
- chr4:122008647-122009473 0.601995 0.001103 
- chr11:120762888-120763212 0.605785 0.001103 
- chr14:52368853-52369291 0.607691 0.027894 
- chr12:4782169-4783512 0.608779 0.005924 
- chr6:35926705-35927122 0.612033 0.032517 
- chr3:19881415-19881726 0.612894 0.018943 
- chr2:36807782-36808427 0.616275 0.001103 
- chr19:57403408-57404282 0.618511 0.009141 
- chrX:109389964-109390256 0.620435 0.007069 
- chr4:100567402-100568050 0.623381 0.002761 
- chr2:146834469-146839495 0.62509 0.016554 
- chr6:49218295-49222769 0.626367 0.019707 
- chr16:4880716-4884302 0.633972 0.01449 
224 
 
- chr7:134660320-134660740 0.638849 0.007637 
- chr8:72156277-72160764 0.642191 0.019707 
- chr1:128520905-128521404 0.64267 0.001103 
- chr7:134661760-134662000 0.64679 0.030571 
- chr6:92087615-92091251 0.648465 0.032233 
- chr1:181282073-181282912 0.649351 0.040675 
- chr18:34954681-34957188 0.651491 0.001103 
- chr4:53791077-53791468 0.653268 0.001103 
- chr19:11958748-11958905 0.666639 0.019707 
- chr3:124385623-124385990 0.667669 0.001103 
- chrX:146599586-146601125 0.673414 0.014135 
- chr11:76600994-76601925 0.673721 0.001103 
- chrX:78856929-78857804 0.677579 0.035407 
- chr3:104752376-104752998 0.680913 0.001103 
- chr4:69854089-69854836 0.680928 0.025626 
- chr5:149660644-149661013 0.683345 0.001984 
- chr6:37805989-37807095 0.687369 0.025626 
- chr8:47675390-47685496 0.688199 0.043172 
- chr3:69314890-69316584 0.691437 0.046815 
- chr19:6152712-6153266 0.69182 0.013733 
- chr17:20661629-20662057 0.691874 0.008178 
- chr12:91590556-91592870 0.69331 0.028719 
- chr8:129263839-129265809 0.694904 0.045635 
- chr13:98613716-98614161 0.699812 0.009141 
- chr15:44282987-44284079 0.704103 0.001103 
- chr12:56189959-56190128 0.704297 0.03586 
- chr14:84758553-84758873 0.707711 0.006501 
- chr6:58017484-58017969 0.710819 0.001103 
- chr2:126677939-126679116 0.717697 0.042045 
- chr17:30576559-30579668 0.7244 0.014135 
- chr1:29737216-29737702 0.72486 0.024679 
- chr7:115172172-115172379 0.725564 0.001103 
- chr17:32852763-32852954 0.736313 0.001103 
- chr14:50978540-50978895 0.736734 0.011101 
- chrX:106283350-106284768 0.738619 0.044185 
- chr5:27860594-27861055 0.739064 0.026681 
- chr7:80990245-80992973 0.74085 0.022438 
- chr6:37686014-37686290 0.744235 0.001103 
- chr15:31531372-31534284 0.744263 0.009141 
- chr15:102397928-102401258 0.748521 0.002761 
- chr2:130284503-130288768 0.754375 0.028447 
225 
 
- chr11:79336194-79339426 0.754526 0.03674 
- chr6:38545281-38545908 0.755505 0.032038 
- chr11:99932294-99933264 0.75727 0.001103 
- chr19:28773052-28773589 0.760004 0.017014 
- chr8:70010114-70011031 0.760958 0.001103 
- chr11:97188563-97191354 0.764144 0.001103 
- chr4:116874045-116876640 0.764429 0.005364 
- chr1:33100883-33101266 0.765155 0.034602 
- chr1:178299351-178299904 0.769144 0.004143 
- chr1:180814319-180817544 0.775863 0.040096 
- chrX:8038794-8039017 0.777078 0.001103 
- chr4:57956584-57966928 0.77927 0.049884 
- chr1:78783634-78784302 0.782275 0.001103 
- chr11:97884545-97885542 0.783795 0.001103 
- chr7:19226501-19228107 0.783818 0.036002 
- chr8:83477343-83477770 0.784305 0.001984 
- chr6:96032931-96033332 0.788598 0.001103 
- chr1:79957562-79958058 0.788979 0.005924 
- chr11:53300595-53301799 0.791706 0.040222 
- chr12:85453890-85455157 0.793197 0.03586 
- chr7:110059904-110061607 0.794218 0.029954 
- chr11:96007457-96012039 0.79518 0.001103 
- chr12:56373556-56373869 0.796783 0.001103 
- chr4:149457291-149457852 0.79813 0.001984 
- chr5:85963078-85966779 0.798534 0.023465 
- chr1:78967610-78968098 0.809539 0.042334 
- chr4:135853337-135855843 0.809789 0.036002 
- chr18:28188650-28189061 0.813861 0.001103 
- chr2:87563376-87563645 0.814539 0.009618 
- chr3:88509105-88510073 0.815134 0.03674 
- chr6:47431790-47433141 0.816384 0.012908 
- chr4:10439478-10439792 0.818542 0.001103 
- chr17:91547931-91548551 0.819418 0.033016 
- chr10:14567222-14567341 0.820002 0.009141 
- chr14:54424698-54426858 0.820402 0.005364 
- chr17:79933462-79933701 0.820839 0.001103 
- chr19:50030164-50030612 0.823044 0.001103 
- chr5:38561891-38564881 0.823637 0.006501 
- chr1:78784403-78784799 0.82591 0.007637 
- chr11:94160605-94162156 0.830475 0.020035 
- chr15:38990482-38990769 0.831446 0.030839 
226 
 
- chr11:6476186-6478362 0.83382 0.018586 
- chr11:98200988-98202892 0.844757 0.032233 
- chr7:110119815-110121754 0.846933 0.029954 
- chr14:62540896-62541547 0.847845 0.001103 
- chr12:54622805-54623144 0.848247 0.001103 
- chr2:154087641-154087874 0.850868 0.002761 
- chr19:15193544-15194002 0.852217 0.001103 
- chr8:124949677-124951899 0.853062 0.044906 
- chr1:118387285-118388886 0.854728 0.009618 
- chr3:8563992-8566074 0.856383 0.027894 
- chr4:132272650-132274306 0.859961 0.028447 
- chr13:23529814-23530941 0.861986 0.033309 
- chr13:21720353-21721761 0.862479 0.04255 
- chr4:143671324-143671672 0.862625 0.012908 
- chr12:118302313-118307366 0.863562 0.001103 
- chr5:121546027-121549607 0.864746 0.014135 
- chr1:30949887-30952025 0.871771 0.032737 
- chr9:91402241-91403376 0.872392 0.001103 
- chr3:88522500-88531570 0.872699 0.02598 
- chr4:72542665-72543083 0.872842 0.022438 
- chr4:23517074-23517823 0.873314 0.048434 
- chr8:117156178-117157862 0.875816 0.040952 
- chr16:90284802-90286988 0.876603 0.013733 
- chr2:14056240-14058576 0.88131 0.0218 
- chr4:152156395-152156612 0.885776 0.029356 
- chr6:149140806-149141380 0.886837 0.037903 
- chr3:63170961-63171433 0.886943 0.01449 
- chr6:57485120-57665279 0.88882 0.001103 
- chr2:30159495-30159797 0.890694 0.011617 
- chr11:6781545-6782784 0.8924 0.012908 
- chr8:43289826-43290037 0.895211 0.001103 
- chr1:4688598-4689239 0.895662 0.001103 
- chr17:88070051-88073616 0.904108 0.008178 
- chr11:58067815-58069226 0.909327 0.04255 
- chr11:49712809-49715102 0.91156 0.011617 
- chr17:88066343-88069956 0.913303 0.001984 
- chr13:54499578-54499776 0.913793 0.001103 
- chr17:19422529-19422788 0.91421 0.009141 
- chrX:106281680-106282184 0.915294 0.011101 
- chr13:3139642-3140129 0.916118 0.001103 
- chr8:122841659-122841957 0.919063 0.039831 
227 
 
- chr16:91513441-91513856 0.919722 0.014135 
- chr13:12679783-12680238 0.926215 0.001984 
- chr4:106908590-106911005 0.926389 0.004143 
- chr1:86486191-86487543 0.927312 0.040096 
- chr6:47787711-47788178 0.928957 0.008667 
- chr2:152399057-152400554 0.930795 0.043645 
- chr15:53346495-53348130 0.93085 0.037676 
- chr7:16399041-16400509 0.930884 0.03405 
- chr5:126025715-126026426 0.937069 0.023465 
- chr11:3193860-3202292 0.937896 0.001103 
- chr1:134093208-134094469 0.940171 0.010606 
- chr2:34769166-34771738 0.941337 0.013321 
- chr11:23304164-23306308 0.943051 0.008667 
- chr5:22471639-22472997 0.944528 0.001984 
- chr12:17346391-17348382 0.94485 0.031734 
- chr4:31961338-31963815 0.946377 0.001984 
- chr11:120633750-120634988 0.946748 0.003497 
- chr2:24179662-24179843 0.947308 0.004143 
- chr1:28800232-28800552 0.949103 0.043172 
- chr12:100744499-100744985 0.951354 0.001103 
- chr14:19985964-19988177 0.952156 0.04114 
- chr7:19318072-19320029 0.954358 0.002761 
- chr17:82539233-82539425 0.955557 0.03674 
- chrX:156442424-156442581 0.956942 0.001103 
- chr10:84308937-84309299 0.959166 0.001103 
- chr5:97822027-97839374 0.959793 0.017855 
- chr1:160213026-160214968 0.95988 0.001984 
- chr19:12796232-12797571 0.96063 0.025626 
- chr6:120663356-120665481 0.962747 0.027894 
- chr12:85374805-85376358 0.968673 0.012501 
- chr9:79760920-79761460 0.974468 0.002761 
- chr12:88334537-88334925 0.975405 0.037349 
- chr11:50325914-50329688 0.980412 0.001103 
- chr14:20641118-20643947 0.981322 0.001984 
- chr16:17734411-17734627 0.981753 0.001103 
- chr5:44405838-44406559 0.990446 0.001103 
- chr2:119477894-119478827 0.992611 0.040096 
- chr17:88856107-88856318 0.996236 0.033016 
- chr4:44234325-44237030 1.00176 0.024679 
- chr15:5464194-5464368 1.00261 0.012039 
- chr6:113045203-113046162 1.00306 0.038161 
228 
 
- chr13:25582999-25583219 1.00563 0.001103 
- chr7:59225871-59228605 1.00584 0.001103 
- chr11:20332940-20334428 1.00592 0.024976 
- chr4:93544950-93545059 1.00594 0.03586 
- chr4:148590250-148591243 1.00708 0.01449 
- chr2:129378391-129378632 1.00819 0.034602 
- chr6:122341035-122341935 1.01015 0.005924 
- chr5:44226796-44243546 1.01269 0.009141 
- chr12:109528890-109530686 1.01747 0.022171 
- chr3:89963453-89966361 1.01812 0.004796 
- chr10:128057482-128058749 1.01851 0.033779 
- chr11:96830212-96831476 1.01924 0.026277 
- chr2:25356461-25357956 1.01944 0.03702 
- chr6:49215702-49217959 1.02088 0.001103 
- chr2:4700288-4700585 1.0217 0.001103 
- chr3:20055350-20057679 1.02486 0.020734 
- chr5:34572287-34573423 1.02883 0.042334 
- chr2:12082984-12083378 1.02887 0.001103 
- chr17:24469536-24470313 1.03428 0.013733 
- chr19:23136154-23138657 1.0354 0.001103 
- chr12:25125125-25126373 1.03624 0.0273 
- chr7:29930814-29965711 1.03671 0.019362 
- chr2:68830993-68831177 1.03992 0.001103 
- chr14:29962413-29968171 1.04022 0.001103 
- chr8:97164402-97164758 1.04299 0.011617 
- chr4:46389535-46390612 1.04328 0.034803 
- chr8:70897593-70899324 1.04389 0.018586 
- chr2:73892954-73893980 1.04591 0.022438 
- chr3:145650069-145653316 1.04685 0.035407 
- chr13:23745668-23746524 1.04964 0.017855 
- chr6:128759970-128760816 1.05321 0.043172 
- chr12:112829723-112831009 1.05444 0.012501 
- chr12:25099670-25100760 1.05544 0.001103 
- chr4:11484505-11484932 1.06036 0.003497 
- chr18:10262478-10262663 1.06065 0.001103 
- chr13:63812854-63815128 1.06097 0.005364 
- chr13:98489476-98489815 1.06289 0.001103 
- chr8:35053276-35053454 1.06295 0.004796 
- chr12:100185542-100187488 1.065 0.001103 
- chr14:52369468-52369869 1.066 0.001103 
- chr2:129379125-129379332 1.06677 0.001103 
229 
 
- chr5:125393209-125394451 1.06789 0.001103 
- chr11:98025471-98026643 1.0746 0.033309 
- chr4:10438710-10439017 1.07754 0.001103 
- chr6:70328013-70328194 1.0784 0.008667 
- chr8:121850150-121852644 1.08195 0.005364 
- chr18:24020906-24022155 1.08523 0.026277 
- chr19:5846023-5846482 1.08623 0.035667 
- chr2:22894325-22895394 1.08718 0.040222 
- chr11:20541122-20542526 1.08774 0.026277 
- chr1:133129861-133131057 1.08915 0.018213 
- chr4:48041128-48042901 1.09407 0.014135 
- chr1:159229837-159231748 1.09417 0.030571 
- chr2:157566486-157568177 1.09508 0.01449 
- chr9:62339512-62340953 1.09628 0.042334 
- chr8:120101771-120105300 1.09884 0.001103 
- chr8:6937971-6939941 1.10194 0.030839 
- chr19:32754613-32755989 1.10248 0.035407 
- chr3:138578274-138578480 1.10514 0.001103 
- chr19:5400229-5401494 1.10783 0.001103 
- chr9:77910954-77913008 1.10865 0.001984 
- chrX:11683921-11684080 1.10904 0.001103 
- chr11:52347846-52358700 1.11104 0.024679 
- chr5:93390553-93391060 1.11135 0.019707 
- chr15:98968808-98970319 1.11231 0.018943 
- chr1:86502438-86504056 1.11288 0.01449 
- chr15:96643094-96644256 1.11349 0.019707 
- chr15:59645894-59648071 1.11529 0.001103 
- chr15:86212961-86214357 1.11592 0.001103 
- chr10:116582101-116583644 1.11637 0.001984 
- chr18:66491581-66491873 1.1229 0.001984 
- chr12:32819134-32820061 1.12882 0.032233 
- chr4:133814405-133818067 1.13054 0.001103 
- chr18:75767108-75767295 1.13112 0.002761 
- chrUn_GL456359:19943-20394 1.1314 0.043436 
- chr2:25365825-25366428 1.13413 0.006501 
- chr19:5325103-5325761 1.13448 0.032233 
- chr10:7956774-7959886 1.13461 0.016554 
- chr15:3217270-3217485 1.1362 0.001103 
- chr8:75108044-75109314 1.13838 0.021093 
- chr1:134059764-134062648 1.14504 0.006501 
- chr3:157888553-157888902 1.14536 0.001103 
230 
 
- chr1:71714248-71714422 1.14752 0.001103 
- chr17:34604327-34605721 1.14793 0.035407 
- chr1:44463842-44464291 1.14873 0.001103 
- chrX:89806465-89806715 1.15022 0.006501 
- chr15:45979752-45980025 1.15148 0.001103 
- chr17:25183201-25184437 1.15156 0.001103 
- chr11:62545140-62550979 1.15287 0.001103 
- chrX:13346008-13347851 1.15344 0.004796 
- chr15:96710198-96711822 1.15716 0.049647 
- chr12:76931278-76931901 1.15738 0.009141 
- chr4:11015494-11015883 1.16038 0.0273 
- chr3:128954961-128955124 1.16279 0.009618 
- chr4:115240444-115240671 1.16686 0.001103 
- chr11:75458668-75461398 1.17266 0.001103 
- chrX:120178941-120179109 1.17361 0.001103 
- chr5:105697072-105699772 1.1752 0.001103 
- chr2:168850787-168851045 1.17635 0.034803 
- chr8:4040071-4040371 1.1773 0.001103 
- chr5:137928153-137928435 1.17862 0.001103 
- chr15:95775824-95775965 1.17974 0.019707 
- chr2:34871128-34872979 1.18279 0.004796 
- chr5:132542611-132542864 1.18327 0.048434 
- chr17:35165105-35167474 1.18397 0.001103 
- chr17:4992836-4994106 1.18417 0.016554 
- chr8:12502712-12504370 1.18643 0.033016 
- chr1:74848341-74851814 1.18844 0.003497 
- chr13:34872738-34874361 1.18927 0.025626 
- chr2:27540404-27542005 1.20427 0.017855 
- chr13:8128310-8128700 1.20732 0.009618 
- chr11:88046242-88047241 1.21079 0.003497 
- chr3:122984765-122988331 1.21296 0.001103 
- chr2:39005290-39007991 1.21444 0.001103 
- chr2:125825782-125827116 1.2155 0.043906 
- chr7:111083325-111084931 1.21866 0.008667 
- chr1:134091888-134093017 1.22194 0.048287 
- chr6:38548663-38551237 1.22463 0.004796 
- chr6:47780490-47780885 1.22697 0.030241 
- chr9:72660515-72662155 1.23167 0.005924 
- chr19:36833234-36834122 1.23287 0.011617 
- chr2:34801438-34802217 1.23497 0.001984 
- chr3:88914049-88915269 1.23613 0.03702 
231 
 
- chr1:177259122-177260696 1.23966 0.028115 
- chr17:24462410-24464543 1.2405 0.001103 
- chr11:102297363-102298663 1.24108 0.021461 
- chr9:108822347-108825179 1.24148 0.001103 
- chr1:146938859-146938982 1.24381 0.020734 
- chr17:37131127-37131345 1.24628 0.001103 
- chr16:16198057-16198222 1.24632 0.001103 
- chr5:34306935-34307226 1.24674 0.018586 
- chr1:10876876-10878406 1.24827 0.032737 
- chr9:96117938-96119196 1.24827 0.03405 
- chr12:106174153-106176220 1.24957 0.024976 
- chr2:146549006-146550386 1.25296 0.017855 
- chr4:106839250-106840027 1.2544 0.03586 
- chr11:11809051-11811288 1.25516 0.001103 
- chr11:69069786-69070727 1.2569 0.036239 
- chr1:43888225-43888419 1.25691 0.001103 
- chr7:73615872-73618176 1.2573 0.001103 
- chr4:127076684-127077226 1.25916 0.001103 
- chr5:57261577-57261711 1.26086 0.001103 
- chr15:3218688-3218895 1.26128 0.001103 
- chr3:157946203-157947205 1.26315 0.033779 
- chr5:113771756-113772424 1.26534 0.005364 
- chr1:58390941-58392724 1.26764 0.003497 
- chr19:6045127-6046399 1.26841 0.003497 
- chr11:33039125-33039696 1.26911 0.001103 
- chr1:10880171-10882321 1.26941 0.044427 
- chr6:148831556-148834106 1.27084 0.001103 
- chr13:5859533-5861133 1.27303 0.001103 
- chr9:123924944-123925311 1.27475 0.005364 
- chr11:85140451-85141471 1.27754 0.032737 
- chr2:22068576-22068938 1.27755 0.019707 
- chr1:152903330-152904699 1.27926 0.003497 
- chr9:53884116-53884468 1.28285 0.002761 
- chr12:19646419-19646575 1.28312 0.023465 
- chrX:153783428-153783538 1.28417 0.001984 
- chr19:28012022-28013167 1.28529 0.028115 
- chrX:77509347-77510607 1.2874 0.007637 
- chr15:98953755-98955023 1.28778 0.024679 
- chr8:18845027-18846147 1.29832 0.039212 
- chr12:20353270-20353384 1.29994 0.020035 
- chr4:118437479-118438771 1.30978 0.032517 
232 
 
- chr11:74724631-74726418 1.31186 0.004143 
- chr7:144940118-144941475 1.31357 0.023186 
- chr2:136678918-136680030 1.31391 0.001103 
- chr16:46497757-46499278 1.31589 0.023186 
- chr5:33532782-33534404 1.31917 0.023465 
- chr15:48888065-48888180 1.31986 0.002761 
- chr7:19665165-19666743 1.31996 0.002761 
- chr4:40117011-40117138 1.31999 0.025296 
- chr12:86885058-86885861 1.32676 0.049647 
- chr6:117879662-117881237 1.336 0.013321 
- chr2:30717350-30718458 1.33646 0.04943 
- chr3:116424236-116425499 1.337 0.006501 
- chr6:7669591-7671610 1.34104 0.001103 
- chr7:128461954-128462922 1.34201 0.01449 
- chr6:149101752-149102646 1.3435 0.048434 
- chr6:122809889-122811223 1.34374 0.001984 
- chr12:72758192-72760835 1.34719 0.001103 
- chr11:62602461-62602708 1.35021 0.045144 
- chr9:110117700-110120078 1.35104 0.001103 
- chrX:154774625-154774889 1.35163 0.022438 
- chr6:87851226-87852254 1.35283 0.038723 
- chr11:31370294-31371289 1.35288 0.016151 
- chrX:151793695-151793879 1.35411 0.007637 
- chr11:60879090-60879808 1.35756 0.009618 
- chr6:128838780-128839831 1.35877 0.001103 
- chr16:22266095-22267077 1.36069 0.021093 
- chr6:148896419-148898621 1.36121 0.006501 
- chr8:31149344-31149965 1.36142 0.001103 
- chr1:19330964-19331325 1.36619 0.011617 
- chr13:23762631-23763567 1.36641 0.008178 
- chr5:9164834-9165077 1.367 0.001103 
- chr4:150912874-150914277 1.36897 0.017014 
- chr4:137387268-137388382 1.37195 0.001103 
- chr5:33530876-33532729 1.37333 0.008667 
- chr8:71745108-71745665 1.37363 0.030571 
- chr4:132513619-132515513 1.37368 0.002761 
- chr7:45016443-45017361 1.37425 0.022438 
- chr13:68156433-68156597 1.37869 0.003497 
- chr7:109516700-109518979 1.37917 0.001103 
- chrX:60046040-60046246 1.37924 0.010606 
- chr7:14304774-14304976 1.38 0.002761 
233 
 
- chr5:108311679-108312722 1.38372 0.005924 
- chrX:91886978-91887347 1.38616 0.044906 
- chr15:12203285-12204792 1.38835 0.023465 
- chr4:39895980-39896124 1.38854 0.03586 
- chr18:10262877-10263285 1.39401 0.006501 
- chr9:77909439-77910481 1.39492 0.031734 
- chr14:56811988-56814751 1.39513 0.001103 
- chr15:37007522-37018719 1.39904 0.001103 
- chr19:53521186-53521871 1.40054 0.002761 
- chr5:149219755-149220590 1.40079 0.033584 
- chr4:105374416-105374606 1.40197 0.001103 
- chr1:134454283-134455284 1.40264 0.030839 
- chr8:47714352-47715456 1.40313 0.018213 
- chr5:28069870-28071078 1.40332 0.004143 
- chr10:119240297-119241300 1.40423 0.031734 
- chr18:61553896-61555050 1.40551 0.009618 
- chr4:73498015-73498180 1.40577 0.001103 
- chr5:121709519-121711344 1.40619 0.001103 
- chr6:43766968-43767287 1.41165 0.005364 
- chr3:90291502-90292900 1.41685 0.024679 
- chr5:57461495-57461592 1.41968 0.03586 
- chr3:131469833-131470922 1.41982 0.023186 
- chrX:95966880-95967753 1.42106 0.040222 
- chr19:44387353-44388542 1.42122 0.017855 
- chr4:108999334-109000448 1.42434 0.009141 
- chr8:19536088-19536264 1.42479 0.001103 
- chr6:37686390-37686574 1.42552 0.001103 
- chr6:145338298-145340731 1.42751 0.001103 
- chr18:61537271-61537668 1.42993 0.003497 
- chr8:97876199-97876479 1.43524 0.001103 
- chr8:84190728-84192651 1.43546 0.001103 
- chr6:136804545-136805655 1.43927 0.011101 
- chr11:94677625-94678698 1.43996 0.036555 
- chr9:102494703-102496925 1.44003 0.006501 
- chr13:58668616-58668799 1.4414 0.001103 
- chr15:81521785-81523271 1.44181 0.002761 
- chr2:164305491-164305599 1.44258 0.040952 
- chrX:157598831-157601173 1.4447 0.008178 
- chr12:87765976-87766294 1.4456 0.024679 
- chr10:31249788-31250028 1.44799 0.001103 
- chr5:64801878-64802809 1.44816 0.009141 
234 
 
- chr2:136677222-136678696 1.45069 0.001984 
- chr8:12439382-12441627 1.45518 0.018213 
- chr2:94158336-94159005 1.4581 0.025296 
- chr15:48889852-48890016 1.4591 0.001103 
- chr15:37170881-37171061 1.46221 0.010123 
- chr5:21056281-21058481 1.46244 0.002761 
- chr2:111183579-111183892 1.46247 0.001984 
- chr18:23953442-23954566 1.4653 0.036239 
- chr15:102672240-102674467 1.46582 0.001103 
- chr1:51940695-51941080 1.46638 0.001103 
- chr7:24529216-24530409 1.46787 0.039212 
- chr14:55539334-55540175 1.46906 0.045814 
- chr2:59610111-59610488 1.47049 0.001103 
- chr1:64122003-64123564 1.47455 0.001103 
- chr7:73618649-73620525 1.47774 0.001103 
- chr2:144165679-144166901 1.48283 0.007637 
- chr5:31220766-31223386 1.49542 0.001103 
- chr11:83471224-83472998 1.49917 0.001984 
- chr1:180849089-180850843 1.50265 0.001984 
- chr4:126102395-126103898 1.50827 0.001103 
- chr3:108911864-108913111 1.5101 0.007069 
- chr17:45164025-45164172 1.51697 0.007069 
- chr2:69591416-69592652 1.52037 0.029708 
- chr5:111329116-111330544 1.52148 0.009141 
- chr9:7837193-7839336 1.52181 0.001103 
- chr13:17805508-17806582 1.52294 0.005924 
- chrX:165680375-165680531 1.52871 0.001103 
- chr18:20549002-20549169 1.53 0.001103 
- chr15:34080426-34082594 1.53327 0.005924 
- chr15:38198586-38199718 1.53541 0.042045 
- chr5:95974094-95974432 1.54059 0.001103 
- chr8:83606578-83607929 1.54259 0.022438 
- chr13:75648132-75648399 1.54338 0.001103 
- chr8:85025603-85026740 1.54911 0.004143 
- chr6:4359402-4359551 1.5523 0.013321 
- chr13:98613419-98613598 1.55268 0.001103 
- chr4:10854928-10855270 1.55697 0.001984 
- chr5:16981096-16981303 1.55746 0.001103 
- chr4:95052749-95054049 1.55816 0.004143 
- chr13:44728888-44729647 1.55862 0.020393 
- chr9:20606302-20607244 1.5608 0.012039 
235 
 
- chr9:95512086-95514174 1.56472 0.001103 
- chr13:77669042-77669145 1.5668 0.001103 
- chr5:129018130-129019671 1.56895 0.012039 
- chr1:152729964-152730573 1.57326 0.001103 
- chr6:149353380-149353524 1.58094 0.001103 
- chr2:129196827-129198378 1.58443 0.001103 
- chr1:111805193-111805325 1.58744 0.001103 
- chr3:35536972-35537272 1.58765 0.001103 
- chr2:167777555-167781230 1.59014 0.001103 
- chr17:10333853-10336091 1.59521 0.011101 
- chr4:34940964-34941217 1.59606 0.005924 
- chr7:16048439-16049238 1.60049 0.010606 
- chr1:134362092-134363207 1.60191 0.027585 
- chr16:91647049-91647663 1.6026 0.040096 
- chr13:14039690-14041342 1.60282 0.003497 
- chr9:115310988-115311923 1.60718 0.023465 
- chr1:52112861-52113711 1.61006 0.008667 
- chr13:64703156-64703444 1.61073 0.001103 
- chr3:32395569-32396888 1.61357 0.046084 
- chr7:43506924-43507344 1.61854 0.001103 
- chr15:76523566-76526378 1.62129 0.001103 
- chr11:97782501-97783650 1.62692 0.008667 
- chr2:55404880-55405814 1.62974 0.004143 
- chrX:131037596-131038757 1.63019 0.008667 
- chr15:81858434-81859136 1.6307 0.023804 
- chr7:16615534-16618539 1.6317 0.001103 
- chr6:29346611-29347736 1.63262 0.001103 
- chr11:83290674-83291555 1.63847 0.027894 
- chr6:72900384-72902704 1.63885 0.001103 
- chr14:62540394-62540795 1.64009 0.001103 
- chr19:32867483-32868534 1.64387 0.001103 
- chr11:20113466-20114320 1.64489 0.010606 
- chr11:72688844-72689884 1.64562 0.009618 
- chr13:91808227-91809273 1.64753 0.027585 
- chr2:104821159-104821712 1.65033 0.001103 
- chr2:140066888-140068595 1.65264 0.004796 
- chr5:125392240-125393149 1.65801 0.048636 
- chr6:58091565-58091712 1.66405 0.005364 
- chr5:142821739-142822382 1.66434 0.01449 
- chr2:32271913-32272184 1.66486 0.001103 
- chr1:72805184-72806125 1.66498 0.001103 
236 
 
- chr13:3139114-3139519 1.66754 0.010123 
- chr1:77066639-77066794 1.66762 0.001103 
- chr10:73202534-73202853 1.66866 0.001103 
- chr1:151520598-151520757 1.6751 0.001103 
- chr12:110696838-110697507 1.67514 0.032233 
- chr2:69721600-69722761 1.67575 0.009618 
- chr5:29194265-29195776 1.678 0.001984 
- chr18:50208988-50209147 1.67813 0.001103 
- chr15:77971146-77972271 1.68563 0.004143 
- chrX:78855464-78855874 1.69385 0.004796 
- chr5:43948235-43949246 1.69581 0.023804 
- chr16:91513952-91514128 1.70455 0.001103 
- chr3:108240241-108241886 1.70458 0.034803 
- chr19:24901586-24902761 1.7057 0.013733 
- chrX:74007122-74007375 1.70815 0.001103 
- chr2:86325790-86325927 1.71169 0.001103 
- chr13:77670296-77670434 1.71973 0.001103 
- chr1:101386086-101386353 1.72035 0.001103 
- chr6:47813776-47815102 1.72118 0.002761 
- chr16:65793764-65793927 1.7212 0.004143 
- chr10:91171965-91172725 1.72144 0.002761 
- chr2:104820276-104820437 1.72207 0.001103 
- chr11:33163353-33164543 1.7305 0.004143 
- chr4:70535357-70536542 1.73734 0.005924 
- chr2:28477092-28477578 1.74066 0.001103 
- chr1:71709715-71709870 1.74227 0.001103 
- chrX:20528302-20528459 1.74447 0.001103 
- chr7:97370845-97371523 1.74451 0.015721 
- chr16:30061984-30063254 1.76014 0.04114 
- chr12:80114478-80115351 1.76691 0.04943 
- chr4:140698617-140701273 1.76746 0.001103 
- chr3:63173128-63173326 1.7764 0.001103 
- chr12:31018684-31018811 1.77886 0.001103 
- chr11:100318622-100319722 1.78112 0.010123 
- chr19:36924394-36926015 1.7853 0.003497 
- chr14:19351418-19351601 1.79327 0.001103 
- chr18:57119793-57119920 1.79483 0.036002 
- chr1:17399372-17399560 1.79613 0.007069 
- chr2:92055601-92056507 1.7994 0.04812 
- chr5:65698470-65699588 1.79963 0.007069 
- chrX:60426185-60426362 1.80354 0.001103 
237 
 
- chr13:58129100-58130292 1.80425 0.001103 
- chr11:111276052-111276182 1.80549 0.001103 
- chr14:13902040-13902289 1.81552 0.001103 
- chr10:59952077-59952755 1.81646 0.018213 
- chr17:65614090-65615151 1.81657 0.045814 
- chr16:17735140-17735267 1.81717 0.046566 
- chr1:51478629-51479824 1.81793 0.002761 
- chrX:141982126-141982292 1.82536 0.001103 
- chr9:42264458-42265918 1.82897 0.006501 
- chr17:80207477-80208593 1.83148 0.043172 
- chr7:55793043-55794043 1.84908 0.021461 
- chr1:144312256-144312408 1.85537 0.001103 
- chr1:33101498-33101671 1.85773 0.001103 
- chr2:4833302-4833707 1.85789 0.001103 
- chr15:81464585-81466068 1.86061 0.011101 
- chr11:100528156-100528998 1.86956 0.042942 
- chr3:27013326-27013467 1.87225 0.017014 
- chr4:137388456-137389409 1.87292 0.042942 
- chrX:114857959-114858093 1.87544 0.001103 
- chr11:94742017-94742558 1.87771 0.001103 
- chr14:62331106-62331996 1.87889 0.044185 
- chr3:104753112-104753274 1.88201 0.001103 
- chrX:89802985-89803141 1.89893 0.001103 
- chr12:25100874-25102109 1.90264 0.045144 
- chr17:53361057-53361333 1.90414 0.03115 
- chr9:14274506-14276159 1.90423 0.040222 
- chr6:39591337-39592449 1.90683 0.016554 
- chr3:95015595-95016479 1.91411 0.035407 
- chr1:4687876-4688186 1.91633 0.001103 
- chr18:84658884-84659051 1.91805 0.001103 
- chrX:116886923-116887191 1.92294 0.004796 
- chr7:144894160-144895774 1.92561 0.001103 
- chr2:107011179-107011322 1.92633 0.012908 
- chr3:123508637-123509188 1.9286 0.036239 
- chr11:52230813-52231897 1.94267 0.03513 
- chrX:36806413-36807961 1.94291 0.001103 
- chr2:24179967-24180109 1.94421 0.001103 
- chr1:164247775-164248734 1.94551 0.017448 
- chr18:38360161-38360416 1.94668 0.004143 
- chr19:28763373-28763519 1.94756 0.001103 
- chr18:64288501-64288782 1.95683 0.001103 
238 
 
- chr17:45163689-45163967 1.96373 0.038723 
- chr11:96248600-96248779 1.96822 0.001103 
- chr6:73528918-73529064 1.96897 0.001103 
- chr9:105545549-105545762 1.96967 0.001103 
- chr6:38365720-38365900 1.97559 0.032737 
- chr11:93995085-93995852 1.9781 0.038161 
- chr5:117059357-117059535 1.9788 0.001103 
- chr5:142367863-142368559 2.01278 0.024418 
- chr6:39558469-39559022 2.0203 0.009618 
- chr9:95636483-95637305 2.02126 0.043645 
- chr11:78550958-78551907 2.02175 0.008178 
- chrX:68319699-68319841 2.03223 0.001103 
- chr2:109889268-109890699 2.03709 0.029046 
- chr2:15128339-15128527 2.03746 0.001103 
- chr7:41335381-41335486 2.04956 0.01449 
- chr9:114844323-114844761 2.06786 0.045344 
- chr11:20115857-20117101 2.07571 0.007069 
- chr1:60901276-60901437 2.08523 0.001103 
- chr15:89766659-89766782 2.109 0.001103 
- chr5:146831946-146832743 2.12287 0.022171 
- chr4:146944232-146944332 2.12623 0.001103 
- chrX:90744663-90744820 2.14101 0.001103 
- chr13:8030821-8030986 2.14347 0.001103 
- chr11:79905989-79906125 2.14453 0.001103 
- chr5:123058253-123059066 2.15079 0.038943 
- chr13:119791383-119791762 2.16542 0.038943 
- chr10:51414802-51415267 2.16855 0.038943 
- chr4:73498312-73498504 2.17309 0.001103 
- chr10:5792106-5792260 2.17657 0.001103 
- chr15:99898389-99898496 2.18291 0.001103 
- chr7:7097434-7097688 2.18452 0.001103 
- chrX:140797524-140797770 2.20347 0.007637 
- chrX:77757246-77757342 2.20916 0.023465 
- chrX:106282534-106282674 2.21024 0.001103 
- chrX:94775205-94775348 2.23636 0.001103 
- chr12:24828390-24830858 2.24061 0.001103 
- chr11:6414143-6415657 2.24858 0.001103 
- chr8:4391967-4392147 2.25204 0.001103 
- chr4:52361743-52361891 2.27493 0.001103 
- chr10:59952823-59953467 2.27513 0.033016 
- chr5:46855978-46857025 2.27696 0.040415 
239 
 
- chr2:4832532-4832716 2.29292 0.001103 
- chr13:78953973-78954125 2.30384 0.006501 
- chr19:37784277-37784384 2.3096 0.001103 
- chr7:104692862-104693074 2.31044 0.001103 
- chr7:116598243-116598423 2.31537 0.001103 
- chr8:19536642-19536753 2.31574 0.001103 
- chr6:7194539-7194665 2.32097 0.001103 
- chr6:71829311-71830655 2.32918 0.033779 
- chr4:148068374-148068534 2.33227 0.001103 
- chr11:100243257-100243667 2.34043 0.029356 
- chr18:79935418-79935557 2.35807 0.001984 
- chr4:98922125-98922839 2.36514 0.02598 
- chr3:37599507-37599697 2.37228 0.010123 
- chr9:99946596-99946764 2.37342 0.018213 
- chr5:142852772-142853150 2.374 0.040675 
- chr1:33372847-33372987 2.3792 0.004143 
- chrX:60483598-60807993 2.38083 0.001103 
- chr15:45979397-45979548 2.38899 0.001103 
- chr4:119294918-119295766 2.39199 0.019362 
- chr17:50227661-50227831 2.39392 0.001103 
- chr11:83299062-83299530 2.39576 0.022171 
- chrX:91887838-91887950 2.40122 0.001103 
- chr2:149356923-149357034 2.40145 0.001103 
- chr7:99358898-99360254 2.41427 0.037349 
- chr17:20570374-20570535 2.44155 0.038161 
- chr5:62004383-62004524 2.44335 0.001103 
- chr7:14307862-14307987 2.46089 0.036555 
- chr7:11845276-11845387 2.50775 0.001103 
- chr2:71367648-71389077 2.51586 0.047876 
- chr11:15049205-15049321 2.52981 0.001103 
- chrX:77757531-77757759 2.53286 0.014135 
- chr16:23718457-23718572 2.53476 0.018586 
- chrX:76919952-76920072 2.53666 0.001103 
- chr7:17686166-17686304 2.54056 0.001103 
- chrX:48010008-48010193 2.55573 0.001103 
- chr2:111182621-111182780 2.55629 0.010123 
- chr17:73870713-73870846 2.56105 0.003497 
- chrX:108893479-108893585 2.57209 0.015296 
- chr15:71310413-71310564 2.57362 0.026681 
- chrX:91887583-91887695 2.585 0.001984 
- chr15:37171394-37171632 2.58566 0.001103 
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- chr1:24595238-24595420 2.58719 0.001103 
- chr3:67607454-67607779 2.62348 0.0273 
- chr16:51363678-51363879 2.63384 0.001103 
- chr2:86328167-86328318 2.63519 0.009141 
- chr8:19537774-19537962 2.63669 0.001103 
- chr10:119090817-119090917 2.64469 0.016554 
- chr18:28188358-28188503 2.64987 0.001103 
- chrX:60483598-60807993 2.67167 0.001103 
- chr3:69716974-69717133 2.69908 0.001103 
- chrX:13302244-13302402 2.72137 0.001103 
- chr15:37172172-37172286 2.73691 0.011101 
- chrX:36213541-36213680 2.75248 0.001103 
- chr3:65968898-65968995 2.75457 0.019362 
- chr16:28951309-28951415 2.75626 0.001984 
- chr18:4485104-4485214 2.76269 0.005924 
- chr17:37842327-37842446 2.76587 0.001103 
- chr17:15846395-15846507 2.77806 0.005924 
- chr13:74533833-74533948 2.77915 0.001103 
- chr14:33213263-33213364 2.78397 0.001103 
- chr10:58757362-58757485 2.7987 0.005924 
- chr5:142622654-142622779 2.82212 0.001103 
- chr3:59431738-59431880 2.82982 0.001103 
- chr9:3495535-3495677 2.83013 0.015296 
- chr12:25099127-25099454 2.83913 0.04628 
- chr16:93630112-93630226 2.84453 0.020734 
- chr18:84659678-84659834 2.84691 0.001103 
- chr8:40855573-40855699 2.85104 0.04943 
- chr9:26960904-26961022 2.92627 0.005364 
- chr1:191992848-191992991 2.93307 0.001103 
- chr3:57362598-57362733 2.9421 0.001103 
- chr3:107631854-107632599 2.96617 0.04628 
- chr16:45205370-45205504 2.97082 0.049647 
- chr12:109540174-109540814 2.98365 0.04628 
- chr14:60141337-60141461 3.00512 0.001103 
- chr8:104845665-104845769 3.01518 0.013321 
- chr11:48996959-48997061 3.02097 0.01449 
- chr14:74297967-74298075 3.02396 0.001103 
- chr11:34833740-34835895 3.02928 0.002761 
- chr1:55127977-55128115 3.08939 0.013321 
- chrX:13303919-13304067 3.09451 0.001103 
- chr2:110209294-110209437 3.09829 0.001103 
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- chr12:70823882-70824985 3.1017 0.040675 
- chr4:10853714-10853889 3.10531 0.001103 
- chr1:89049087-89049199 3.12271 0.013321 
- chr3:65613855-65614075 3.12736 0.009618 
- chr13:3138930-3139041 3.15054 0.013321 
- chr2:142577083-142577252 3.20222 0.038943 
- chr4:143460099-143460212 3.23329 0.001103 
- chr2:87333831-87333952 3.25181 0.044631 
- chr6:79541406-79541541 3.27795 0.049211 
- chr6:7194971-7195086 3.27853 0.049884 
- chr17:37842030-37842141 3.32808 0.009618 
- chr2:147642931-147643032 3.33003 0.001103 
- chr16:23050623-23050746 3.34296 0.001103 
- chr7:52755408-52755509 3.34362 0.009141 
- chr13:58546281-58546384 3.381 0.001103 
- chr14:120713290-120713427 3.39064 0.001103 
- chr1:27991041-27991195 3.39678 0.001103 
- chr5:100513237-100513368 3.41181 0.034803 
- chrX:109390401-109390496 3.42242 0.008178 
- chr6:117473188-117473309 3.43593 0.036002 
- chr9:3497050-3497157 3.436 0.001103 
- chrX:60045122-60045236 3.4454 0.028719 
- chr13:97015008-97015134 3.52559 0.001984 
- chr19:11438294-11438491 3.53981 0.008667 
- chr4:10946588-10946687 3.68159 0.008178 
- chr7:25792722-25792845 3.69701 0.005364 
- chr1:43887989-43888102 3.70033 0.001103 
- chr4:52900649-52900764 3.70393 0.001103 
- chr1:14550776-14550883 3.7342 0.032737 
- chr11:58097119-58097236 3.75938 0.032737 
- chrX:85793229-85793452 3.7595 0.024418 
- chr17:50228085-50228197 3.78372 0.005364 
- chr5:137928628-137928767 3.78918 0.007069 
- chr7:41326383-41326504 3.81308 0.027585 
- chr15:56414802-56414905 3.81341 0.004796 
- chr2:50522888-50523003 3.83666 0.005364 
- chr18:20548675-20548788 3.8378 0.001103 
- chr2:172100871-172100996 3.87478 0.005364 
- chr3:90760929-90761046 3.90302 0.004143 
- chr7:41048716-41048822 3.94659 0.024418 
- chr4:59162886-59163008 3.96784 0.001103 
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- chr13:101349017-101349118 4.01117 0.001103 
- chr3:98821083-98821190 4.04647 0.002761 
- chr7:125547973-125548172 4.0624 0.002761 
- chr15:37171878-37171989 4.17182 0.024152 
- chr6:109126188-109126284 4.21118 0.024152 
- chr9:79346923-79347034 4.25135 0.001103 
- chr17:41102021-41102121 4.38416 0.024152 
- chr15:44281892-44282061 4.44334 0.033779 
- chr11:60816475-60816570 1000 0.001103 
- chr17:53196690-53196823 1000 0.001103 
- chr2:154789851-154790396 1000 0.001103 
- chr3:57963314-57963411 1000 0.001103 
- chr4:56643774-56644303 1000 0.001103 
- chr5:125465001-125465663 1000 0.001103 
- chr9:32369156-32369533 1000 0.001103 
Table 9.2: List of statistically significant changes in intergenic regions following Skiv2l2 
knockdown in P19 cells. Cuffdiff results were filtered based on M and q. Intergenic 
regions (loci with no geneID) with M greater than .58  and q-values less than .05 were 
considered elevated. Intergenic regions (loci with no geneID) with M or less than -.58 
and q less than .05 were considered downregulated. 
9.3 Transcripts of interest dysregulated following Skiv2l2 knockdown in P19 cells 
Gene ID  Gene Symbol 
RNA levels in Skiv2l2 knockdown 
cells 
NR_035500 mir1983 accumulating 
NR_030451 mir681 accumulating 
NR_024198 RPRl3 accumulating 
NR_030484 Mir703 accumulating 
NR_002898 snoRNA65 accumulating 
NR_033595 Gm13498  accumulating 
NR_002899 snoRNA70 accumulating 
NR_046233 Rn45s accumulating 
NR_002142 A930003A15Rik accumulating 
NR_028515 Snora78 accumulating 
NR_001460 Rmrp accumulating 
NR_002897 Snora64 accumulating 
NR_045268 2810013P06Rik accumulating 
NR_029432 1500015A07Rik accumulating 
NR_027059 Snhg20 accumulating 
NR_045618 Gm9958 accumulating 
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NR_028078 Snora21 accumulating 
NR_045289 RAB26 accumulating 
NR_027923 C630043F03Rik accumulating 
NR_036602 4933421O10Rik accumulating 
NR_027987 C030016D13Rik accumulating 
NR_030677 BC025920 accumulating 
NR_004432 Rnu12 accumulating 
NR_040469 5031425E22Rik accumulating 
NR_030695 B330016D10Rik accumulating 
NR_003363 Gm6548 accumulating 
NR_040708 E130102H24Rik accumulating 
NR_024078 Btbd19 accumulating 
NR_024068 Snhg7 accumulating 
NR_015601 Fam120aos accumulating 
NR_028421 D430020J02Rik accumulating 
NR_015552 5330434G04Rik accumulating 
NR_026848 C030034I22Rik accumulating 
NR_015510 4632427E13Rik accumulating 
NR_029440 2010320M18Rik accumulating 
NR_029441 2810454H06Rik accumulating 
NR_003964 Tubb2a-ps2 accumulating 
NR_004445 Snord22 accumulating 
NR_030711 Mir22hg accumulating 
NR_027446 A230072C01Rik accumulating 
NR_027958 D930048N14Rik accumulating 
NR_015476 1500011K16Rik accumulating 
NR_033601 4930519F09Rik accumulating 
NR_033599 Gm6682 accumulating 
NR_027009 Gt(ROSA)26Sor accumulating 
NR_033215 3000002C10Rik accumulating 
NR_033780 2810001G20Rik accumulating 
NR_033619 Gm6623 accumulating 
NR_130973 H19 downregulated 
NR_038037 E130307A14Rik downregulated 
NR_040286 Gm11627 downregulated 
NR_033641 Crnde downregulated 
NR_028428 2610005L07Rik downregulated 
NR_102690 
M-phase phosphoprotein 9 
(Mphosph9) downregulated 
NR_131212 Neat1 downregulated 
NR_015517 5930412G12Rik downregulated 
NR_028263 B130006D01Rik downregulated 
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NR_015555 4933404O12Rik downregulated 
NR_004442 Gm15421 downregulated 
NR_015488 A930003A15Rik downregulated 
Table 9.3: Non-coding RNAs dysregulated in P19 cells following Skiv2l2 knockdown. 
RNA levels were deemed as accumulating if M>0.3 and downregulated if M<-0.3. For all 
M values, q <0.05.  
Gene ID  Gene Symbol RNA levels in Skiv2l2 knockdown cells 
NM_018853 Rplp1 upregulated 
NM_011290 Rpl6 upregulated 
NM_025587 Rps21 upregulated 
NM_025592 Rpl35 upregulated 
NM_013765 Rps26 upregulated 
NM_009077 Rpl18 upregulated 
NM_022891 Rpl23 upregulated 
NM_013721 Rpl7a upregulated 
NM_001048057 Rpl38 upregulated 
NR_038063 Rplp2-ps1 upregulated 
NM_026020 Rplp2 upregulated 
NM_018730 Rpl36 upregulated 
NM_011300 Rps7 upregulated 
NM_020600 Rps14 upregulated 
NM_025963 Rps10 upregulated 
NM_016959 Rps3a1 upregulated 
NM_001271590 Rpl37rt upregulated 
NM_023372 Rpl38 upregulated 
NM_019865 Rpl36a upregulated 
NM_007475 Rplp0 upregulated 
NM_023133 Rps19 upregulated 
NM_026768 Mrps18a upregulated 
NM_026055 Rpl39 downregulated 
NM_009096 Rps6 downregulated 
NM_016980 Rpl5 downregulated 
NM_025586 Rpl15 downregulated 
NM_016738 Rpl13 downregulated 
NM_026517 Rpl22l1 downregulated 
Table 9.4: Ribosomal protein mRNAs dysregulated in P19 cells following Skiv2l2 
knockdown. RNA levels were deemed as accumulating if M>0.3 and downregulated if 
M<-0.3. For all M values, q <0.05. 
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